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Abstract
The spindle checkpoint ensures the fidelity of chromosome segregation by
delaying anaphase until all sister chromatids form proper bipolar attachments to the
mitotic spindle. Spindle checkpoint proteins localize to unattached or maloriented
kinetochores in mitosis and generate a signal that prevents dissolution of sister chromatid
cohesion. Checkpoint signaling requires binding of Mad2 to the checkpoint protein
Madl and Cdc20, a subunit of the Anaphase Promoting Complex. We have
characterized the interactions of human Mad2 with Madl, Cdc20, and CMT2, a
checkpoint inhibitor. Cdc20 and Madl form competitive high affinity complexes through
contacts in the peptide binding cleft of Mad2, while CMT2 binds noncompetitively to the
closed conformation of the Mad2 C-terminus. I propose a model by which conformation-
specific binding of CMT2 silences Mad2 signal generation.
The requirement for active checkpoint inhibition in mitosis is not known. We
examined the role of CMT2 in mitosis by fixed- and live-cell microscopy. CMT2
localizes to kinetochores in a Mad2-dependent manner and forms ternary complexes with
Madl-Mad2 and Cdc20-Mad2 in vivo. Surprisingly, CMT2 is required for completion of
mitosis even in the absence of spindle damage. I show that CMT2 opposes Mad2
function at kinetochores and in the cytosol and propose that active silencing of the Mad2-
dependent checkpoint is required for completion of mammalian mitosis.
Thesis Supervisor: Peter K. Sorger
Title: Professor of Biology, Professor of Biological Engineering
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Chapter 1
The Spindle Checkpoint
6
1.1 Introduction: Mitosis, Genomic Stability, and the Spindle Checkpoint
A critical problem for the dividing eukaryotic cell is to ensure that its progeny
receive exactly one copy of every chromosome. Chromosome segregation, the process
by which a duplicated genome is equally partitioned into daughter cells, requires that
sister chromatid pairs form bipolar attachments to opposite ends of the mitotic spindle.
Because these attachments form through a stochastic search-and-capture mechanism, the
time required for spindle assembly and complete chromosome attachment may vary
widely from cell to cell. The spindle checkpoint ensures that the dissolution of sister
chromatic cohesion, and hence entry into anaphase and chromosome disjunction, does
not occur until the last chromosome pair has become properly attached to the spindle. In
this way, the irreversible steps of cell-cycle progression are made dependent on an error-
checking mechanism. This chapter examines the mechanistic details of the spindle
checkpoint and compares them with other cell cycle checkpoints.
Because mitotic chromosomes can be visualized by light microscopy, their
complex movements have been studied by cytologists for over a century. Even before
Thomas Hunt Morgan demonstrated that chromosomes were the objects of genetic
transmission, their role in the pathobiology of human disease was suspected. Theodor
Boveri and Walter Sutton both noted the abnormal chromosome complement of tumor
cells compared to normal neighboring cells. In the intervening century, the association of
aneuploidy and tumorigenesis has been firmly established. Because genome instability
drives tumorigenesis (Hanahan and Weinberg, 2000; Kinzler and Vogelstein, 1996), we
must ask whether errors of chromosome segregation contribute to or result from cellular
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transformation. However, the contribution of spindle checkpoint failure to human cancer
is not yet known, and thus there is an urgent need to understand the mechanistic workings
of the checkpoint.
1.2 Cell cycle checkpoints
Cell division requires that several key tasks - genome duplication, chromosome
segregation, and cytokinesis - occur with both high fidelity and in the proper order. To
ensure that each phase does not begin until the previous step is completed free of errors,
and to render movement between phases unidirectional and irreversible, phase-specific
cyclins associate with cyclin-dependent kinases (Cdks) to drive progression through the
cell cycle (Nigg, 2001). Cyclin binding activates Cdks and in many cases directs their
substrate specificity. In metazoans, complexes of Cdk2 with either cyclin E or cyclin A
coordinate the G1/S transition and DNA replication (Hinchcliffe et al., 1999; Meraldi et
al., 1999). Once this is complete, Cdkl/cyclin B complexes orchestrate mitotic events
such as nuclear envelope breakdown (NBD), Golgi fragmentation, centrosome
separation, chromosome condensation, and spindle assembly (Murray, 2004).
Cdkl/cyclin B also phosphorylates and regulates the anaphase promoting complex, or
cyclosome (APC/C). APC/C, a multisubunit ubiquitin ligase, drives the metaphase-
anaphase transition by directing the tagging and proteolysis of securin, thus allowing the
dissolution of sister chromatid cohesion (Cohen-Fix et al., 1996; Visintin et al., 1997).
The events of late mitosis and mitotic exit require the timely and complete inactivation of
Cdkl and destruction of cyclin B, which is itself ubiquitinated by Cdc20-directed APC/C.
Proteolytic destruction of specific cyclin pools extinguishes their activity completely and
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irreversibly, moving the cell cycle forward in a ratchet-like manner. In this way, while
cyclin-dependent kinases and the ubquitination machinery mutually regulate each other,
allowing the coupled, oscillating waves of kinase activity and proteolysis to order the
events of mitosis (Peters, 1999).
1.2.1 Formal definition of a checkpoint
While phase-specific cyclin activity and regulated proteolysis confer the order of
cell division events, cell cycle checkpoints render the transition between phases sensitive
to the completion of key cellular tasks and the presence of errors. The canonical
checkpoint was defined by Weinert and Hartwell in a genetic screen for S. cerevisiae
mutants with an impaired response to DNA damage (Weinert and Hartwell, 1988). After
irradiation with X-rays, wildtype yeast cells arrest in G2 and do not enter mitosis until
genome damage has been resolved. Mutants in the RAD9 gene fail to arrest, enter
mitosis, and show decreased viability after irradiation. Notably, loss of Rad9p does not
alter cell cycle progress or cell viability in the absence of DNA damage, and rad9
mutants survive irradiation if mitosis is prolonged by treatment with nocodazole, a
microtubule depolymerizing agent (Hartwell and Weinert, 1989; Weinert and Hartwell,
1989). These results suggested that the function of Rad9p is not to repair DNA damage
but to delay entry into mitosis until after DNA repair has occurred. Thus, early models
defined checkpoints as cell cycle subroutines that monitor but do not participate in the
underlying cell division process. Formally, a minimal checkpoint is thought to consist of
a sensor, which detects underlying errors; a transducer, which relays and perhaps
amplifies the sensed signal; and an effector, which halts the cell cycle until damage has
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been repaired. In reality, these tasks may rely on shared components, and crosstalk or
feedback between them may exist. Additionally, checkpoints may possess a shutoff step
to ensure that prolonged cell cycle arrest following repair does not impair the health of a
cell.
Since the RAD screen, cell cycle checkpoints that monitor multiple DNA
structural lesions, replication fork progress, unreplicated DNA, spindle position, and
chromosome segregation in mitosis and meiosis have been identified (Bartek et al., 2004;
Yang et al., 1997; Zhou and Elledge, 2000). While many elements of cell cycle
checkpoints are conserved throughout evolution, further characterization of yeast and
metazoan checkpoints has modified the classical model in two broad ways. First, it has
become clear that many checkpoints not only alter the cell cycle but also actively regulate
the appropriate response, i.e. repair or apoptosis. For example, budding yeast Rad24p
participates in both DNA double strand break (DSB) repair and cell cycle arrest (Aylon
and Kupiec, 2003). Second, while classical checkpoint genes are nonessential in yeast
because they do not contribute to core processes, genetic deletion of homologous genes in
higher metazoans has proven lethal (Basu et al., 1999; Brown and Baltimore, 2003;
Dobles et al., 2000; Kitagawa and Rose, 1999). At least three non-exclusive models can
explain these findings. First, the lesions monitored by such checkpoints occur in nearly
every cell cycle in higher organisms and thus checkpoint activity is made necessary by
the frequency of its use; unlike with Rad9p, a basal level of activity exists in the absence
of an exogenous insult. Second, any given checkpoint is not active in every cell cycle,
but the survival of a multicellular organism can be compromised by checkpoint failure in
a few cells or at specific stages of development. Third, a checkpoint protein in higher
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organisms may participate in the underlying repair process or contribute directly to cell
cycle progression. Metazoan checkpoint proteins often have more complex multidomain
structures than their yeast homologs and serve to integrate arrest and repair functions.
The requirement for cell cycle checkpoints in the fitness of multicellular
organisms is illustrated by their frequent disruption in hereditary and acquired cancers.
The study of familial cancer syndromes led to the identification of the Fanconi anemia,
BRCA, and NBS families, and inherited mutations in p53 and the Chk kinases have been
detected in Li-Fraumeni syndrome (McDonald and El-Deiry, 2001; Zhivotovsky and
Kroemer, 2004). Disruption or mutation of these genes leads to the accumulation of
genetic lesions and decoupling of the appropriate apoptotic response. The resulting cell
can execute the movements of mitosis unaware of or powerless to respond to the genomic
damage it is accumulating.
1.3 Chromosome segregation, the spindle, and kinetochores
Eukaryotic cells rely on a self-assembling array of microtubules (MTs) known as
the spindle to effect chromosome segregation. Microtubules emanate from microtubule
organizing centers (MTOCs) called spindle pole bodies (in yeast) or centrosomes (in
metazoans) and form attachments with the cell cortex and with anti-parallel MTs from
the opposite pole. In addition, microtubules attach to chromosomes by binding to the
kinetochore, a massive multiprotein complex that assembles on centromeric DNA.
Correct genome partitioning requires that the kinetochores of a joined pair of sister
chromatids form bipolar spindle attachments; that is, the two kinetochores must attach to
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MTs radiating from opposite ends of the cell. Microtubules undergo periods of rapid
assembly and disassembly that allow them to scan the volume of the cell randomly
(Mitchison and Kirschner, 1984; Mitchison and Kirschner, 1985). Kinetochore-MT
capture thus happens in a stochastic rather than directed or ordered fashion, allowing
errors of both orientation and timing. Before describing the error-sensing mechanism of
the spindle checkpoint, I will describe the relevant details of the mitotic spindle and the
kinetochore.
1.3.1 The Mitotic Spindle
Microtubule dynamicity directs spindle assembly and contributes to the forces
necessary for chromosome segregation. Microtubules are hollow filaments
approximately 25nm in diameter (Amos and Klug, 1974). Each tubule forms from the
parallel association of 13 linear tubulin protofilaments, which in turn form from the GTP-
dependent polymerization of ap-tubulin heterodimers (Weisenberg and Deery, 1976).
The asymmetry of the tubulin heterodimer imposes directionality on the microtubule. a-
tubulin subunits are exposed at the more stable minus end of the microtubule and tend to
be buried in MTOCs. -tubulin subunits are exposed at the less stable, dynamically
growing plus end of the microtubule.
Microtubule plus ends undergo periods of rapid growth and shrinkage, termed
"dynamic instability" (Allen and Borisy, 1974; Mitchison and Kirschner, 1984). While
both a- and P-tubulin bind GTP, only f3-tubulin can hydrolyze and exchange GTP and
GDP (Desai and Mitchison, 1997; Spiegelman et al., 1977). GTP occupancy controls
tubulin polymerization, as only GTP-bound ap-tubulin can be added to the plus end.
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Because polymerization drives GTP hydrolysis, the majority of P-tubulin in a
protofilament is GDP-bound. Preventing GTP hydrolysis by newly incorporated
heterodimers may prevent depolymerization, thereby "capping" or stabilizing a
protofilament. In this way, control of GTP hydrolysis by microtubule associated proteins
(MAPs) contributes to microtubule dynamics. In addition, microtubules undergo
catastrophe (a rapid transition from growth to shrinkage) and rescue (a sudden switch
from shrinkage to growth). The interplay between polymerization, rescue, and
catastrophe determines the dynamic nature of microtubules and allows them to generate
variable force at the plus end (Rieder and Salmon, 1998). Microtubule dynamics
increase drastically upon entry into mitosis, with polymerization and catastrophe rates
increasing 5.. to 10-fold (Belmont et al., 1990; Mitchison, 1986; Schulze and Kirschner,
1986; Verde et al., 1992). This increase in overall MT turnover allows the spindle to
probe the cytoplasm for chromosomes more efficiently. In addition, microtubule
dynamics provides some of the force required for movement of unattached kinetochores
in prophase and prometaphase and for chromosome segregation in anaphase (Dogterom
and Yurke, 1997; Inoue and Salmon, 1995; Rieder and Salmon, 1994). Motor proteins
and MAPs also contribute to force generation both directly and by crosslinking
microtubules and regulating their dynamicity (Hunter and Wordeman, 2000; Rogers et
al., 2004; Sharp et al., 2000).
1.3.2 The Kinetochore
Kinetochores are the focal point for the critical processes of the metaphase-
anaphase transition: microtubule attachment, spindle checkpoint activation, sister
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chromatid separation, and anaphase force generation. First identified cytologically as the
primary chromosomal constriction, these complexes assemble on centromeric DNA in S
phase (McCarroll and Fangman, 1988). Budding yeast centromeres were identified as
genetic loci required for stable chromosome transmission (Clarke and Carbon, 1980;
Cottarel et al., 1989), and an extensive body of work has shown that each of the 16 S.
cerevisiae chromosomes contains a single, well-conserved 125bp sequence that is
necessary and sufficient for centromeric function in both mitosis and meiosis (Sullivan et
al., 2001). Electron microscopy, genetic screens, and biochemical reconstitution have
shown that yeast kinetochores have at least three distinct regions: a DNA-binding layer, a
microtubule-binding layer, a linker layer between them. While schematically simple, this
single microtubule-DNA linking apparatus requires over 60 known proteins (De Wulf et
al., 2003). The DNA-binding components of the yeast kinetochore, including the CBF3
complex, Cbflp, and the histone variant Cse4p, makes sequence-specific contacts with
regions of the point centromeres. The linker layer contains several discrete
subcomplexes that are essential for kinetochore function but do not exhibit DNA- or MT-
binding activity. The MT-binding layer is known to contain both MAPs and motors of
the kinesin-like protein (KLP) family, and these proteins contribute to microtubule
capture, tension generation, and poleward movement (Cheeseman et al., 2004). Electron
microscopy reveals that budding yeast kinetochores bind and stabilize a single
microtubule that is sufficient for segregation (Winey et al., 1995).
The centromeres of metazoans and even Schizosaccharomyces pombe are far
more complex and are defined not by specific kinetochore-nucleating sequences but by
heterochromatin structure. S. pombe centromeres span 40-100kbp and are characterized
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by a non-conserved core sequence flanked by large inverted repeats, all of which is
necessary for centromere function (Cleveland et al., 2003). Human centromeres range
from 0.3-5Mbp and contain 1500-30,000 copies of tandemly repeated 17lbp a-satellite
sequence (Clarke, 1998) These centromeres are characterized by the deposition of
proteins such as CENP-A and CENP-C, homologs of S. cerevisiae Cse4p and Mif2,
respectively (Meluh et al., 1998), and the resulting heterochromatin may persist and mark
the site for the next cell cycle. Ablation or spontaneous deletion of centromeres results in
neocentromere formation elsewhere on the same chromosome, and these neocentromeres
are competent for chromosome transmission (Amor et al., 2004; Amor and Choo, 2002;
Saffery et al., 2000). Interestingly, these a-satellite arrays contain interspersed regions of
CENP-A and histone H3, suggesting that they may consist of modular subunits, each of
which attaches to a single microtubule (Vafa and Sullivan, 1997; Zinkowski et al., 1991).
An important functional difference between budding yeast and higher eukaryotes is that
while S. cerevisiae kinetochores attach to a single microtubule (Winey et al., 1995), S.
pombe and metazoan kinetochores bind 15-30 MTs, suggesting that attachment may
result from stages of capture, recruitment, maturation, and force generation (Brinkley and
Cartwright, 1971; Rieder, 1982). Despite the added complexity of centromeres and
kinetochores in higher eukaryotes relative to S. cerevisiae, metazoan kinetochores
maintain the basic ultrastructural organization of a linker layer between DNA- and MT-
binding layers (Blower et al., 2002).
While the genetic and epigenetic components of centromere formation appear
largely conserved in metazoans, centromere location on chromosomes is not. Mouse
centromeres are situated in a subtelomeric region of each chromosome and are hence
15
termed telocentric. C. elegans chromosome are holocentric and attach microtubules
along the entire length of mitotic chromosomes (Albertson and Thomson, 1982). As a
result, comparative genomic analysis has shown that C. elegans lacks obvious homologs
of many yeast or mammalian kinetochore proteins, and the homologs that can be
identified are often strikingly divergent when compared to nearer neighbors such as
Drosophila. C.elegans appears to have evolved novel kinetochore and checkpoint
proteins to deal with the unusual structural, geometric, and regulatory consequences of
regulating microtubule attachment and centromere cohesion along the length of its
chromosomes rather than at a specific region (Dernburg, 2001; Murray and Marks, 2001)
1.3.3 Kinetochore-Microtubule interactions
The early stages of kinetochore-microtubule interaction differ between yeast and
higher organisms. Because S. cerevisiae undergo a closed mitosis without nuclear
envelope breakdown, centromeres remain associated with spindle pole body (SPB)
microtubules throughout the cell cycle. Budding yeast centromeres replicate early in S
phase (McCarroll and Fangman, 1988), and upon entry into M phase sister chromatid
pairs associate with one SPB until bipolar attachment is achieved and the equalized
forces cause them to congress (Goshima and Yanagida, 2000). Because the time required
for bipolar attachment varies between chromosomes, sister pairs may oscillate
dynamically between the poles as incorrect attachments form and are corrected. Upon
attachment, centromere pairs come under tension and separate transiently but remain
attached until the onset of anaphase (He et al., 2000). Metazoan centromeres replicate
late in S phase and cannot form MT attachments until after NBD and spindle assembly in
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prometaphase (Cleveland et al., 2003). As in yeast, mature kinetochore-MT attachments
result in centromere stretching, equalized interkinetochore forces, and congression to the
metaphase plate. Improperly attached or untensed kinetochores localize near the
centrosome or "float" away from the spindle axis until capture occurs.
Multiple types of improper kinetochore-mictrotubule interactions have been
observed in vivo, among them amphitelic, monotelic, syntelic, and merotelic attachment.
Amphitelic chromosome pairs form bipolar attachments in which the two associated
kinetochores attach to microtubules from the two opposing centrosomes (Figure 1.1).
Because each kinetochore is attached to only one centrosome, and the centrosomes are at
opposite ends of the spindle, forces on such a chromatid pair rapidly equalize and the pair
congresses to the metaphase plate. These amphitelic attachments do not activate the
spindle checkpoint and are permissive for progression into anaphase. Monotelic (or
mono-oriented) attachment, which is typical of early prometaphase, occurs when only
one of two paired kinetochores is captured by the spindle; this chromosome will
experience pulling forces from only one end of the cell and thus will localize to that pole
until the other kinetochore undergoes capture by MTs from the opposing pole.
Chromosomes can also form syntelic attachments in which both kinetochores in a pair
bind to microtubules emanating from the same pole. Under physiological conditions,
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Figure 1.1
Attachment
Amphitelic
Monotelic
Chec)oint
§
Sptelic
Merotelic
etochore
es
-4 microtubule
pull
Figure 1.1: Kinetochore-Microtubule attachments
Proper bipolar orientation occurs when a sister chromatid pair forms an amphitelic
attachment with microtubules from opposite ends of the cell. In monotelic attachment,
one kinetochore remains unattached to microtubules. In syntelic attachment, both
kinetochores bind microtubules emanating from the same pole and tension is not
established. In merotelic attachment, one kinetochore of a pair is stably bound to
microtubules from both poles, preventing proper segregation even though the checkpoint
is inactivated.
~
-.
i
both syntelic and monotelic kinetochores efficiently activate the spindle checkpoint and
arrest cell cycle progression (Rieder et al., 1995; Rieder et al., 1994; Sluder et al., 1997).
Merotelic attachment occurs when a single kinetochore within a sister pair
becomes attached to both spindle poles (Figure 1.1). Often the sister kinetochore is
attached to one pole as well, and such attachments do not activate the spindle checkpoint
because both kinetochores are attached and tension is generated. This state occurs
commonly when centrosome separation is delayed until after NBD (Cimini et al., 2001;
Kapoor et al., 2000). After loss of sister cohesion, a merotelic chromatid may fail to
segregate and lag behind at the metaphase plate because it experiences equal pulling
forces from both poles. Lagging merotelic chromosomes occur frequently in tissue
culture cells (Rieder and Maiato, 2004) and provide an attractive mechanism for
chromosome instability because they are not sensed by the canonical spindle checkpoint
and the resulting lesion - gain or loss of a single chromosome - is milder than gross
aneuploidy or polyploidy and thus is less likely to prove fatal to the daughter cell.
1.4 The spindle checkpoint
1.4.1 Discovery of the spindle checkpoint
Cells cannot enter anaphase until the spindle has been assembled and all
chromosome pairs have formed bipolar attachment. Due to the stochastic process of
microtubule search-and-capture, however, the time required to attach the last kinetochore
pair may vary widely from cell to cell. Even before the formal definition of cell cycle
checkpoints, several lines of evidence suggested that anaphase entry might be controlled
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by some interaction between chromosomes and the spindle. In the late 1950s, work
performed in preying mantid spermatocytes demonstrated that a single unpaired X
chromosome led to a permanent meiotic arrest, the first demonstration that chromosomes
actively regulate the cell cycle (Callan and Jacobs, 1957). Zirkle observed that focal
irradiation of the metaphase spindle dislodged chromosomes from the metaphase plate
and delayed anaphase onset drastically (Zirkle, 1970). Finally, the development of anti-
microtubule compounds led to the observation that budding yeast cells whose spindles
are disrupted by drugs such as nocodazole or benomyl or by temperature-sensitive tubulin
mutations undergo cell cycle arrest with large buds and an undivided nucleus (Fuchs and
Johnson, 1978; Huffaker et al., 1988; Jacobs et al., 1988). Similar effects were observed
in mammalian cells treated with the chemotherapeutic agent taxol (Zieve et al., 1980).
These observations led directly to isolation of the canonical spindle checkpoint
genes in two genetic screens for budding yeast mutants whose cell cycle progession is
resistant to anti-microtubule drugs. Li and Murray screened for S. cerevisiae mutants that
did not form colonies after continuous growth on low-dose benomyl plates (Li and
Murray, 1991). These mitotic arrest-deficient mutants were named MAD], MAD2, and,
MAD3. A second screen for mutants that fail to arrest after only 20 hours of growth on
high-dose benomyl yielded the budding uninhibited by benzimidazole mutants, BUB1,
BUB2, and BUB3 (Hoyt et al., 1991). None of the canonical BUB or MAD genes are
essential in budding yeast, though bublA and bub3A cells have a slow growth phenotype
that eventually may be overcome in culture by compensating mutations (Hoyt et al.,
1991; Roberts et al., 1994). In addition, mad and bub mutants exhibit high rates of
spontaneous chromosome loss when grown under normal conditions (Li and Murray,
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1991; Warren et al., 2002). Subsequent work has shown that the MAD1-3, BUBI, and
BUB3 genes are the canonical members of a checkpoint, commonly called the spindle
checkpoint or spindle assembly checkpoint (SAC), that monitors kinetochore-
microtubule attachment and the establishment of tension across kinetochore pairs before
entry into anaphase. BUB2, in comparison, participates in a checkpoint that links mitotic
exit to spindle position (Bardin and Amon, 2001; Bardin et al., 2000; Hu and Elledge,
2002). The sections below discuss in detail the genes and proteins of the spindle
checkpoint.
1.4.2 Checkpoint gene families
Following the initial discovery and cloning of the six MAD and BUB genes, the
number of genes found to function in the spindle assembly checkpoint has continued to
expand. The majority of these genes exhibit strong conservation from yeast to humans,
though certain important features of checkpoint signaling appear restricted to higher
eukaryotes. The essential budding yeast kinase MPS 1 was shown to be required for both
spindle pole body (SPB) duplication and arrest in response to nocodazole (Lauze et al.,
1995; Weiss and Winey, 1996). Homologs of Madl, Mad2, Bubl, Bub3, and Mpsl were
subsequently discovered in higher organisms (Musacchio and Hardwick, 2002). No
mammalian Mad3 exists, but a protein kinase containing homology to both Mad3p and
Bublp has been identified in metazoans and named Bub-related 1, or BubRI (Taylor et
al., 1998). A regulatory subunit of budding yeast protein phosphatase 2A, Cdc55p, is
required for maintenance of checkpoint arrest; cdc55 mutants cannot prevent inhibitory
phosphorylation of the cell cycle regulator Cdc28p and exit mitosis despite spindle
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damage (Minshull et al., 1996; Wang and Burke, 1997). Treatment of human cells or
Xenopus laevis egg extracts with nocodazole activates the MAP kinase p3 8, and
pharmacologic inhibition of p38 or ERK2 impairs nocodazole arrest in Xenopus embryos
(Minshull et al., 1994; Takenaka et al., 1997; Takenaka et al., 1998). CENPE is a plus
end-directed kinesin-like motor that localizes to kinetochores, is required for checkpoint
function, and may activate BubR1 kinase activity (Abrieu et al., 2000; Wood et al., 1997;
Yen et al., 1991), The budding yeast kinase Ipllp and its mammalian homolog Aurora B
regulate the turnover of incorrect kinetochore-MT attachments and may contribute to the
sensing of decreased interkinetochore tension (Biggins and Murray, 2001; Tanaka et al.,
2002). A complex of the Rough Deal (ROD) and Zeste-white 10 (ZW10) proteins is
required for checkpoint signaling in yeast and mammals and may assist in recruiting
dynein and the Mad proteins to kinetochores (Chan et al., 2000; Kops et al., 2005). The
relationshipts of these proteins in the spindle checkpoint is summarized in Figure 1.2 and
discussed in more depth below.
A critical common feature of the diverse spindle checkpoint proteins is their
localization to kinetochores in mitosis. Mad2 was the first checkpoint protein to be
observed at kinetochores (Chen et al., 1996; Li and Benezra, 1996), and similar
localization patterns were observed for the other Mad, Bub, and Mps 1 proteins (Vigneron
et al., 2004). Because budding yeast nuclei and spindles are so small and undergo a
closed mitosis, the kinetochore localization of yeast checkpoint proteins was not
characterized until the development of more precise microscopic methods (Gillett et al.,
2004). Notably, while all known checkpoint proteins transit through kinetochores in
mitosis, their localization is
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Figure 1.2
Figure 1.2: The spindle checkpoint proteins
Spindle checkpoint proteins bind to unattached kinetochores via the Hecl/Nuf2R
complex. Upstream signaling from Mps 1, dynein, and the RZZ complexes are required
for localization of Mad and Bub complexes. Activated Mad2, BubR /Bub3, and Bub
inhibit Cdc20 directly and in combination, thus preventing ubiquitination of securin and
anaphase entry.
neither identical nor static. While Madl and Bubl remain stably bound to kinetochores,
Mad2, BubR1, Bub3, and Mpsl rapidly bind and dissociate from kinetochores with
replenishment half-lives of 10-25 seconds (Howell et al., 2000; Howell et al., 2004; Shah
et al., 2004). Late in metaphase, Mad2, Madl, and Mps 1 leave the kinetochore and
relocalize to the spindle and centrosomes. Bubl, Bub3, and BubRI levels on
kinetochores decrease noticeably but do not fall below the detection limit. This
relocalization is proposed to silence the checkpoint, but it does not rule out the possibility
that checkpoint proteins, once activated, may remain active in the cytosol ((Howell et al.,
2001). The critical role of the kinetochore in checkpoint signaling is reflected in the fact
that intact kinetochores are required for checkpoint function (Gardner et al., 2001).
Indeed, deletion or depletion of core kinetochore proteins such as Ndc80p/HEC 1,
Nuf2p/Nuf2R, Spc24p, Spc25p, or Mis6p/CENP-1 abrogates the spindle checkpoint,
likely because under such conditions Mad and Bub proteins do not bind kinetochores
(Liu et al., 2003; Martin-Lluesma et al., 2002; Meraldi et al., 2004).
1.4.3 Checkpoint inputs
What molecular or ultrastructural lesion does the spindle checkpoint sense to
ensure the fidelity of chromosome segregation? While signals could in theory emanate
from any part of the mitotic machinery, including the spindle and the centrosomes,
cytologic experiments suggest that kinetochores are the focus of both sensing and signal
generation. Careful monitoring of PtK1 cells showed that, while the time between
nuclear envelope breakdown and anaphase ranged from 23 minutes to many hours,
anaphase robustly began 23+ 1 minute after capture of the last unattached kinetochore
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(Rieder et al., 1994). Models of checkpoint activation have thus traditionally focused on
two characteristics of kinetochore bipolarity: microtubule occupancy at kinetochores and
tension across paired centromeres.
The classical tension model proposed that proper attachment of metaphase
kinetochore pairs occurs when they are subject to equal poleward forces (McIntosh,
1991), and untensed or relaxed kinetochore pairs generate a signal that arrests the cell
cycle. This :model allows for a single relaxed kinetochore pair to signal above the
background of many attached pairs. Early evidence for this model came from elegant
experiments in preying mantid spermatocytes. These cells arrest for many hours in
meiosis I when there is an unpaired X chromosome. Li and Nicklas applied tension to
unpaired X chromosomes by pulling on them with a microneedle and observed that such
cells initiate anaphase approximately one hour later (Li and Nicklas, 1995). Application
of tension also decreased kinetochore phosphorylation as measured by staining for the
multi-protein 3F3/2 phosphoepitope (Cyert et al., 1988; Gorbsky and Ricketts, 1993; Li
and Nicklas, 1997). Following on these cytologic studies, Stem and Murray exploited
budding yeast cdc6 mutants to study cells in which kinetochores can attach to
microtubules without exerting tension. Cdc6p is an initiator of DNA replication, and
cdc6 mutants enter mitosis with unreplicated chromosomes (Piatti et al., 1995). Without
sister chromatids, kinetochores become attached and mono-oriented in mitosis and cause
a spindle checkpoint-dependent delay before entering anaphase, suggesting that the
checkpoint is sensing lack of tension rather than microtubule binding (Stem and Murray,
2001). Important caveats exist for the experiments on which the tension model is based,
blurring the distinction between tension and attachment. Most critically, tension is
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known to stabilize microtubule binding, so it is difficult to distinguish between the
mechanical aspect of tension and its role in promoting cooperative binding of
microtubules to kinetochores (King and Nicklas, 2000; Nicklas and Koch, 1969; Nicklas
and Ward, 1994; Rieder and Alexander, 1990). The classic "glass needle experiment"
was performed in invertebrate meiosis and may reflect different sensing functions
between meiosis and mitosis. Concurrently, the time scale of mitotic exit in that
experiment is consistent with the possibility that the exogenously tensed chromosome
recruited MTs before anaphase ensued. The suggestion that the 3F3/2 phosphoepiptope
is an indicator of attachment, tension, or checkpoint arrest has been hampered by the
discovery that in some species it stains kinetochores regardless of attachment status even
into anaphase (Waters et al., 1996). It is not clear that the kinetochores of unreplicated
chromosomes, such as those in cdc6 cells, are functionally equivalent to replicated
kinetochores. Finally, recent experiments with engineered dicentric minichromosomes in
budding yeast suggest that tension inherently implies attachment (Dewar et al., 2004).
Does the spindle assembly checkpoint sense kinetochore-microtubule attachment
rather than tension across kinetochore pairs? Cytologic studies in PtK1 cells
demonstrated that a single unattached kinetochore is sufficient to engage the checkpoint
(Ault et al., 1991; Ault and Rieder, 1992), and subsequent ablation of the unattached
kinetochore by laser irradiation leads to anaphase onset (Rieder et al., 1995). In fact,
spermatocytes in which all chromosomes have been removed execute anaphase and
cytokinesis (Zhang and Nicklas, 1996). A powerful argument for the monitoring of
attachment comes from checkpoint protein localization studies. In higher eukaryotes,
Mad, Bub, and other checkpoint proteins localize to kinetochores in late prophase and
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prometaphase, before microtubule attachment occurs, and this localization is enhanced by
treatment with high doses of spindle poisons that prevent tubulin polymerization (Chen et
al., 1996; Jablonski et al., 1998; Taylor and McKeon, 1997; Vigneron et al., 2004). In
mono-attached pairs, Bub , Bub3, and Mad2 become asymmetrically enriched on the
unattached or more weakly attached kinetochore (Chen et al., 1996; Martinez-Exposito et
al., 1999; Taylor et al., 2001; Waters et al., 1998). Equally instructive have been
experiments in which PtK1 or HeLa cells are treated with sufficiently low doses of taxol
or vinblastine to inhibit microtubule dynamics (and thus tension) but not destroy
microtubule attachment. Under these conditions, Mad2 and Bub3 do not relocalize to
kinetochores, suggesting that they are not responsive to tension sensing when
kinetochores are microtubule-bound (Waters et al., 1998).
The subtle differences in Mad and Bub protein localization during metaphase or
after exposure to certain spindle poisons has led to the proposal that the spindle
checkpoint consists of two parallel pathways: sensing of microtubule occupancy at
kinetochores by Mad2 and sensing of tension on kinetochores by BubRI (Skoufias et al.,
2001). However, this separation of attachment and tension is based on experiments from
a wide range of organisms, often combining details from meiosis and mitosis, and with
critical assumptions about the uniformity of response to drug application (Rieder and
Maiato, 2004). Given the difficulty in disentangling tension and attachment
experimentally, it remains possible that they are in fact two manifestations of the same
phenomenon. In maize, Mad2 appears to sense tension in meiosis I and occupancy in
mitosis (Yu et al., 1999). This may reflect geometric differences in the orientation of
meiotic and mitotic kinetochores. Mitotic kinetochore pairs are held in close apposition
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in prometaphase, and attachment of one kinetochore to a pole may orient its partner to
face the other pole, thus drastically reducing the likelihood of syntelic attachment. In
mitosis, therefore, attachment of both members of a pair may be sufficient to ensure
tension. Homologous chromosomes in meiosis I are held together by chiasmata and the
four kinetochores in a homologous pair may orient with a greater degree of freedom than
a mitotic pair (Lew and Burke, 2003). In this case, homologous pairs are more likely to
form syntelic or other incorrect attachments, and sensing of tension may confer a higher
degree of accuracy. Thus, many of the differences that are attributed to attachment and
tension may in fact reflect different requirements for proper kinetochore-microtubule
interactions in different cells, species, or developmental stages.
1.4.4 Outputs of the spindle assembly checkpoint
Spindle checkpoint activation arrests the cell cycle by inhibiting the multisubunit
ubiquitin ligase known as the Anaphase Promoting Complex, or cyclosome (APC/C).
APC/C directs the metaphase-anaphase transition and mitotic exit by tagging substrates
with polyubiquitin chains, thus targeting them for proteolysis by the 26S proteasome
(Glotzer et al., 1991; Hershko et al., 1991). Orderly cell cycle progression requires that
pools of critical substrates are tagged for proteolysis and rapidly destroyed in coordinated
waves rather than in a continuous stream. As a result, APC/C activation occurs through
regulated association with specificity factors that link the ligase and substrate rather than
by direct association with substrates as they become available, as is the case for other
ubiquitin ligases such as the SCF complex. Two WD proteins direct APC/C activity in
budding yeast: Cdc20p directs entry into anaphase and Cdhlp controls mitotic exit
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(Schwab et al., 1997; Visintin et al., 1997). APC/CCdc2o ubiquitinates cyclin A and B, but
non-degradable cyclin mutants arrest yeast cells in telophase, after the arrest observed in
cdc20 mutants, suggesting that they are not the critical substrates for anaphase entry
(Holloway et al., 1993; Surana et al., 1993). The critical substrate was found to be
Pds lp/securin, a protein that prevents the activation of the protease Esp 1 p/separase
(Yamamoto et al., 1996a; Yamamoto et al., 1996b). Because separase degrades members
of the cohesin complex and leads to separation of sister chromatids, the destruction of
securin and ensuing activation of separase are the final triggering events of anaphase.
Spindle checkpoint activation leads to the inhibition of Cdc20 and its homologs
by several different mechanisms. A major landmark in checkpoint biology was the
discovery that Mad2 binds Cdc20 in vivo and inhibits APC/CCdc20 in vitro (Fang et al.,
1998; Hwang et al., 1998; Kim et al., 1998). Budding yeast cdc20 mutants that cannot
interact with Mad2p cannot arrest in the presence of spindle poisons, suggesting that this
interaction is critical for checkpoint activation (Schott and Hoyt, 1998). These findings
were followed by the discovery that Mad3p co-immunoprecipitates with Cdc20, and
BubR1 can directly bind and inhibit APC/CC d c20 independent of Mad2 (Hardwick et al.,
2000; Tang et al., 2001; Wu et al., 2000). While Mad3/BubRl and Mad2 each inhibit
Cdc20, several lines of evidence suggest that they may work together. In both budding
yeast and mammalian cells, Mad2 and Mad3/BubR1 copurify with Bub3 and Cdc20 in a
large mitotic checkpoint complex, or MCC (Fraschini et al., 2001 a; Sudakin et al., 2001).
BubRI and Mad2 inhibit APC/CCdc2 O synergistically in vitro (Fang, 2002), and in fission
yeast Mad3p is required for the arrest caused by overexpression of Mad2p (Millband and
Hardwick, 2002). While Bub 1 does not participate in the larger checkpoint complexes,
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human Bubl phosphorylates Cdc20 in vitro (Tang et al., 2004a). Phosphorylated Cdc20
does not efficiently activate APC/C in vitro, and mutation of all Cdc20 phosphoacceptor
sites to alanine renders it dominant negative to checkpoint function in HeLa cells. These
results implicate Bub as a direct catalytic inhibitor of APC/C. Thus, at least four
possible Cdc20 inhibitors can be found among the canonical spindle checkpoint genes:
Bubl, Bubrl/Mad3p, Mad2, and the MCC complex. Because these checkpoint proteins
exist in multiprotein complexes with mutual interdependencies for function and
localization, it is difficult to order them in a linear or epistatic pathway. The following
sections discuss in more detail the components of the spindle checkpoint.
1.4.5 Madl, Mad2, and Cdc20
Madl and Mad2 form the nucleus of a dynamic stoichiometric inhibitor of Cdc20.
Madl and Mad2 form a stable complex throughout the cell cycle in yeast and metazoans,
and this complex is required for checkpoint activity (Chen et al., 1999; Jin et al., 1998).
Upon checkpoint activation, Mad2 also binds to and inhibits Cdc20. Crystallographic
analysis has revealed that Madl is a homodimeric coiled-coil protein, while Mad2 is a
small ap-sandwich (Sironi et al., 2002). Mad2 and Madl form a 2:2 tetramer in which
the C-terminal tail of Mad2 wraps around an exposed intercoil region of Madl and
refolds into the main P-sheet of Mad2, thus encircling Madl like a safety belt (Figure
1.3).
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Figure 1.3: Madl-Mad2 structure
Mad2 binds and encloses Madl with a safety belt mechanism. Ribbon (A) and surface
(B, C) diagrams of the Madl-Mad2 crystal structure of Sironi et al (Sironi et al., 2002)
were generated in PyMOL. The C-terminal tail of Mad2 (dark blue) encloses an inter-
coil section of Madl (orange) and inserts into the body of Mad2 (cyan).
In solution, Mad2 adopts at least two distinct folds that represent the open and closed tail
conformations, referred to as O-Mad2 and C-Mad2 (Luo et al., 2004). The open and
closed conformers are stable and interconvert spontaneously with extremely slow
kinetics. However, while bacterially expressed Mad2 can be separated
chromatagraphically into 0- and C-Mad2, only O-Mad2 is detected upon purification
from nocodazole-arrested HeLa cells. This is surprising given that NMR analysis
suggests that Mad2 also adopts the closed conformation upon binding to Cdc20, and this
complex is known to exist in HeLa cells. However, because of the difficulty of
expressing and purifying Cdc20, structural analysis has been confined to complexes of
Mad2 with short Cdc20 fragments that lack the large C terminal WD domain. Binding of
full length Cdc20 may induce structural rearrangements in Mad2 that are not yet known.
The likelihood that Madl and Cdc20 compete for Mad2 binding is seemingly at odds
with the observation in budding yeast that Madl is required genetically for binding of
Mad2 to Cdc20. However, this requirement has not been documented in higher
eukaryotes and may result from different levels of basal checkpoint signaling in yeast
versus metazoans.
Interphase Madl is saturated with Mad2, and these complexes localize to nuclear
pore complexes in budding yeast and the nuclear periphery in metazoans (Campbell et
al., 2001; louk et al., 2002). Upon entry into M phase, Madl/Mad2 localizes to
kinetochores, though the bulk of Mad 1-free Mad2 remains cytosolic. FRAP experiments
reveal that the Mad I-bound pool of Mad2 remains stably bound to Madl, while the
cytosolic pool undergoes rapid cycles of kinetochore binding and dissociation (Howell et
al., 2000; Howell et al., 2004; Shah et al., 2004). This cycling or "kinetochore flux" of
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Mad2 is believed to occur through an unusual heterotypic homodimerization in which O-
Mad2 from the cytosolic pool binds C-Mad2 bound to Madl at kinetochores. Mad2
mutants lacking 10 residues from the extreme C terminus (Mad2AC) cannot complete tail
closure and thus remain locked in the open state, while full length Mad2 bound to
fragments of Mad I or Cdc20 remain in the closed state. Using these approximations of
the open and closed state, it has been shown in vitro that O-Mad2 can bind to C-Mad2-
Madl and C-Mad2-Cdc20, but neither O-Mad2 nor C-Mad2 can self-associate. Mad2
mutants that cannot dimerize do not localize to kinetochores when transiently expressed
in HeLa cells and act as dominant negative inhibitors of the checkpoint. The Mad2-
Mad2-Madl structure is not known and is the focus of intense investigation.
Mad Ilp is a phosphoprotein in budding yeast, and checkpoint activation results in
hyperphosphorylation that requires the kinase Mpslp. While Mpslp is presumed to
phosphorylate Madlp, this activity has not been reconstituted in vitro, and
hyperphosphorylated Madl has not been observed in higher eukaryotes. The
phosphorylation status of Mad2 is equally uncertain. Phosphorylation of four serines in
the Mad2 tail upon nocodazole arrest has been reported, and mutation of these residues to
mimic phosphorylation abrogated the in vivo binding of Mad2 to Mad l, Cdc20, and the
APC/C subunits Cdc16 and Cdc27 (Wassmann et al., 2003). However, this modification
of Mad2 has not been reported elsewhere.
While most features of Mad2-Madl signaling are conserved from yeast to
mammals, higher eukaryotes appear to have adapted Mad2 to other purposes. A Mad2-
like protein known as Mad2B or Mad2L2 exists in frogs and mammals and functions to
inhibit Cdhl late in mitosis (Cahill et al., 1999; Chen and Fang, 2001; Pfleger et al.,
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2001). Human Mad2B is 48% similar and 26% identical to human Mad2 in the
conserved regions. Two notable areas of divergence are at positions 133-134 of Mad2,
which mediate Mad2 dimerization, and the C terminal 35 residues of Mad2, which
perform tail closure and thus control binding to Mad and Cdc20. These differences
suggest that Mad2B may be unable to dimerize or bind Madl or Cdc20. Human Mad2B
binds and inhibits Cdhl but not Cdc20, while Xenopus Mad2B inhibits both Cdc20 and
Cdhl in vitro (Chen and Fang, 2001; Pfleger et al., 2001). One speculative explanation
for this divergence is that Mad2B arose as a result of duplication of the Mad2 locus and
has become progressively more specific for Cdhl inhibition throughout evolution. Far
from being a mere oddity, the existence of Mad2B points to the notion that the yeast and
mammalian spindle checkpoints share most of their components but connect them
differently.
While Mad 1 and Mad2 are nonessential in yeast, Mad2 is essential in higher
eukaryotes. Deletion of Mad2 in mice results in embryonic lethality, while loss of
function mutants of either Mad 1/mdf-I or Mad2/mdf-2 are embryonic lethal in C. elegans
(Dobles et al., 2000; Kitagawa and Rose, 1999). However, it is notable that both mouse
and worm embryos execute numerous rounds of cell division before succumbing to high
levels of apoptosis. Mice that are heterozygous for Mad2 develop lung papillary
adenocarcinoma very late in life, suggesting that Mad2 is a haploinsufficient tumor
suppressor (Michel et al., 2001). Complete RNAi knockdown of Mad2 abrogates
checkpoint response to nocodazole and causes HeLa cells to degrade cyclin B and securin
soon after nuclear envelope breakdown (Meraldi et al., 2004; Michel et al., 2004). These
cells enter anaphase before chromosomes fully condense and align, resulting in a
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catastrophic mitosis, multinucleation, and cell death. Strikingly, Madl knockdown
prevents checkpoint arrest in nocodazole but does not lead to premature anaphase in
unperturbed cells, pointing to a role for Mad2 in constraining Cdc20 activity early in
mitosis, thus setting a default delay in mitotic timing apart from checkpoint function
(Martin-Lluesma et al., 2002).
What is required for Mad2 and Madl to localize to kinetochores? An extensive
set of experiments has examined checkpoint protein localization in the context of RNAi
of a variety of both checkpoint and kinetochore proteins (Rieder and Maiato, 2004;
Vigneron et al., 2004). Because checkpoint proteins exist in several overlapping
complexes with mutual interdependencies, it is difficult to order their functions in a linear
or epistatic pathway. While results differ slightly between systems, it seems clear that
Mad2 localization is a final effector step in the pathway, requiring Madl, Bub 1, BubR1,
Mpsl, Bub3, Aurora B, CENP-E, and the kinetochore Hecl/Nuf2r. Madl localization
requires the Hecl/Nuf2r complex as well as Bub 1. In addition, Madl interacts directly or
indirectly with Bub 1, BubR 1, and another mitotic kinase Nek2A, and phosphorylation of
BubR1 in mitosis requires Madl (Brady and Hardwick, 2000; Chen, 2002; Lou et al.,
2004). While the details of all these interactions remain to be clarified, Madl may be
considered to function as a kinetochore scaffold for recruiting and activating several
components of the checkpoint, most notably Mad2.
1.4.6 Mad3/BubRl and MCC
The mammalian serine-threonine kinase BubRI and its yeast homolog Mad3p,
which lacks the kinase domain, are checkpoint effectors that inhibit Cdc20 alongside
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Mad2, but the details of Mad3/BubR1 function and biochemistry are not as well
understood. Several important parallels exist between Mad2 and Mad3/BubR1.
Mad3/BubR1 exists in a stable, stoichiometric complex throughout the cell cycle with
Bub3 (Taylor et al., 1998). BubR1/Mad3 mutants whose Bub3-binding region is deleted
do not localize to prometaphase kinetochores. BubR1 and Bub3 cycle through
kinetochores with rapid kinetics like Mad2 (Howell et al., 2004). Deletion of BubR1 in
flies and mice is embryonic lethal, and BubRI depletion leads to early anaphase entry,
loss of nocodazole arrest, and catastrophic mitosis similar to Mad2 RNAi (Basu et al.,
1999; Meraldi et al., 2004; Wang et al., 2004a). Mad3p, BubR1, and kinase-deficient
BubR1 all bind Cdc20 independent of Mad2 and inhibit APC/C in vitro. Finally,
Mad3p/BubR1 participates with Mad2 and Bub3 in the larger MCC complex throughout
the cell cycle (Fraschini et al., 2001b; Sudakin et al., 2001). The function and regulation
of MCC as a whole is not known. MCC purified from interphase, mitotic, and
checkpoint-active cells is equally potent at inhibiting APC/C in vitro, suggesting that
APC/C sensitivity to regulation by the checkpoint varies over the cell cycle.
Is BubR1/Mad3 simply another Cdc20 inhibitor that acts parallel to Mad2?
Several clues suggest that BubRl plays a subtly different role in sensing kinetochore
status and effecting checkpoint arrest. In addition to Bub3, BubR1 also forms a
stoichiometic complex with CENP-E, a kinesin-like motor that is not found in MCC
(Abrieu et al., 2000; Yao et al., 2000). Because CENP-E is a motor protein that localizes
to kinetochores and can bind microtubules, it is an attractive candidate for sensing the
state of tension between kinetochores and the spindle. CENP-E binding stimulates
BubRI activity, which is in turn required for Mad2 to localize to kinetochores (Mao et
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al., 2003). Surprisingly, CENP-E kinetochore localization in Xenopus extracts requires
the BubR1 kinase domain but not kinase activity, suggesting that CENP-E may directly
bind and stimulate the BubRI kinase analogous to cyclin-Cdk activation (Weaver et al.,
2003). This suggests a model in which localization of BubRI to kinetochores recruits
CENP-E independent of phosphorylation. Upon binding, CENP-E activates BubR1
kinase activity, leading to phosphorylation of unknown substrates that promote Mad2
localization and checkpoint activation. BubRI kinase activity is then silenced either by
MT attachment or the establishment of tension, perhaps via a tension-dependent
conformational change in CENP-E. The idea that BubR1 responds to tension rather than
attachment is discussed in section 1.4.3 and rests largely on the finding that BubR1
persists, albeit in lower amounts, on attached kinetochores in late prometaphase and
metaphase, while Mad2 and Madl do not. In mono-attached kinetochore pairs, Bubl and
Mad2 become enriched at the unattached kinetochore while BubRI is present equally on
both.
Unlike Mad2, BubRI is proposed to have both catalytic checkpoint activating and
non-catalytic APC/C inhibitory activities. The addition of a Bub -like kinase domain to
Mad3 during evolution suggests that BubRI may have acquired functions in addition to
Mad3-like checkpoint signaling, and these functions may have evolved as both
kinetochores and kinetochore-microtubule attachment became more complex. Because
both the structural mode of APC/Ccdc 2O inhibition by BubRl/Mad3p and the relevant
substrates of BubR1 kinase remain unknown, significant further investigation is required.
Additionally, while it is known that BubR1 binds and dissociates from kinetochores with
the same kinetics as Mad2, it is not known whether they cycle as monomers, as members
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of a complex, or as members of separate complexes. Finally, the difficulty of assaying
BubR1 kinase or non-kinase activity has prevented researchers from determining whether
active BubR1 exists in the cytosol or is confined to kinetochores.
Does BubRI possess non-checkpoint functions? Careful analysis of BubRI
RNAi cells suggests that BubR1 may actively regulate kinetochore-microtubule
attachment (Lampson and Kapoor, 2005). Mammalian BubR1, along with Bubl, binds to
and phosphorylates the tumor suppresseor Adenomatous Polyposis Coli (Apc), and
mouse embryonic stem cells harboring Apc mutations lose chromosomes at elevated rates
(Fodde et al., 2001; Kaplan et al., 2001). Truncated Apc mutants abrogate the
nocodazole arrest, and studies in BubRl +/ - ApcMin / mice suggest that decreased BubR1
expression exacerbates the tumor phenotype of ApcMin+'- mice (Rao et al., 2005; Tighe
et al., 2004). Remarkably, mice bearing a BubRI hypomorph allele that causes
progressively decreased expression do not develop tumors but instead exhibit genomic
instability and a profound accelerated aging phenotype (Baker et al., 2004). These mice
develop infertility, suggesting that the stoichiometric functions of BubRI are absolutely
required for meiosis. The pleiotropic effects of BubR1 mutation are just as profound in
the heritable human disorder mosaic variegated aneuploidy, in which recessive BubR1
mutations lead to growth retardation, microcephaly, and childhood cancer (Hanks et al.,
2004). Because BubR1/Mad3p is a point of divergence between the checkpoints of yeast
and higher organisms, it presents a fascinating opportunity to study how basic cell
biology is manifested at the level of tissue and organism.
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1.4.7 Bubl: a multifunctional checkpoint kinase
Like BubR1, Bubl is a multifunctional serine-threonine kinase that inhibits
Cdc20 directly. Bub can directly inhibit Cdc20 in vitro by phosphorylating several sites
in the Cdc20 N-terminus(Tang et al., 2004a). The contribution of Bub 1 kinase activity to
checkpoint activation remains unclear due to conflicting data. The highly atypical Bubl
kinase domain is strongly conserved from yeast to man but is not required for checkpoint
activity in budding yeast and some Xenopus egg extract activities (Sharp-Baker and
Chen, 2001; Warren et al., 2002). In other Xenopus experiments, Bub 1 kinase activity
enhances the efficiency of checkpoint arrest in response to weaker stimuli such as a
single unattached kinetochore, suggesting that it may be required for amplification of
checkpoint signal (Chen, 2004).
As with BubR l, Bub3 binds to Bub 1 and appears to act as an adaptor protein that
localizes Bubl to kinetochore. In some systems, the Bub I -Bub3 interaction is required
for Bub 1 kinetochore localization, while in others Bub3 requires Bub 1 (Sharp-Baker and
Chen, 2001; Taylor et al., 1998). Bub 1 localizes to kinetochores in very early prophase,
before BubRl or Mad2. Unlike Mad2 or BubRI, Bubl binds statically to kinetochores
and does not shuttle to the cytoplasm. Because Bub 1 resides at kinetochores and is
required for the localization of BubRl, CENP-E, CENP-F, Madl, and Mad2 (Johnson et
al., 2004; Sharp-Baker and Chen, 2001), Bubl appears, like Madl, to act as a scaffold for
activation of other checkpoint effectors. Bub 1 may interact with Mad 1 in budding yeast
(Brady and Hardwick, 2000), but they do not co-fractionate and this interaction has not
been detected in other organisms.
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Disagreement exists on the effect of Bub depletion in human cells. While RNAi
of Bub I RNAi does not lead to premature anaphase like RNAi of BubRI or Mad2, it has
been reported to inactivate the checkpoint (Meraldi and Sorger, 2005; Tang et al., 2004a),
activate the checkpoint by causing defects in chromosome attachment (Tang et al.,
2004b), and have no effect on checkpoint activation (Johnson et al., 2004). Despite these
disagreements, it is clear that mammalian Bub 1 is required for proper chromosome
congression and attachment in addition to a checkpoint signaling role. Several possible
models may explain these findings, including direct interaction with Apc or indirect
interaction with CENP-E via BubR1, but strong evidence points to an interaction between
Bub 1 and the Shugoshin/Sgo 1 protein. Shugoshin family members were discovered in
flies and yeast for their role in maintaining centromeric cohesion in meiosis by protecting
specialized meiosis-specific cohesin complexes from proteolysis by separase (Katis et al.,
2004; Kerrebrock et al., 1992; Kitajima et al., 2004; Marston et al., 2004; Rabitsch et al.,
2004). In higher eukaryotes and fission yeast, shugoshin also maintains centromeric
cohesion in mitosis, and loss of Sgo proteins leads to a loss of tension and mitotic delay
or arrest (Marston et al., 2004; Salic et al., 2004). Bubl is required in fission yeast and
mammals for Sgo localization to kinetochores, and cells depleted of either Bub 1 or Sgo
appear to undergo premature centromere separation (Kitajima et al., 2005; Tang et al.,
2004b). The phenotype of Bub I RNAi in human cells may be explained by partial
knockdown effects; strong but incomplete RNAi may deplete Bub 1 levels below the
threshold required for Sgo 1 localization (i.e. by stoichiometric binding to Bub 1) but
above the threshold required for spindle checkpoint activation (i.e. by catalytic kinase
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activity). Presently, no interaction between Bub 1 and Sgo has been demonstrated. It
remains critical to determine whether Bub binds or phosphorylates Sgo.
Bub l mutations have been found in a subset of colorectal and pancreatic cancers
that exhibit chromosome instability and impaired spindle checkpoints (Cahill et al., 1998;
Hempen et al., 2003). Like BubR1, Bubl binds and phosphorylates the tumor suppressor
Apc, but the significance of this interaction is not known (Kaplan et al., 2001).
Therefore, a causal link between Bub 1 and cancer development remains to be established.
Other checkpoint genes: Mpsl, Aurora B, and ROD/ZwlO/Zwilch
MPS 1 was identified as a checkpoint gene shortly after the classic MAD and
BUB screens, but little is known about its function. Mps 1 is a serine-threonine kinase
like the Bubs and simple overexpression of Mpslp in budding yeast causes a metaphase
arrest that requires Mad and Bub proteins but, strangely, not functional kinetochores
(Fraschini et al., 200lb; Poddar et al., 2004). Budding yeast MPS I1 is also required for
spindle pole duplication, but this function is clearly absent in the fission yeast homolog
Mph 1. RNAi depletion of Mps 1 in mammals abrogates the checkpoint as expected, but
conflicting reports exist on whether Mps overexpression drives centrosome duplication.
Mps 1 is also required for wound healing in zebrafish and hypoxia response in Drosophila
embryos (Fischer et al., 2004; Poss et al., 2002). While chemical genetic analysis has
begun to dissect the contribution of budding yeast Mps Ilp to both spindle assembly (Jones
et al., 2005) and tension monitoring (Dorer et al., 2005), the checkpoint substrates of
Mps 1 in both yeast and mammals remain unknown. As mentioned previously, budding
yeast MPS 1 is required for Madlp hyperphosphorylation during benomyl arrest, but this
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interaction is not know to be direct and has not been observed in other systems. Budding
yeast Mpslp does phosphorylate the SPB components Spcl 10p, Spc42p, and Spc98p
(Castillo et al., 2002; Friedman et al., 2001; Pereira et al., 1998), but illumination of
Mps 1 checkpoint function awaits the identification of relevant checkpoint substrates.
Another serine-threonine kinase, Aurora B, has been implicated in assisting
spindle checkpoint response to loss of tension at kinetochores. Aurora B and its yeast
homolog Ipl p exist in at tight complex with the chromosomal passenger protein
survivin/Birlp and the inner centromere protein INCENP/Slil5p. Aurora B/Ipllp is not
required for metaphase arrest following kinetochore-microtubule detachment, but it is
required for arrest when attached kinetochores are not under tension, such as taxol
treatment in mammalian cells or cohesion or replication mutants in yeast (Biggins and
Murray, 2001; Ditchfield et al., 2003; Tanaka et al., 2002). Ipllp destabilizes
kinetochore-mircotubule attachments that do not result in tension generation, and
inhibition of Aurora kinase activity with a small molecule show that the Aurora kinases
(which include Aurora A and C) are required for correction of attachment that is not
bipolar (Hauf et al., 2003). Thus, the function of Aurora B/Ipllp in sensing tension is not
clear: checkpoint deficiency in Aurora/Ipll impaired cells might result from an inability
to create detachment by clearing microtubules from kinetochores that are not under
tension. The Aurora kinases are the subject of intense scrutiny because of their frequent
amplification and overexpression in a variety of human cancers (Bischoff et al., 1998;
Taylor et al., 2004).
While Mps 1 and the Aurora/lpl 1 complexes are conserved between yeast and
mammals, at least one complex required for checkpoint function appears limited to
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higher eukaryotes. Each member of the Rough Deal (ROD)/Zeste-white 10
(Zw 10)/Zwilch or RZZ complex is required for checkpoint activation in nocodazole, and
the complex is collectively required for kinetochore localization of Mad 1 and Mad2
(Buffin et al., 2005; Karess, 2005; Scaerou et al., 1999). Intriguingly, the role of ROD
and Zw 10 in the checkpoint was first discovered by their requirement for kinetochore
localization of dynein, which may function to deplete Madl and Mad2 from kinetochores
during checkpoint inactivation (Scaerou et al., 2001; Starr et al., 1998). How the RZZ
complex influences Madl and Mad2 localization is not known, as direct interactions
between them have not been detected and neither Mad 1 nor Mad2 fractionates with the
large, 700kD RZZ complex. However, RZZ complexes in syncitial Drosophila embryos
cycle through kinetochores with the same kinetics as Mad2 and BubR1, suggesting that
they are positioned for sensing kinetochore status in the same way (Basto et al., 2004).
The RZZ complex has the distinction of being the only checkpoint complex in which
mutations are frequently detected in human cancers (Wang et al., 2004b). Coupled with
their non-conservation throughout evolution, this observation suggests that the RZZ
complex may have evolved as an additional layer of regulation atop the ancient "core"
checkpoint proteins.
1.5 Checkpoint inactivation
How can a cell arrested in mitosis by the spindle checkpoint resume progression
into anaphase once all kinetochores finally achieve proper bipolar attachment and
tension? Given the multiplicity of proven and potential APC/C inhibitors, it seems
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unlikely that checkpoint silencing could occur by a single mechanism. One possibility is
that the absence of unattached or untensed kinetochores simply halts generation of the
"wait anaphase" signal, and any existing signal decays passively until it falls below the
threshold required for Cdc20 inhibition. While this idea is attractive in its simplicity, it
predicts that the time to recover from arrest will vary widely between cells with
qualitatively or quantitatively different checkpoint-engaging lesions. Measuring and
comparing time differences in anaphase entry after checkpoint shutoff has proven
difficult in mammalian cells because of the reliance on microtubule poisons as tools for
activating the checkpoint. These drugs accumulate to wildly different levels in different
cell types and persist within cells for varying times after washout (Rieder and Maiato,
2004). Furthermore, drugs such as nocodazole and taxol are often applied at doses that
activate stress response kinases and pathways and thus affect cell cycle progression
differently than, for example, kinetochore protein RNAi. In addition, common
population-based assays such as FACS or immunoblotting do not give as precise
measurements of anaphase entry kinetics as do single cell assays. Thus, while it remains
possible that passive decay of checkpoint signal leads to variable kinetics of mitotic exit,
there is little data to argue for passive checkpoint inactivation in higher eukaryotes. In
comparison, the classic PtK1 experiments described in section 1.4.3 found that anaphase
ensued with a precise, robust time lag of 23+ 1 minutes after the final attachment event
regardless of the length of time spent in prometaphase. The essentiality of the checkpoint
and the kinetochore localization of checkpoint proteins in every mitosis argue strongly
for a default "on" state in metazoans, while in yeast the checkpoint is "off' until activated
by a lesion.
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In budding yeast, it has been proposed that cells can pass the metaphase-anaphase
transition without APC/C activation. Mutation of the phosphatase Cdc55p allows
inhibitory phosphorylation of the cyclin-dependent kinase Cdc28p, and adaptation to
prolonged spindle checkpoint arrest occurs when Cdc28 activity falls and cells enter
anaphase without degrading cylin B (Minshull et al., 1996; Rudner and Murray, 1996).
Cdc28p activity also activate APC/CCdc20 in yeast directly, suggesting that improper
Cdc28p activity or loss of Cdc55p could bypass spindle checkpoint signaling (Rudner et
al., 2000; Rudner and Murray, 2000). Because adaptation occurs only after prolonged
drug arrest, it may not reflect physiological checkpoint silencing, and this phenomenon
has not been observed in cells other than budding yeast.
If the checkpoint is not bypassed by direct APC/C inactivation, it might be turned
off actively by displacement of checkpoint proteins from the kinetochore. An elegant
mechanism for silencing might involve simple competition between microtubules and
checkpoint complexes for the same binding site on kinetochores. Because of the
interdependency of checkpoint proteins for kinetochore localization, their many binding
interactions, and the synergy of BubR1 and Mad2 activities in vitro, displacing these
complexes into the cytoplasm may extinguish further signal generation, though it may not
suffice to silence already active complexes or re-activate inhibited Cdc20.
Two candidate checkpoint inhibitors have been identified by yeast two-hybrid
screens for checkpoint protein interactors. Breast cancer specific gene 1, BCSG 1, binds
to BubR1 and may promote its degradation by the 26S proteasome (Gupta et al., 2003).
However, the function of BCSG1 in either checkpoint inactivation or mitotic progression
has not been established. Another protein, CMT2, was identified as a Mad2 interactor.
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In the following section I discuss relevant details of CMT2's discovery and present for
the first time data from public genome resources regarding the CMT2 locus and CMT2
expression.
1.5.1 Identification of CMT2
CMT2 was identified in a two-hybrid screen for human Mad2 binding proteins
(Habu et al., 2002). CMT2 lacks obvious homologs in budding or fission yeast, and
sequence analysis does not reveal known domains. CMT2 levels in synchronized HeLa
cells were low or absent in interphase, increased in S phase, and decreased late in the
subsequent M phase. CMT2 immunoprecipitates with Mad2 in late mitosis, but debate
exists over whether CMT2-Mad2 binding competes with or coincides with Cdc20 Mad2
binding (Habu et al., 2002; Xia et al., 2004). Overexpression of CMT2 causes a slight
decrease in the mitotic index of cell populations arrested in nocodazole, suggesting that
CMT2 can silence a strongly activated checkpoint. Depletion of CMT2 by antisense
oligonucleotides leads to apoptosis following a very transient delay in anaphase onset as
measured by FACS. CMT2 in these studies was observed in nucleoplasmic speckles in
mitosis and at the spindle midzone in anaphase and telophase. The authors proposed that
CMT2 acts by a "handoff" mechanism in which Mad2 is transferred from Cdc20 to
CMT2, thus allowing APC/C activation. Because cells treated with CMT2 antisense
progressed normally until metaphase and undergo apoptosis only in the presence of an
assembled spindle, the authors inferred that CMT2 also functions to suppress apoptosis
late in mitosis. In a subsequent study, the same authors examined the effect of CMT2
RNAi on HeLa cells and found mild impairment of checkpoint release by population
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FACS assay (Xia et al., 2004). In this study, CMT2 and Cdc20 bound Mad2
simultaneously, and CMT2 binding to Mad2-Cdc20 was sufficient for APC/C activation.
Thus, neither the basic function of CMT2 nor the details of it mechanism are clear. In
addition, the basic biology, expression, and conservation of CMT2 are not known.
1.5.2 Characterization of CMT2
Human CMT2 maps to chromosome 6p2 1.1, a region notable for its frequent
amplification and translocation in human cancers (Figure 1.4A). Northern blots
performed by the Kasuza cDNA Project using the EST probe KIAAO 110, which encodes
human CMT2, revealed that CMT2 mRNA is expressed ubiquitously, with enrichment in
testis, colon, and skeletal muscle (Figure 1.4B). Searches for CMT2 homologues by
iterative protein psiBLAST revealed broad but surprising species conservation. CMT2
gene homologs are present in the genomes of mammals, birds, fish, insect, and plants but
noticeably absent from nematodes and yeast (Figure 1.5A). As discussed above, C.
elegans possess holocentric chromosomes and have novel or highly divergent
kinetochore and checkpoint proteins. BLAST searches also revealed a second CMT2-
like protein in both mice and humans, which we term CMT2B. Human CMT2B is
predicted to be a 3' splice variant of hCMT2 but has not been detected experimentally
(data not shown). Mouse CMT2B differs from mmCMT2 throughout its sequence, and
reverse translation of mmCMT2B does not map to any locus in current builds of the
mouse genome, suggesting that the database mmCMT2B sequence may contain errors.
Comparison of CMT2 protein sequences reveals three highly conserved regions,
termed CR1-3 (Figure 1.5B and 1.6A).
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Figure 1.4: Genomic locus and expression of CMT2
(A) The genomic of human CMT2 at chromosome 6p21.1 as visualized by the NCBI
Map Viewer (www.ncbi.nlm.nih.gov). The sequence is oriented such that the 6p
telomere is at the top and the centromere is at the bottom. CMT2, listed as MAD2L1BP,
is highlighted (red). Neighboring genes are depicted at their relative positions. (B)
Tissue expression of CMT2. Human EST KIAA0110, which encodes CMT2, was used
as a Northern blot probe against mRNA samples from a panel of 16 adult human tissues.
This data is from the public dataset at www.kazusa.or.jp/huge.
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Figure 1.5: Evolutionary conservation of CMT2
(A) Phylogenetic tree analysis of CMT2 protein sequences from 17 eukaryotic species.
Numbers indicate relative distance from the consensus sequence. (B) Alignment and
consensus of conserved regions 1-3 from 17 CMT2 sequences. Yellow indicates
completely conserved residues. Blue indicates blocks of conservation. Green indicates
blocks of similarity. Light green type indicates weak similarity. Phylogenetic analysis
and alignments were performed using the AlignX program of the Vector NTi software
suite.
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Figure 1.6 CMT2 domain structure, splicing, and SNPs
(A) Similarity levels over the aligned length of CMT2 protein sequences from 17
eukaryotic species. Numbering is based on the consensus sequence from alignments
generated in Figure 1.5. The low degree of similarity in consensus residues 1-160 are
due to the unusually long N-terminus of T. rubribes CMT2. (B) Splicing of human
CMT2 mRNA and CMT2 protein domain structure. The putative bipartite NLS at
positions 99-116 was reported by Habu et al. (C) Single nucleotide polymorphisms
(SNPs) in human CMT2 genomic sequence. SNPs deposited in the NCBI Genome Build
35.1 are imposed on the human CMT2 mRNA and genomic locus.
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At the extreme C terminus CR3 (human residues 259-272) is the most highly conserved,
with 61.5% similarity over 17 species. CR1 (human 62-88, 59.3%) and CR2 (human
125-169, 45.3%/0) are less conserved. By comparison, the predicted bipartite NLS (human
99-116) shows no conservation (4.2% similarity). The human CMT2 locus at 6p21.1
contains three exons (Figure 1.6B), with conserved regions clustering in exons 2 and 3.
The amino termini of CMT2 homologs show little sequence conservation, and certain
species such as T. rubribes (fugu) contain much longer amino terminal sequences.
Human genome databases contain evidence of four single nucleotide polymorphisms
(SNPs), all of which are in non-coding regions (Figure 1.6C).
1.6 Conclusion
The spindle checkpoint poses a unique biochemical and cell biological problem.
A brief, critical moment in the life of the cell depends both on the proper sensing of
complex moving structures and the proper coupling of mechanical signals to cell cycle
progression. This mechanism must be exquisitely precise, rapid, and sensitive. Because
the transcriptional machinery is largely silent during mitosis, the spindle checkpoint must
be mediated almost entirely by the action of proteins. As a result, it is a field rich in
opportunities for the study of protein interactions, modifications, and conformational
changes. At the same time, the dynamic behavior of these proteins and the complexity of
chromosome-spindle interactions provide many opportunities for cell biological
exploration.
Much progress has been made by combining the power of yeast genetics with the
high-resolution imaging of mammalian cells, allowing the identification and early
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characterization of the canonical checkpoint proteins. However, comparison of yeast and
mammals has exposed the differences in their spindle checkpoints that overlie their
commonalities. As the field moves forward, the pressing questions fall into two broad
categories.
First, at a biochemical and structural level, what are the mechanisms by which
spindle checkpoint proteins localize to the kinetochore, interact with each other, and
transduce the "wait anaphase" signal? Many of the molecules involved were identified
more than a decade ago but still have not been assigned a clear function. Mad2 is the
most intensively studied of the checkpoint proteins, yet new Mad2 functions continue to
be found and new mechanisms for its action proposed. In chapter 2 of this thesis I focus
on the interaction of Mad2 with different classes of binding proteins and discuss a new
model for Mad2 binding, activation, and regulation.
Second, given the increased complexity of the spindle checkpoint in metazoans,
what are the consequences of checkpoint dysfunction in mammals? The differences
between mammalian and yeast checkpoints likely stem from the added complexity of
metazoan centromeres and kinetochore-microtubule interactions, but they are likely
reinforced by the deleterious effects of chromosome missegregation in multicellular
organisms. The connection between the spindle checkpoint and tumorigenesis remains
unclear, but existing work suggests that cancer rarely, if ever, results from simple
mutation or deletion of checkpoint genes. Less simplistic models of checkpoint
dysfunction must necessarily consider metazoan-specific aspects of checkpoint signaling
such as checkpoint gene transcription, apoptosis following checkpoint arrest or
chromosome missegregation, and checkpoint silencing. The question of how an active
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checkpoint is inactivated in human cells remains unanswered. In chapter 3 of this thesis I
examine the role of CMT2 in opposing Mad2 function and propose a model for CMT2
function at kinetochores and in the cytosol. Finally, in chapter 4, I discuss a new
cooperative model of checkpoint activation and propose further avenues of research.
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Chapter 2
Conformation-specific Binding of Mad2 by Spindle Checkpoint Proteins
Madl, Cdc20, and CMT2
73
2.1 Abstract
The spindle assembly checkpoint monitors kinetochore-microtubule interactions
in mitosis to prevent errors of chromosome segregation. Mad and Bub checkpoint
proteins localize to unattached or maloriented chromosomes and generate a signal that
delays anaphase onset until all chromosomes achieve bipolar attachment. This signal is
transmitted to Cdc20, an essential activator of the anaphase promoting complex. Mad2
plays a critical role in checkpoint signaling through its association with partner proteins
such as Mad , Cdc20, and the recently-discovered CMT2 protein. In this paper, we
compare directly the association of Mad2 with its binding partners and show that whereas
Madl, Cdc20, and other Mad2 interactors compete with each other with each for binding
to a single site on Mad2, CMT2 binding is non-competitive. Madl and Cdc20 constitute a
class of high affinity interactors that contact the Mad2 peptide-binding cleft. CMT2
selectively binds the closed conformation of the Mad2 C-terminal tail. As a consequence,
ternary complexes containing Mad2, CMT2 and either Madl or Cdc20 can form. Based
on the Mad2 crystal structure, we propose that CMT2 inhibits Mad2 function by capping
the Mad2 homodimerization surface.
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2.2 Introduction
The spindle assembly checkpoint constitutes a signal transduction system that
makes the dissolution of sister chromatid cohesion dependent on correct kinetochore-
microtubule binding (Chan and Yen, 2003; Cleveland et al., 2003; Hoyt, 2001; Lew and
Burke, 2003; Musacchio and Hardwick, 2002). Spindle checkpoint genes were first
isolated in S. cerevisiae and are highly conserved among eukaryotes (Hoyt et al., 1991; Li
and Murray, 1991). During prometaphase in animal cells, Madl, Mad2, BubRl, Bubl,
Bub3 and Mpsl accumulate to high levels on kinetochores and then dissociate as
microtubule attachments form. Mad and Bub proteins remain bound to the kinetochores
of unattached and maloriented chromosomes, however, and maintain mitotic arrest until
spindle assembly is complete (Hoffman et al., 2001). Checkpoint activation leads to the
inhibition of Cdc20, an essential activator of the anaphase promoting complex/cyclosome
(APC/CCdC20'. APC/CCdc2O is a multi-subunit ubiquitin ligase that targets cyclin B,
securin and a variety of other proteins for destruction at the metaphase-anaphase
transition (Nasmyth, 2002; Peters, 2002). Mad2 and BubR1 can be co-purified as part of
a large mitotic checkpoint complex (MCC) and the two proteins appear to function
together in Cdc20 regulation (Sudakin et al., 2001). Thus, we can think of kinetochores as
the input to the spindle checkpoint pathway and activated Mad2 and BubRl as the output.
Despite intense study, the mechanisms of checkpoint signals generation at
kinetochores and propagation through the cell to regulate APC/CCdc2 remain poorly
understood. Of particular interest are the activation of Mad2 at kinetochores and the
Mad2-dependent inhibition of Cdc20. Dissection of Mad2 activity has proven difficult
due to its multiple binding partners and dynamic localization. In cells with an activated
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checkpoint, Mad2 is found both on kinetochores and in the cytosol. FRAP experiments
show that Mad2 cycles between kinetochore-associated and cytosolic pools with a half-
life of 25 sec., although a subset of Mad2 also remains stably kinetochore-bound (Howell
et al., 2000). A considerable body of data suggests that the formation of Mad2-Madl and
Mad2-Cdc20 complexes is essential for Mad2 trafficking and checkpoint signaling. Madl
lies upstream of Mad2 in the checkpoint pathway (Chen et al., 1999; Chen et al., 1998;
Luo et al., 2002), is highly concentrated at kinetochores (Chen et al., 1998) and, at least
in yeast and frogs, is required for the formation of Mad2-Cdc20 complexes (Chung and
Chen, 2002; Hwang et al., 1998). In contrast to Madl and Mad2, Cdc20 and APC are
found at multiple locations in cells such as the kinetochore, spindle, and spindle poles
(Kallio et al., 2002). Thus, it is generally assumed that checkpoint signaling involves the
Madl -dependent activation of Mad2 at kinetochores followed by Mad2's dissociation
from kinetochores and re-association with cytoplasmic Cdc20.
Structural analysis of Mad2 shows that it has two meta-stable conformations that
interconvert on a time scale of hours in the absence of bound ligand (Luo et al., 2004).
These are refered to as "open" (O-Mad2) and "closed" (C-Mad2). The formation of the
closed conformation of Mad2, which is facilitated by Madl and Cdc20 binding, involves
a major rearrangement of the Mad2 C-terminal tail (Luo et al., 2002; Sironi et al., 2002).
Crystallography of Madl-Mad2 co-complexes reveals that Madl binds within a cleft in
Mad2 and that tail closure creates a "safety belt" locking Madl in place (Sironi et al.,
2002). NMR analysis suggests a similar mode of binding for Cdc20 (Luo et al., 2002),
although it remains unclear how closely the large multi-component checkpoint complexes
found in cells correlate with Mad2 binding activities observed for purified proteins. A
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paradox of these structural findings is that they involve Madl-Mad2 and Mad2-Cdc20
complexes whose half-life of 16 hours or more is much greater than the half-life of the
checkpoint signal (which shuts off in cells within minutes of chromosome-microtubule
binding (Rieder et al., 1994)) or the 25 sec required for Mad2 to cycle between
kinetochore and cytosolic pools (Howell et al., 2000). The high affinity with which
Mad2 binds to Mad 1 and Cdc20 seems incompatible with dissociation from one protein
and re-association with the other, and even if this were possible, it is not clear how an
activated state could be transmitted from Madl to Cdc20. One possibility is that Mad2
might be co-valently modified. Phosphorylation of Mad2 has been detected in human cells
(although not in yeast) and is proposed to block binding to both Mad and Cdc20 rather
than to transmit a signal (Wassmann et al., 2003). A second possibility is that Mad2
signaling might involve a switch between the two Mad2 conformations, which have been
shown to have different potencies as Cdc20 inhibitors (Luo et al., 2004). A third
possibility is that Mad2 might bind to a protein other than Madl and Cdc20 and
formation of this complex might be involved in signal transmission.
Recent work points to a variation on this third possibility that is somewhat
counterintuitive: the extra Mad2-binding protein is Mad2 itself. De Antoni et al have
shown that Mad2 undergoes selective heterotypic homodimerization in which open Mad2
(O-Mad2) can dimerize with closed, ligand-bound Mad2 (C-Mad2), but neither
conformer can self-associate (De Antoni et al., 2005). Mutation of two residues, R133A
and Q134A, abrogates Mad2 dimerization, and such mutants cannot localize to
kinetochores in vivo, presumably because they cannot bind Mad l-C-Mad2 complexes.
De Antoni et al propose that Mad2 dimerization serves to enrich O-Mad2 at kinetochores,
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thus positioning it for Cdc20 binding when the checkpoint becomes active. They propose
that, in theory, heterotypic Mad2 dimerization could also be nucleated on C-Mad2-Cdc20
complexes in the cytoplasm, thus providing a platform for signal amplification. If
correct, this model of Mad2 complex assembly would resolve the apparent paradox of
stable kinetochore complexes and rapid exchange of Mad2 between the kinetochore and
the cytosol. However, if O-Mad2 activation is nucleated on C-Mad2 complexes, which
are known to exist throughout the cell cycle (Iouk et al., 2002; Poddar et al., 2005; Shah
et al., 2004), it remains unclear how either generation of active Mad2 or amplification of
Mad2 signal is made sensitive to kinetochore-microtubule attachment. Furthermore,
neither Mad2 dimerization nor its rapid cycling through kinetochores has been observed
in yeast, suggesting that they may not be necessary for some aspects of Mad2 checkpoint
function. Finally, Mad2 is not sufficient for checkpoint activity in the absence of other
checkpoint effectors such as BubR1, which may act synergistically (Sudakin et al., 2001).
The work of De Antoni et al in identifying an intermediate step in checkpoint activation
calls into question the exact molecular composition of the "wait anaphase" signal.
BubR1 and Mps I cycle through kinetochores with kinetics similar to Mad2 (Howell et
al., 2004; Shah et al., 2004) and it remains to be seen how Mad2 dimerization relates to
formation of a larger checkpoint complex such as MCC.
CMT2 has recently been shown to be an additional Mad2 binding partner in
higher eukaryotes. It has been proposed that CMT2 negatively regulates the checkpoint
by competing with Cdc20 for Mad2 binding at the metaphase to anaphase transition
(Habu et al., 2002). However, it is not known whether CMT2 binds to Mad2 in the same
manner as Mad 1 and Cdc20 and its precise roles in regulating mitotic regulation remain
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unclear. In this chapter, we investigate the biochemistry of interactions between Mad2
and its binding partners, focusing particularly on CMT2. We demonstrate that short
peptides in Mad and Cdc20 bind with high affinity to Mad2 in a manner that requires
pocket and tail residues, but that CMT2 interacts with Mad2 in a fundamentally different
manner that is not competitive with Madl or Cdc20. This different binding mode also
manifests itself as a difference in function that is described in the following chapter:
while Mad 1 and Cdc20 act to maintain cell cycle signaling, CMT2 antagonizes it,
apparently by associating with and inactivating the Mad2 closed conformer.
2.3 RESULTS
2.3.1 Identification of Mad2-binding regions in Madl and Cdc20
As a first step in dissecting interactions between Mad2 and its binding partners,
we mapped the sequences in Madl and Cdc20 required for Mad2 association. Mad2 has
been shown to bind stably to a 100 residue fragment of Madl (Sironi et al., 2002) and to
the N-terminal 153 residues of Cdc20 (Zhang and Lees, 2001). Mutations near positions
205-210 of budding yeast Cdc20 and 131 of fission yeast Cdc20 (Slp 1) abrogate Mad2
association and disrupt checkpoint control (Hwang et al., 1998; Kim et al., 1998).
However, Mad2 residues required for Mad2-Mad 1 and Mad2-Cdc20 interaction have not
been determined experimentally. Indeed, one recent structural analysis relied on phage
display to find short tight-binding Mad2 peptides (Luo et al., 2002). We therefore
examined the ability of in vitro translated fragments of Madl, Cdc20, and CMT2 to bind
bacterially expressed GST-Mad2 in a simple pull-down assay (Figure 2. 1A). Both hMadl
and hCdc20 exhibit striking species-specificity and bind well to hMad2 but poorly to S.
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Figure 2.1: Mapping Mad2 binding interactions
(A) hMadl, hCMT2, hCdc201'-6 5, and hCdc2016 5500 were 35S-labeled by in vitro
translation and incubated with GST, GST-scMad2, or GST-hMad2. After centrifugation
and washing, bound proteins were quantitated following SDS-PAGE and
autoradiography. The input lane represents 20% of the total labeled protein in the
binding reaction. (B) Schematic of Madl mapping experiments. In vitro translated Madl
fragments corresponding to the indicated sequences were analyzed by pull-down as
described in (A). Fragments of 200 residues or less were translated as fusions to maltose
binding protein (MBP) to ease detection on gels. (C) Short Mad 1 and Cdc20 fragments
bind Mad2. Madl and Cdc20 fragments spanning the indicated residues were fused to
MBP and binding to yeast (y) or human (h) Mad2 was assayed as in (A). Graph indicates
mean and range of two independent experiments. (D) Nine residue motifs in both Madl
and Cdc20 are required for Mad2 binding. Full length Madl, MadlA9 lacking residues
541-549, Cdc201'-6 4 and Cdc20 -164 A9 lacking residues 129-137 were examined in pull-
down assays as described in (A). Binding to non-deleted proteins was set at 100% in both
cases. Error bars show the range of two independent experiments.
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cerevisiae Mad2, while hCMT2 binds nearly equally to yeast and human Mad2. Under
these assay conditions, a deletion series identified a nine residue Madl sequence
(positions 538-546) as the sole Mad2-binding sequence in Mad (Figure 2. l1B and 2. 1C
and data not shown). Similar truncation analysis of Cdc20 limited its Mad2-binding
activity to a 9aa region in the amino terminus (Figure 2.1A and 2.1C). When these nine
residue regions were deleted from full-length Madl and Cdc20, binding to Mad2 was
abolished (Figure 2.1 D). Significant truncation of CMT2 from either the N- or C-
terminus also abrogated Mad2 binding (data not shown and M. Mapelli, personal
communication).
2.3.2 Refinement and characterization of the Mad2-binding motif
When a peptide array comprising successive 20 residue peptides spanning Madl
positions 538-546 was probed with in vitro translated Mad2, two tight-binding peptides
were identified (Figure 2.2A). Similar array analysis of human Cdc20 12mers identified
a sequence centered on position 130 as sufficient for high affinity Mad2 association
(Figure 2.2B). When an array of peptides carrying point mutations in the tightest binding
Cdc20 peptide was probed with recombinant Mad2, Cdc20 positions 129-133 were found
to be critical for Mad2 association (Fig 2.2C). Combining mapping data and sequence
analysis of Madl and Cdc20 from fourteen different species results in an overall
consensus Mad2-binding sequence of (K/R)(I/V)(I/V/L)XqXXXP (Figure 2.2D and E
and Supplemental Figure 2.1).
Synthetic peptides containing this consensus motif were assayed for Mad2
binding by surface plasmon resonance (SPR) and found to have non-ideal Langmuir
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Figure 2.2: Refinement of the Mad2-binding motif
(A) Successive 20-residue Madl peptides spanning the region 532-562 and synthesized
on a nitrocellulose membrane were probed for Madl binding using 35S-labeled Mad2
translated in vitro. Filters were scanned on a PhosphorImager for quantitation. Bars
indicate Mad2 binding activity for each peptide spot in arbitrary units. (B) As in (A),
successive 12 residue peptides from Cdc20 residues 119-148 were synthesized on filters
and probed with 35 S-labeled Mad2. (C) Synthetic 12-residue Cdc20 (127-138) peptides
representing wild-type (EAKILRLSGKPQ) and mutated sequences were spotted and
probed with 35S-labeled Mad2 as in (C). (D) Alignment of the minimal Mad2 binding
motif from several proteins. Asterisks indicate residues whose mutation abrogates Mad2
association in vivo; bold text denotes residues that conform to the Mad2-binding
consensus. Arrows indicate the position of known checkpoint-defective mutants in
budding yeast. See Table for further details. (E) Graphical depiction of the relative
contribution of each residue in the optimal Mad2-binding motif from all known Cdc20
and Madl homologs, human TACE, and human ERP. Graphic was generated using the
WebLogos program.
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association and dissociation kinetics suggestive of a conformational change (data not
shown). To estimate the affinity of Mad2 for a 25-residue Madl peptide, Mad2 was
immobilized and probed with Mad 1 peptide that had been pre-bound to titrated Mad2
(Figure 2.3A), giving an approximate Kd of 25nM. Isothermal titration calorimetry (ITC)
with bacterially expressed Mad2 showed high affinity binding (Kd of 20-40 nM;
Figure2.3B and Table 2.1) to 20-25 residue peptides and to internal peptides as short as
nine residues (Kd of 80 nM for Madl KVLHMSLNP). From these data we conclude that
a short nine residue epitopes at Mad1 54 1' 54 9 and Cdc20129-137 are necessary and sufficient
for tight Mad2 binding.
With this consensus sequence we identified by inspection putative Mad2-binding
sequences in other Mad2 partners of unknown physiological significance, the estrogen
receptor ER[l and the metalloprotease TACE/ADAM17 (Nelson et al., 1999; Poelzl et al.,
2000). Peptide array and mutant analysis (Supplemental Figure 2.2) revealed that these
sequences were indeed the sites of Mad2 interaction and that both mERP and TACE bind
to Mad2 in manner similar to Mad and Cdc20. Scanning the human genome with an
optimized consensus motif revealed a wide array of putative Mad2 binding proteins
which are summarized in Table 2.2. Cdc20 possesses a second putative Mad2 binding
site in its WD domain, but this domain does not exhibit measurable Mad2 binding
(Figure 2.1 A) and likely is constrained within the tight WD fold. In contrast, even low
stringency searches with the Mad2 consensus sequence did not reveal any evidence of a
second Mad2 binding site in human Madl, confirming our mapping data. Moreover, no
potential Mad2 binding sites were found in CMT2, implying that CMT2 might bind to
Mad2 in a different manner than Mad and Cdc20.
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Figure 2.3: A Mad1534-558 peptide binds Mad2 with high affinity
(A) Synthetic Mad 1534-558 was immobilized on BIAcore sensor chips (BIAcore
International SA, Neuchatel, Switzerland). Recombinant Mad2 was pre-incubated with
indicated concentrations of Mad 1534-558 peptide and then passed over Mad 1534-558-coupled
surfaces. Binding was followed by surface plasmon resonance. (B) Calorimetric analysis
of Mad 1S4-558-Mad2 binding. Mad153s4-58 peptide was injected with mixing into a
solution of Mad2 and evolved enthalpies were measured. Graph shows evolved
enthalpies fit with the standard model data for a single binding site.
Model: OneSites
x'= 125085
N 0.5889 ±0.002062
K 5.426E7 ±5.3385E6
deltaH -3.189E4 ±187.9
dekaS -73.72
Table 2.1
Table I: Affinities of Mad2-peptide complexes by ITC
Protein Residues Kd (nM) Source
Madl 534-558 DYDQSRTKVLHMSLNPTSVARQRLR 18.411.83 1
539-557 RTKVLHMSLNPTSVARQRL 36.7±20.0 1
541-549 GSGKVLHMSLNPGSG 82.6+18.9 1
523-550 EAQLERRALQGDYDQSRTKVLHMSLNPT 270 2
540-551 TKVLHMSLNPTS ND 1
Cdc20 124-138 DVEEAKILRLSGKPQ 28.417.74 1
127-141 EAKILRLSGKPQNAP 15.6±3.71 1
129-137 GSGKILRLSGKPGSG 36.518.94 1
129-147 KILRLSGKPQNAPEGYQNR 42.717.03 1
118-138 LNLNGFDVEEAKILRLSGKPQ 100 3
127-137 EAKILRLSGKP 3600 4
TACE 723-734 SVRIKPFPAPQ ND
mERI3 180-191 GYRIVRRQRSAS ND
MBP1 SWYSYPPPQRAV 90 2
MBP2 DARIIKLPVPKP ND
(1) This study
(2) De Antoni et al., 2004 (submitted)
(3) Sironi et al., 2002
(4) Luo et al., 2002
Residues in bold were added as spacers for the terminal charges.
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2.3.3 Binding of Mad2 to CMT2 is noncompetitive with Cdc20 and Madl
To determine directly whether the manner of CMT2 binding to Mad2 differs from
that of Mad 1 and Cdc20, binding competition studies were performed. Bacterially-
expressed GST-Mad2 was incubated sequentially with peptides from Madl or Cdc20 or
control peptides and then with in vitro translated human Madl, Cdc20 or CMT2. Mad2-
bound proteins were then isolated by centrifugation and quantified on gels. The pull-
down experiments were reproducible, although 6 hour binding reactions were not
representative of true equilibrium binding states for 20 nM interactions. Using pull-
downs, we observed that Cdc20-Mad2 binding was reduced 10 to 20-fold in the presence
of excess Madl or Cdc20 peptide as compared to a scrambled control peptide (Figure
2.4A). Similarly, Madl-Mad2 binding was reduced by an excess of either Madl or
Cdc20 peptide (Fig 2.4B). For reasons that are not clear, a tight-binding Cdc20 peptide
was less effective as an inhibitor of Mad I-Mad2 binding than an equal affinity Mad l
peptide. This phenomenon was reproducible and may reflect the non-equilibrium
conditions of the competition assay. Importantly, the observed cross-competition between
Madl and Cdc20 peptides confirms the expectation from sequence analysis that the two
proteins bind to a common site on Mad2. This competition is not affected by
immobilization of Mad2 on a solid support, as peptides also compete for Mad2 binding in
solution as assayed by native gel electrophoresis (Supplemental Figure 2.4A and 2.4B).
In contrast, the binding of CMT2 to Mad2 was not affected by the presence of excess
Madl or Cdc20 peptides (Fig 2.4C). Thus, CMT2 binds to Mad2 in a fashion that is not
competitive with Madl and Cdc20.
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Figure 2.4: Madl and Cdc20 binding peptides do not compete with CMT2 for Mad2
binding. Purified GST-Mad2 on beads was preincubated overnight with buffer, Madl
peptide (534-558), Cdc20 peptide (129-147), or a scrambled Madl control peptide and
then mixed for 6 hours with in vitro translated (A) Cdc20, (B) Madl, or (C) CMT2 and
pull-downs performed as described in Figure 1. Bars indicate percentage of co-
precipitated in vitro translated protein; error bars show the range of two independent
experiments.
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2.3.4 CMT2 binds the Mad2 C-terminal tail
As a different approach to probing interactions involving Mad2, we constructed
point mutations in Mad2 surface residues thought to play a role in Madl binding.
Structurally., these mutations comprise two distinct classes: cleft mutations lying in the
Mad2 peptide-binding sheet and tail mutations lying in the C-terminus of the protein and
along the P-strand formed when the C-terminal tail closes back over the binding cleft to
form the "safety belt" (Figure 2.5A). Eight mutant Mad2 proteins were expressed in E.
coli, purified to homogeneity and analyzed in parallel for binding to Madl, Cdc20 and
CMT2 (Figure 2.5B). Both cleft and tail mutations in Mad2 were observed to abrogate
binding to Mad 1 and Cdc20, consistent with predictions from the Mad 1 -Mad2 structure.
These data suggest that it may be possible to identify Mad2 mutations that discriminate
between binding to Madl and Cdc20. V197R, for example, binds moderately well to
Madl but not at all to Cdc20 in a pull-down assay. It will be necessary, however, to
recapitulate this finding in vivo to determine its utility in dissecting the mechanisms of
checkpoint signaling. Importantly, three double-mutations in the cleft exhibited clear
separation-of-function in that they bound well to CMT2 and poorly or not at all to Mad 1
or Cdc20. In contrast, H19lA, S195D and V197R, which lie in the tail of Mad2,
abolished binding to CMT2 as well as to Mad and Mad2. We conclude from these data
and from competition experiments that, unlike Mad and Cdc20, CMT2 does not bind to
Mad2 by inserting into the cleft but by contacting either the C-terminal tail or regions
whose structure are affected by tail positioning. Conformational changes in the Mad2 C-
terminal tail are responsible for switching Mad2 between open and closed states, and this
conformational switch may direct CMT2 binding.
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Figure 2.5: Mad2-CMT2 binding involves the Mad2 C terminus but not the peptide-
binding cleft. (A) Mad2 mutants in the tail (blue) or cleft (red) residues of Mad2.
Yellow backbone depicts the Mad2-binding portion of Madl from Sironi et al (Sironi et
al., 2002). (B) Binding of wildtype or mutant GST-Mad2 to Madl, Cdc20, or CMT2
translated in vitro was assessed using a pull-down assay as described in Figure 1. Bars
indicate percentage of co-precipitated protein; error bars show the range of two
independent experiments. Mad2 pseudophosphorylation mutants S195D, 3xS-D, and
4xS-D are named following the convention of Wassmann (Wassmann et al., 2003). 3xS-
D incorporates mutations at positions S 178, S 185, and S 195, all of which lie in the Mad2
tail. 4xS-D has an additional mutation at S 170 in the overlying safety belt. Equal
loading of GST-Mad2 mutants was ensured by quantitation of mutant proteins on SDS-
PAGE gels followed by Coomassie staining.
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2.3.5 Formation of ternary CMT2 complexes in vitro
The cross-competition and mutant analysis described above strongly suggests that
CMT2 binds to Mad2 in a distinct fashion from Mad and Cdc20. If this is true, then it
should be possible to form ternary complexes involving CMT2, Mad2 and either Madl or
Cdc20. To test this idea, gel filtration chromatography was used to analyze the
hydrodynamic properties of various complexes assembled in vitro from recombinant
proteins and protein fragments. Bacterially-expressed Mad2 eluted from a Superdex 75
column as a dimer (Figure 2.6A), while CMT2 eluted from the same column in a position
consistent with a monomer. The behavior of Mad2 under these conditions has been
analyzed in detail previously and reflects the existence of an equilibrium between open
and closed Mad2 states and between monomeric and dimeric forms (De Antoni et al.,
2005; Luo et al., 2004; Sironi et al., 2001). When CMT2 and Mad2 were mixed and
then subjected to column analysis, all of the CMT2 and a fraction of the Mad2 co-eluted
at an apparent molecular weight larger than Mad2 dimer and consistent with a 1:1
Mad2:CMT2 complex (Figure 2.6A, lower panel fractions 2-8). The fraction of Mad2
that did not bind CMT2 (lower panel fractions 9-10) may represent a conformer pool that
is not competent for CMT2 binding. This pool elutes at the Mad2 monomer size and
suggests that CMT2 binding dissociates the C-Mad2-O-Mad2 dimer into a Mad2-CMT2
dimer and a Mad2 monomer. Similar dimer dissociation is observed with binding of
synthetic peptides to recombinant Mad2 (Figure 2.6D red trace, Supplemental Figure
2.4E) and is consistent with the idea that single Mad2 conformers cannot homodimerize
(De Antoni et al., 2005). This suggests that in this in vitro context CMT2 is binding to
either C-Mad2 or O-Mad2, but not to both or to a Mad2 dimer.
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Figure 2.6: Formation of ternary complexes involving CMT2, Mad2, Madl and Cdc20
Size exclusion chromatography of complexes containing Mad2, CMT2 and other proteins
on Superdex 75 (A, B, C) or Superdex 200 (D). In each panel, column traces are shown
above and Coomassie-stained SDS-PAGE gels of successive fractions are shown below.
Colored traces represent the elution of profile of individual components and the heavy
black trace represents the elution profiles of mixtures following 1 hr of incubation at
room temperature. Molecular weight markers are shown as a dotted line. Experiments
were performed with CMT2 alone and CMT2 mixed with (A) wild-type Mad2, (B) a
Mad2AC mutant lacking the C-terminal tail, (C) Mad2 co-expressed with Mad1485584, or
(D) Mad2 Cdc20 bound to Cdc20 (111-138) peptide.
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Because O-Mad2 and C-Mad2 cannot be distinguished chromatographically, we
tested the ability of CMT2 to bind a conformation-specific Mad2 mutant. Mad2AC lacks
C-terminal residues 196-205, does not bind Madl or Cdc20, and exerts a dominant
negative effect on checkpoint activation in nocodazole (Luo et al., 2000; Luo et al.,
2002). Mad2AC did not shift CMT2 into a higher molecular weight form (Figure 2.5B),
suggesting that CMT2 specifically requires an intact Mad2 tail for binding.
Peptide fragments of Madl and Cdc20 do not compete with CMT2 for Mad2
binding (Figure 2.4C). While it is possible that CMT2 forms ternary complexes with
Mad2 and either Cdc20 or Mad 1, it is also possible that CMT2 either actively displaces
Mad2 ligands (abu et al., 2002) or stabilizes Mad2 in a conformation that promotes
peptide release. To test whether a ternary complex can form with Mad 1, recombinant
CMT2 was mixed with Mad2 that had been co-expressed with a 100-residue fragment of
Mad Il (co-expression of Mad2 with Mad1485-584 is necessary for solubility; Sironi et al.
2002). Gel filtration revealed formation of a species that eluted more rapidly than either
CMT2 or Mad2- Mad1485-584 alone and represented a single large complex containing all
three proteins (Fig 2.5C). When eluted fractions were analyzed by SDS-PAGE and
Coommassie staining, stoichiometric amounts of each protein were observed, suggestive
of a 1::1: or 2:2:2 complex.. To investigate whether a triple complex could also assemble
between CMT2, Mad2 and Cdc20, Cdc20 peptide in excess was added to CMT2 and
Mad2. All of the Mad2 and CMT2 were observed to shift into a single large species
(Figure 2.5D). Under the conditions used here, Mad2 is known to bind avidly to Cdc20
peptide and we presume that CMT2-Mad2 association is increased in the presence of
peptide because Mad2 is driven into a closed conformation (see discussion for details).
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We conclude from these data that stable Madl-Mad2-CMT2 and Cdc20-Mad2-CMT2
ternary complexes can assemble from recombinant proteins and that CMT2 must
therefore bind to the closed conformation of Mad2 regardless of ligand occupancy.
2.4 DISCUSSION
Here we report a biochemical analysis of interactions between the spindle
checkpoint protein Mad2 and three binding partners known to play a role in mitotic
regulation: Mad l, Cdc20 and CMT2. We establish that Mad2 binds to these three
proteins in two distinct ways. Peptides as short as 9 residues derived from Madl, a
protein which lies upstream of Mad2 in the checkpoint signaling pathway, and Cdc20, a
downstream protein, compete with each other for binding to a common site on Mad2.
High resolution structural analysis has shown that this binding involves interactions
between Mad2 and peptide ligands within a defined cleft, as well as a major structural
rearrangement of Mad2 from an open into a closed conformation (Luo et al., 2002; Sironi
et al., 2002). In the closed conformation, the C-terminal tail moves over the cleft
(forming a "safety belt") and blocks ligand release. Proteins such as TACE and ERP,
which make tight complexes with Mad2 of unknown physiological significance, also bind
in the Mad2 cleft. In contrast, we find that CMT2 binds to Mad2 in a distinct fashion that
is not competitive with Madl and Cdc20 but appears to be selective for the closed Mad2
conformation. As a consequence, stable triple complexes comprising Mad2-CMT2-
Madl or Mad2-CMT2-Cdc20 can form. RNAi and over-expression studies described in
chapter 3 establish that the structural distinction between Madl/Cdc20-Mad2 and CMT2
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-Mad2 binding reflects a distinct role for CMT2 as a repressor of Mad2-mediated spindle
checkpoint signaling in vivo.
2.4.1 Binding of Mad2 to Madl, Cdc20 and CMT2
Because the checkpoint signal is "transmitted" in some manner from Madl to
Cdc20, an obvious question is whether Mad2 binds identically to its target sequence in
these two proteins. It has been proposed that Mad2 might be channeled from Madl to
Cdc20 (Luo et al., 2002; Luo et al., 2004; Sironi et al., 2002), although the mechanisms
behind such exchange remain obscure. De Antoni et al suggest that binding of an
additional O-Mad2 molecule to C-Mad2-Madl primes and positions O-Mad2 for binding
to Cdc20. Structural analysis establishes that residues along an extended cleft in Mad2
are responsible for sequence-selective binding to extended peptide motifs in Mad and
Cdc20. However, some controversy remains whether the short sequences implicated in
binding by structural analysis are really sufficient for high-affinity association of Mad 1
and Cdc20 to Mad2; one recent structural analysis, for example, relied on phage display
to find high-affinity Mad2-binding peptides (Luo et al., 2002). It has been suggested that
Mad I-Mad2 binding may be stabilized either by Madl dimerization or by Madl
sequence elements outside the Mad2-binding region, although this has been difficult to
interpret due to asymmetry of the two Madl -Mad2 units in the crystal structure (Sironi et
al., 2002). The peptide-based analysis in this chapter, in addition to mutagenesis and ITC
data, establishes conclusively that short nonamer peptides from Mad and Cdc20 are both
necessary and sufficient for high affinity Mad2 binding with a Kd - 20-40 nM. In
addition, we show that no other sequence in Mad 1 is sufficient for binding Mad2. This
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supports the assertion that Mad2 dimerization is respondible for formation of an O-Mad2-
C-Mad2-Madl complex and not a second Mad2 binding site on Madl (DeAntoni et al.,
2005). As expected, the mutation of Mad2 residues along the cleft involved in Madl and
Cdc20 binding abrogates association in vitro (Figures 2.5 and 2.7A and B). Short Madl
and Cdc20 peptides also compete with each other for binding to Mad2 (Supplemental
Figure 2.4A) whereas peptides mutated at contact positions lack Mad2 binding activity.
Moreover, when Mad2-binding nonamers in Cdc20 and Madl are aligned from the
fourteen species for which they are available, a clear consensus can be derived -
((K/R)(I/V)(I/V/L)XqXXXP - representing a refinement of a previously described
consensus (Sironi et al., 2002)).
In the Mad2-Madl crystal structure, residues 1-5 of the binding nonamer are
overlaid by the Mad2 safety belt and participate in -augmentation with strand P6 of
Mad2, largely via backbone interactions. The next three positions bulge out from Mad2
and are followed by a proline that serves to orient the ensuing Madl helix for a
homodimeric coiled-coil interaction. Our mutagenesis of the Cdc20 nonamer
complements the analysis of Mad l by Sironi and colleagues, who saw stringent
requirements at positions one, three, and five of the nonamer. The motif-ending proline
contributes only weakly to the affinity of short peptides, as all classes of substitution
cause a two-fold decrease in binding (Figure 2.2C). In contrast, other positions in the
nonamer are less selective and tolerate certain substitutions but show more marked
decreases in Mad2 binding. Notably, this proline is conserved in Madl and Cdc20 in the
vast majority of surveyed species (Supplemental Figure 2.2). The substitution of alanine
in S. pombe Slp 1 and human TACE, for example, suggests that if helix or domain
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orientation is the major function at this position, a flexible linker may substitute in
contexts where there is not a nearby bulky structure such as a coiled-coil. It should be
noted that reducing the Mad2-peptide interaction to its barest minimum may result in
more stringent selection than would occur in a full-length protein. For example, the
Madl-Madl homodimer interaction may stabilize the binding of Mad2, as mutations in
the coiled-coil interface appear to influence Mad2 binding indirectly despite the lack of
Mad2 contacts at that site. A clearer understanding of Mad 's contribution to Mad2
activation will require crystallographic characterization of the O-Mad2 bound to the C-
Mad2-Madl core.
2.4.2 Phosphorylation of the Mad2 tail
Wassmann et al have reported that up to four serines in the C-terminal tail of
Mad2 are phosphorylated in nocodazole-arrest HeLa cells (Wassmann et al., 2003).
When transiently expressed, Mad2 mutants in which these serines are replaced by
aspartic acid fail to interact with Mad or APC/C and act as dominant negatives with
regard to checkpoint function. However, it is not clear if these mutants fold correctly in
vivo and in yeast it is not known if they are imported into the nucleus. Wassmann et al
suggest that rapid phosphorylation and dephosphorylation cycles of Mad2 allow it to
dissociate from Madl and bind Cdc20, despite the fact that S 195 on Mad 1-bound closed
Mad2 is not accessible for phosphorylation. We show that mutation of one (S 195), three,
or four serines to aspartic acid in the Mad2 C terminus abrogates binding to Madl,
Cdc20, and CMT2 (Figure 2.5B). Both classes of Mad2 interactors require tail closure
for binding, and CMT2 binds selectively to C-Mad2 regardless of whether the Mad2
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ligand cleft is occupied (Xia et al., 2004). Because S195 is not solvent exposed in the C-
Mad2 conformer as mentioned, it seems likely that pseudophosphorylation mutants
instead represent "always open" mutants similar to the well-studied Mad2AC truncation
mutant. Indeed, in vivo studies describe similar behavior for Mad2 tail S-D and AC
mutants; both abrogate the checkpoint in a dominant-negative fashion and fail to bind
Madl or APC/C (De Antoni et al., 2005; Wassmann et al., 2003). While the localization
of Mad2 S-D mutants was not determined, Mad2AC localizes to kinetochores by
associating with Madl-bound endogenous C-Mad2. How do "always open" mutants
inhibit checkpoint function? Presumably, because they are able to dimerize with Madl-
bound C-Mad2, they accumulate at kinetochores and prevent the binding of cytosolic 0-
Mad2, thus preventing the formation of Mad2-Cdc20 complexes. Such a scenario might
occur on cytosolic C-Mad2-Cdc20 complexes as well.
2.4.3 Binding to Non-checkpoint proteins
Despite its well established role in mitotic progression, Mad2 has multiple other
binding partners, including including a hormone receptor (ERP), a transmembrane
metalloprotease (TACE/ADAM 17), a growth factor receptor (insulin receptor, IR), a
cytokine receptor (GM-CSFR), and a ubiquitin-like protein (FAT10) (Liu et al., 1999;
Nelson et al., 1999; O'Neill et al., 1997; Poelzl et al., 2000; Takeda et al., 2001). What is
the significance, if any, of these interactions? Because Mad2 is expressed throughout
interphase, it might have "moonlighting" functions in other pathways (Jeffery, 2003).
The Mad2-binding motif in TACE is adjacent to proline-rich sequences, suggesting that
Mad2 may negatively regulate TACE binding by SH3 domain proteins (Nelson et al.,
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1999). Levels of Mad2-IR interaction were inversely proportional to insulin stimulation,
suggesting that insulin signaling displaces Mad2 from IR in anticipation of mitogenesis
following a pro-growth signal (O'Neill et al., 1997). Strikingly, Mad2 does not associate
with the IR-related IGF R, and IR possesses an obvious Mad2-binding motif
(RILSFYYSP) in the carboxy-terminal region necessary for Mad2-binding. Human
MAD2 maps to a genomic locus associated with insulin resistance (Krishnan et al.,
1998), suggesting that alteration of Mad2 expression might affect IR signaling.
However, neither FAT10 nor GM-CSFR contain obvious Mad2-binding motifs and thus
perhaps interact with Mad2 via a different binding mode like CMT2. Another is that
non-mitotic proteins may sequester Mad2 to reduce the effective concentration in the cell
when it is not required and release it during mitosis. A similar situation has been
proposed in budding yeast, where Mad 1 p and Mad2p associate with nuclear pore
complexes. This association may control import of Cdc20 into the nucleus in early
mitosis (louk et al., 2002), and release of Mad2 from yeast nuclear pore complexes is
necessary for checkpoint activation (Quimby et al., 2005). Thus, establishment of
sequestered pools at the cell and nuclear periphery may enable the early mitotic Mad2
function to be rapidly established immediately upon nuclear envelope breakdown. A
final possibility is that these receptors are involved in the spindle checkpoint. Our finding
that both TACE and mER3 bind the same site of Mad2 that binds Mad l and Cdc20 is
consistent with this hypothesis, although other interpretations are equally likely.
2.4.4 Anatomy of Mad2
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The experiments shown here show that Madl and Cdc20, to a first approximation,
bind to Mad2 in a similar (and competitive) manner. It is striking however, that when
chordata or fungal Madl and Cdc20 sequences are analyzed on their own, Mad2-binding
sites on Madl are found to be more similar to each other, and those on Cdc20 to each
other, than Cdc20 sequences are to Madl sequences (Supplemental Figure 2.1A and B).
These data hint at differential control over these two sets of interactions. In support of
this, at least one mutant in the tail of Mad2 (V197R) shows partial separation of function
in biochemical assays by binding more tightly to Mad than to Cdc20. Overall, we
believe that available data supports a working model in which Mad and Cdc20 bind to
Mad2 in a fundamentally similar manner. However, the data also warrant a direct search
for separation-of-function binding mutants in Mad2, as well as a careful analysis of their
biochemical and biological properties.
The most significant conclusion from our biochemical analysis is that CMT2
binds Mad2 in a fundamentally different fashion from Madl and Cdc20. Even low
stringency sequence searches fail to uncover a potential Mad2-binding nonamer in
CMT2. Madl and Cdc20 peptides do not compete with CMT2 for Mad2 binding, and
stable triple complexes involving CMT2-Mad2-Madl or CMT2-Mad2-Cdc20 can be
reconstituted in vitro and isolated in vivo (Chapter 3). Moreover, whereas mutants in the
Mad2 binding cleft abolish binding by both Cdc20 and Madl, they do not affect binding
by CMT2, implying that CMT2 does not bind in the Mad2 cleft (Figure 2.7A and B).
Why then, is the binding of CMT2 to Mad2 blocked by mutations in the Mad2 C-terminal
tail? Perhaps CMT2 contacts the Mad2 tail by making sequence-specific contacts with
residues H 191, V197 and S195 such that their mutation interferes with CMT2-Mad2
104
complex formation. Alternatively, CMT2 might be selective for the closed conformation
of Mad2, in which case the H 191A, S 195D, V 1 97R mutations would exert their effects
by preventing formation of the closed state. In weighing these possibilities, it is important
to note that Madl- and Cdc20-binding stabilize the closed Mad2 conformation and the
existence of stable CMT-Mad2-Madl and CMT2-Mad2-Cdc20 complexes therefore
demonstrates that CMT2 can bind Mad2 in the closed state (Luo et al., 2002; Luo et al.,
2004; Sironi et al., 2002). Moreover, in the closed Mad2 conformation, the side chains of
tail residues H 191, S 195, and V 197 are buried in the interior of the protein, making it
unlikely that they make stereo-selective contacts with CMT2 (Figure 2.7A and B). Thus,
it seems likely that CMT2 binds selectively to the closed form of Mad2 via contacts
outside the binding cleft. Consistent with this, a Mad2 fragment spanning residues 45-78
bound CMT2 in a two-hybrid screen (Habu et al., 2002). These residues form an alpha-
helix and beta-turn that traverse the space between the cleft and residues R133 and Q134,
which have been implicated in Mad2 dimerization (Figure 2.7C). We therefore propose
that CMT2 binds to Mad2 in the closed conformation, perhaps in a manner that affects
the ability of Mad2 to self-associate (Figure 7C). The closed and open conformations of
Mad2 interconvert slowly in the absence of binding partners, however, and biochemical
reconstitution suggests that CMT2 can bind not only to Madl-Mad2 and Cdc20-Mad2
but also apo-Mad2 (Figure 2.1A).
2.4.5 Implications for checkpoint control
A significant mystery surrounds the mechanism by which Madl-Mad2 binding at
kinetochores generates a transmissible signal leading to the Mad2-dependent inhibition of
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APC/CCdc20 throughout the cell. No covalent modifications of Mad2 have been found
with the right properties to represent an activated state. However, the existence of two
slowly inter-converting Mad2 conformers, an open apo state and closed state in which the
safety belt is engaged, suggests that a conformational change might be involved in
signaling (Luo et al., 2004). The closed conformation of Mad2 has been shown to be
more potent in APC inhibition and is presumed to be the active form. The question
therefore arises as to how conformational changes in Mad2 are regulated. Data in this
chapter show that short peptides from Mad and Cdc20 bind tightly to Mad2 in a
competitive fashion, consistent with earlier work using longer Madl and Cdc20
fragments (Luo et al., 2002; Sironi et al., 2002). The affinity of these interactions is such
that exchange from Mad l to Cdc20 on the time scale of checkpoint signaling, with or
without preservation of conformational state, seems very unlikely (at least in the absence
of as-yet undiscovered catalysts) and we have been unable to detect rapid exchange
events either in the presence or absence of CMT2 (unpublished observations). Thus, it is
surprising that Mad2 cycles on and off kinetochores with a half-life of 25 seconds
(Howell et al., 2000) given that kinetochore binding requires Madl (Chen et al., 1998).
We have found no evidence for a second lower-affinity Mad2 binding site on Madl or
Cdc20, supporting the idea that the exchangeable pool of Mad2 on kinetochores binds to
a Mad2-Mad 1 complex (Sironi et al., 2001) via Mad2-Mad2 dimer contacts (De Antoni
et al., 2005). In the conformational signaling model, this freely exchanging Mad2 is
presumed to carry the checkpoint signal. While the experiments in this chapter do not
address this model directly, CMT2 binding to Mad2-Madl and Mad2-Cdc20 near the site
of Mad2-Mad2 interaction should block the recruitment of additional Mad2,
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extinguishing signal generation (Figure 2.7). Moreover, the binding of CMT2 to apo-
Mad2 in the closed conformation should negatively regulate any Mad2 actively involved
in signal transmission.
2.4.6 Model for CMT2 inhibition of Mad2
CMT2 must be able to inhibit Mad2, or "de-inhibit" Cdc20 in a ternary complex.
By identifying Madl-CMT2 ternary complexes, we beg the question of how CMT2
inhibits Mad2 when it is bound to Madl as well. Madl-Cdc20 and Madl-Mad2 binding
are believed to be structurally similar, though Cdc20 may undergo conformational
changes as well. We have shown that CMT2 binds selectively to the closed conformation
of Mad2, and residues required for this binding are spatially apposed - though
sequentially distant - to the region required for Mad2 dimerization. We suggest that
CMT2 functions primarily to "cap" or occlude the Mad2 homodimerization site, thus
preventing the association of O-Mad2 and C-Mad2. De Antoni et al suggest that Mad2
dimerization occurs both on the kinetochore and in the cytosol, but this remains to be
established experimentally (De Antoni et al., 2005).
Xia et al show in vitro that a recombinant CMT2-Mad2-Cdc20 complex activates
APC/C, suggesting that CMT2 somehow relieves the inhibitory effect of Mad2 on Cdc20
without dissociating them from each other (Xia et al., 2004). One possibility is that
CMT2 binding causes Cdc20 to re-adopt an APC/C-activating conformation that is
occluded in the Mad2-Cdc20 complex. However, little is known about the structure of
Cdc20 or its mechanism of APC/C activation. Understanding the mechanism of Mad2
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inhibition requires structural characterization of CMT2 ternary complexes, as well as an
understanding of post-translational modifications of CMT2, Cdc20, and APC/C.
2.4.7 Summary and Conclusions
We show that CMT2 forms a complex with the mitotic spindle checkpoint protein
Mad2 that is biochemically distinct from previously known Mad2 complexes. Because
previous Mad2 complexes were required for checkpoint activation, the existence of a
second binding mode is consistent with CMT2's putative role as a checkpoint inactivator.
We explore the cell biological implications of CMT2 complex formation in chapter 3.
The results presented here beg several important questions. First, does CMT2 form
complexes with Mad2 in the cytosol, at the kinetochore, or both? Does CMT2 cycle on
and off of kinetochores with rapid kinetics, as does Mad2, or is its localization
constrained by association with other proteins? Second, our biochemical data point to a
model in which CMT2 binds selectively to closed Mad2 and prevents Mad2 dimerization.
It will be important to map in detail the Mad2-CMT2 binding interface and to test
whether CMT2 competes with O-Mad2 for binding to C-Mad2 complexes. Just as it
remains unknown why Mad2 dimerization only occurs between two different Mad2
conformers, it is hard to envision how tail closure might control CMT2 binding.
Does CMT2 form complexes with other checkpoint proteins? At the same time, the
control of Mad2 tail opening and closing is unknown. Closed Mad2 complexes exist
throughout the cell cycle, but it is not known if these complexes form passively with the
slow kinetics of open-closed interconversion or if there is an active "Mad2-loading"
activity. Finally, the relative contributions of the two ternary complexes discussed here,
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Cdc20-Mad2-CMT2 and Madl-Mad2-CMT2, to checkpoint activation and inactivation,
remains to be understood. Mad2 and the spindle checkpoint proteins monitor complex,
undefined cellular lesions in the crowded space of the mitotic spindle with very rapid
resolution. Understanding this system will require a careful cytological study of its
dynamic components as well as in-depth structural understanding of these protein
complexes.
2.5 MATERIALS AND METHODS
Generation of plasmids
Mad2 was generated by PCR subcloning of an EST clone (Genbank ID R10991)
into pGEX-6P-2 (Amersham Biosciences). CMT2 was PCR subcloned from IMAGE
clone 321778 (ATCC). Plasmids encoding Cdc20 were the kind gift of J.-M. Peters.
Plasmids encoding Madl were obtained from N. Pavletich and K.-T. Jeang, while
constructs for TACE and ER3 were obtained from M. Mendelsohn and C. Blobel,
respectively. The Mad2 and CMT2 cDNAs were subcloned into pEGFP-C 1 (BD
Biosciences Clontech). For expression in insect cells, CMT2 was subcloned into a
pFASTBAC-derived vector from K. Kaplan. Mad2 mutants shown in Figure 4 were
created by the QuickChange method (Stratagene). The cDNA for mRFP, a kind gift of R.
Tsien, was fused to histone H2B in pCDNA3.1 (Invitrogen). All PCR-derived plasmids
were confirmed by sequencing. The Mad2-Madl coexpression construct has been
previously described (Sironi et al., 2002).
Protein expression
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Bacterial expression: GST fusion proteins were expressed in BL21 (DE3) or BL21
Codon Plus E. coli (Stratagene). Cells were resuspended in breakage buffer (50mM
Hepes pH 8.0, 150mM NaCI, 2mM EDTA, lmM DTT, mM PMSF, 10% glycerol) and
the bacteria lysed by sonication. Lysates were clarified and incubated with glutathione
sepharose beads (Amersham Pharmacia Biotech).
Baculovirus expression: The human CMT2 cDNA was subcloned into a modified
pFastBac transfer vector (GIBCO-BRL) in frame with an N-terminal GST tag cleavable
by PreScission protease (Amersham-Pharmacia Biotech). A GST-CMT2 baculovirus was
used to infect Sf9 cells growing in suspension. Cells were harvested 72 hours post-
infection and resuspended in lysis buffer (20 mM Tris-HCl pH 8, 0.15 M NaCl, 0.1 %
Triton, 1 mM DTT, 0.5 mM EDTA and a tablet of protease inhibitor cocktail (Roche)).
Cells were lysed by sonication and the extracts were clarified by centrifugation at
150,000g for 45 minutes at 4 °C. The supernatant was incubated with glutathione
sepharose beads for 3 hours at 4 °C. After extensive washing in 20 mM Tris-HCl pH 8,
0. M NaCl, 1 mM DDT and 0.5 mM EDTA, beads were incubated overnight with
PreScission protease for GST tag removal. The purity of the eluted CMT2 preparation
was assessed by SDS-PAGE and the concentration determined by absorbance at 280nm.
Procedures fir the expression and purification of recombinant 6H-Mad2, 6H-Mad2C,
and Mad2-Mad1485584 have been described (Sironi et al. 2001; Sironi et al. 2002).
In vitro translation. Proteins were made in vitro using the TnT T7, TnT T3, and
TnT T7 Quick for PCR systems (Promega). DNA templates for in vitro translation were
made by two rounds of PCR amplification to add a T7 promoter to the 5' end, and to
improve translational yield at least 12 bases were added 3' to the STOP codon. The 5'
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added sequence includes 10 bases to improve translational yield, a T7 promoter, a BamHI
site, a Kozak consensus sequence, and an HA epitope. Mutants shown in Figure ID and
Supplemental Figure 3 were generated by megapriming PCR before in vitro translation.
Peptide synthesis
Cdc20, TACE and ERA peptides were synthesized on a PEG 500-modified
cellulose membrane (AbiMed ACO 1-12, MIT Biopolymers Facility) via coupling to P-
alanine residues. A membrane spotted with Madl peptides was obtained from Research
Genetics. Membranes were moistened in MeOH, washed in TBST (25mM Tris pH8.0,
137mM NaCl, 13.4mM KCI, 0.1% Tween-20), and blocked overnight at 40C in TBS-T
with 2% BSA. In vitro translated, radiolabeled Mad2 was purified on a Sephadex G-25
spin column to remove unincorporated 3 5S-methionine. Membranes were then washed in
TBST and probed with 50[t1 Mad2 in 1.5-3ml TBST with 1% BSA for one hour at room
temperature. Membranes were rinsed with TBST and washed in the following solutions:
TBST, TBST with 0.5M NaC1, TBST with 0.5% Triton-X 100, and TBST. Dried
membranes were exposed on a Phosphorlmager and binding was quantitated using
Molecular Dynamics software. Madl and Cdc20 peptides were synthesized by
Biosynthesis, Inc (Lewisville, Texas) and the Center for Cancer Research BioPolymers
Lab (MIT). A scrambled Madl peptide, GGCRVVSKLYARLTDNQRQMRPHLSTDS,
was used as a control.
Binding Assays
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Pull-down assays: In vitro binding assays were performed with 35 S-methionine
labeled in vitro-translated protein and GST-fusion protein immobilized on glutathione
sepharose beads (Pharmacia). After repeated washing in breakage buffer, beads were
incubated with fusion protein lysates in the presence of 1% Triton X-100 at 40C with
gentle rocking for 2 hours. The beads were pelleted, washed with IP buffer (50mM
Hepes pH 8.0, 150mM NaCl, 50mM f3-glycerophosphate, 50mM NaF, mM EDTA, 10%
glycerol, 1/c, Triton-X 100) and resuspended to a 50% slurry. Binding reactions were
performed for 6 hours at 4°C in IP buffer with lmM DTT. Beads were pelleted, washed 3
times in IP buffer, boiled in SDS loading buffer, and resolved by SDS-PAGE. Dried gels
were exposed on a PhosphorImager (Molecular Dynamics). Signals from radiolabeled
protein were quantified using Moleculare Dynamics software.
Isothermal Titration Calorimetry: ITC measurements were carried out using a
VP-ITC titration calorimeter (MicroCal, Inc). Peptides at a concentration of 30-200[tM
were injected into a solution of 5-20tM hMad2 in 150mM NaC1, 50mM Hepes pH 8.0 at
1 8°C. Binding isotherms were corrected for dilution enthalpies by subtraction of a blank
titration of peptide into buffer and the corrected data were fitted using Origin software.
Size exclusion chromatography: 30gg of pure CMT2 was incubated for 1 hour at
20°C with equimolar amounts of Mad2, Mad26c or Mad2-Mad148 5 -584 complex in binding
buffer (20 mM Tris-HCI pH 8, 0.1 M NaCl, 1 mM DTT and 0.5 mM EDTA). To generate
a Mad2-Cdc20 complex, 30[tg of Mad2 was pre-incubated for 1 hour at 200C with a 20-
fold molar excess of a synthetic Cdc20 (111-138) peptide. An equimolar amount of
CMT2 was then added, and after a new incubation of 1 hour at 200C the reaction was
resolved by size-exclusion chromatography. The incubation mixtures were separated on a
113
SMART FPLC system (Pharmacia) using Superdex S75 or Superdex S200 size-exclusion
chromatography columns equilibrated with binding buffer. Eluted fractions were resolved
by SDS-PAGE.
Surface plasmon resonance: All experiments were performed at 25°C one a
Biacore 2000 (Biacore). Peptides were coupled to CM5 sensor chips with EDC and NHS
according to the manufacturer's instructions. Roughly 4000-10000 RU of peptide were
coupled per flow cell. Aliquots (20 jL) of 20nM Mad2 in Hepes-buffered saline (HBS,
20mM Hepes pH 7.0, 150mM NaCl, mM EDTA pH 8.0) were preincubated with
different concentrations of peptide before injection at a flow rate of 5 L/min. After
binding, surfaces were washed, regenerated with 50mM glycine pH 2.2, and washed
again. Binding data were interpreted using the BiaEvaluation 3.2 software (Biacore) and
fit using a simple Langmuir interaction model.
Supplemental Material
A phylogenetic analysis of Mad2 binding peptides can be found in Supplemental Figure
2.1. Peptide array analysis of Mad2-binding regions in TACE and ER[ is presented in
Supplemental Figure 2.2. Characterization of Mad2 binding peptides in solution is
presented in Supplemental Figure 2.3
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Supplemental Figure 2.1: Evolution of the Mad2 binding motif
(A) Phylogenetic tree of Mad2-binding nonamers derived from Cdc20 and Mad I in eight
fungal species. Relative contributions at each position are depicted below as in Figure
2.2. (B) As in (A), phylogenetic tree of Mad2-binding nonamers from Cdc20 and Madl
in six chordata. (C) Phylogenetic tree of combined fungal and chordata Mad2-binding
nonamers. (D) Phylogenetic tree analysis of Mad2 sequences from fungal and chordate
species. Trees were generated using the AlignX program in the Vector NTi software
suite. Within the Mad2-binding consensus sequence in (C), chordata Cdc20 and Madl
sequences (red boxes) are closer to each other than they are to their respective fungal
counterparts (green boxes), mirroring the phylogenetic tree for Mad2 in (D) and
suggestive of co-evolution among Mad2 and its binding motifs in both Madl and Cdc20.
121
Supplemental Figure 2.2
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Supplemental Figure 2.2: TACE and mERbeta contain Madl/Cdc20-like Mad2 binding
motifs. Successive 12 residue peptides from mERbeta (233-267) and TACE (705-739)
were synthesized on filters and probed with radiolabeled Mad2 as in Figure 1 (A-C).
Bars indicate Mad2 binding activity for each peptide in arbitrary units.
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Supplemental Figure 2.3: Characterization of Mad2-binding peptides. (A) Madl and
Cdc20 peptides compete for Mad2 binding in solution. Titrations of synthetic Cdc20,
control, or Mad 1 peptides were incubated with recombinant Mad2 before native gel
electorphoresis and Coommassie staining (lanes 1-10). To test for competition, Mad2
was preincubated with 100 tM Madl (lanes 11-13) or Cdc20 (lanes 14-16) peptide
before titration of competing peptide. (B) A polymorphism detected in lung cancers
does not alter Mad2 binding. A subset of human lung tumors possess the polymorphism
MadlR555H (Nomoto et al., 1999). As in (A), peptides from Cdc20 (lanes 2-4), control
(5-7), and MadlR555H were incubated with Mad2 and binding was assayed by native gel
electrophoresis. (C) In vitro crosslinking demonstrates the existence of a Mad2 dimer.
Recombinant Mad2 was crosslinked with EGS and reactions were quenched and
subjected to SDS-PAGE. Arrows indicate -23kD monomer and -46kD dimer. (D)
Preincubation with binding peptides alters the proteolytic sensitivity of Mad2.
Recombinant Mad2 was incubated with Cdc20, Madl, or control peptide and digested
with trypsin or chymotrypsin as indicated. Reactions were quenched and resolved by
SDS-PAGE. (E) Ligand binding converts Mad2 from dimer to monomer. Mad2 was
incubated with Cdc20, Madl, or control peptides and mixtures were subjected to size
exclusion chromatography on a SMART Supderdex 75 FPLC column. Protein was
detected by absorbance at 280nm.
124
Chapter 3
Negative Regulation of the Mammalian Spindle Checkpoint by CMT2 is Required
for Completion of Mitosis
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3.1 Abstract
The spindle assembly checkpoint links anaphase onset to the completion of
chromosome-microtubule attachment. Checkpoint signaling begins when Mad and Bub
proteins bind to kinetochores of unattached or maloriented chromosomes. Dynamic
transit of Mad2 protein between the kinetochore and cytosol allows it to bind and inhibit
Cdc20, an essential activator of the anaphase promoting complex. CMT2, a Mad2-
binding protein, may control the rate of recovery from checkpoint arrest, but its full
function and site of action are not known. We examine the role of CMT2 in mitosis by
live- and fixed-cell microscopy and find that it localizes to kinetochores and the cytosol.
Critically, CMT2 is required for exit from mitosis. CMT2-depleted cells arrest in
metaphase, and their checkpoints remain active even though Mad and Bub proteins leave
the kinetochore. We propose that, in contrast with previous models of checkpoint
adaptation, mammalian cells cannot complete mitosis without actively silencing the
Mad2-dependent spindle checkpoint.
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3.2 Introduction
The spindle assembly checkpoint prevents chromosome segregation errors by
linking the dissolution of sister chromatid cohesion to the formation of correct
kinetochore-microtubule attachment (for reviews see(Chan and Yen, 2003; Cleveland et
al., 2003; Hoyt, 2001; Lew and Burke, 2003; Musacchio and Hardwick, 2002). Spindle
checkpoint genes were first isolated in S. cerevisiae and are highly conserved among
eukaryotes (Hoyt et al., 1991; Li and Murray, 1991). The presence of unattached or
maloriented chromosomes in prometaphase or metaphase initiates a signaling cascade
among the Mad, Bub, and Mps 1 protein families that converges on Cdc20, an essential
regulator of the anaphase promoting complex/cyclosome (APC/C). Mad2 and BubR1 are
the final effectors of Cdc20 inhibition and the three proteins can be co-purified in a large
mitotic checkpoint complex, or MCC (Sudakin et al., 2001). Mad2, BubR1, and Cdc20
shuttle rapidly between the cytosol and kinetochores (Howell et al., 2000; Shah et al.,
2004), and this dynamic localization is believed to be necessary for generation of the
"wait anaphase" signal. Transient dimerization between the closed conformation of
Mad2, which is stably bound to Mad at kinetochores, and the open, cytosolic
conformation may promote formation of Mad2-Cdc20 complexes and APC/C inhibition
leading to metaphase arrest (Shah et al., 2004). In addition, recent results suggest that the
Mad2-BubR-Cdc20 regulatory circuit may function to constrain APC activity early in
mitosis (Meraldi et al., 2004), before the spindle checkpoint becomes active.
While much is known about the generation and transmission of spindle
checkpoint activity, very little is known about how the checkpoint is extinguished once
chromosomes become attached. Classic cytologic experiments showed that in PtK1 cells,
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anaphase begins 2311 minutes after the last chromosome pair becomes attached (Rieder
et al., 1994). At least two models might explain this phenomenon. One possibility is that
attachment of the last kinetochore ends active generation of a "wait anaphase" signal, and
anaphase ensues once this signal decays sufficiently to allow Cdc20 and APC/C
activation. In this scenario, the time required for anaphase onset reflects the time
required for the active checkpoint signal to decay. This signal may be comprised of the
individual activities of Mad2, Bubl, and BubRl/Mad3, as well as the synergistic activity
of the larger MCC complex (Sudakin et al., 2001; Tang et al., 2004). A second
possibility is that attachment of the last kinetochore is permissive for active inhibition of
checkpoint activity and generation of a "go anaphase" signal. The former model fits well
with classical conceptions of checkpoint signaling in which cell cycle checkpoints are not
activated until the presence of a frank lesion (Hartwell and Weinert, 1989). The second
model is consistent with the idea that the Mad2- and BubRl-dependent checkpoint is
active in every mitosis in some organisms (Dobles et al., 2000; Kalitsis et al., 2000). In
this case, a uniformity of anaphase-onset time would only result from passive decay if the
pool of Cdc20-inhibiting signal was equally uniform from cell to cell. If there is
variation in the amount of "wait anaphase" signal generated in otherwise unperturbed
cells, then the time from attachment to anaphase should vary unless the signal is actively
silenced. How might the checkpoint be actively silenced? One proposed mechanism
suggests that bulk removal of checkpoint complexes from kinetochores to the spindle by
a minus end-directed motor such as dynein could render the checkpoint insensitive to
kinetochore status (Howell et al., 2001). The search for binding partners of known
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checkpoint proteins has identified two putative checkpoint inhibitors: BSCG1, which
binds BubR1 (Gupta et al., 2003), and CMT2, which binds Mad2.
CMT2 ("Caught by Mad2") was identified as a Mad2 interactor in higher
eukaryotes that accumulates in HeLa cells before mitosis and is degraded at the
beginning of G 1 (Habu et al., 2002). CMT2 was proposed to compete with Cdc20 for
Mad2 binding, thus liberating Cdc20 and leading to anaphase onset (Habu et al., 2002),
In contrast, other studies demonstrate that CMT2 forms a stable ternary complex with
Mad2 and Cdc20 (Habu et al., 2002; Xia et al., 2004). These authors observed
nucleoplasmic speckles of CMT2 in early mitosis and CMT2 on the spindle and at the
midzone after metaphase. Fixed-cell assays suggested that RNAi depletion of CMT2
suppresses the rate of recovery from checkpoint arrest, causing a transient delay in
mitotic exit after cells are released from nocodazole. These findings implicate in CMT2
in adaptation to prolonged checkpoint signaling (Minshull et al., 1996) but do not point
to a role for CMT2 in unperturbed mitosis. We test the function of CMT2 by fixed- and
live-cell methods and show that it is essential for mitotic progression. While canonical
cell cycle checkpoints are dispensable error-monitoring pathways, we suggest that the
metazoan spindle checkpoint is a fundamental subroutine of mitosis and active silencing
of Mad2 is necessary for mitotic progression.
3.3 Results
3.3.1 CMT2 RNAi arrests cells in mitosis and opposes Mad2 function
To probe the function of CMT2 in vivo, we tested a panel of siRNA duplexes
targeted against the human CMT2 mRNA in HeLa cells. Two duplexes, CMT2-1 and
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CMT2-3, caused an approximately 20- to 50-fold depletion of CMT2 in asynchronous
cells by western blot (Figure 3.1A and data not shown). When cells were examined by
light microscopy, CMT2 RNAi caused an increase in the mitotic index (21%) compared
to control RNAi (5%, Figure 3.1B). Mad2 RNAi, which decreases the time spent in
mitosis, decreased the mitotic index (4%) slightly as expected.
To examine the mitotic phenotype of CMT2 RNAi more closely, we transfected
HeLa cells stably expressing Histone 2B-mRFP or Histone 2B-GFP with GFP-CMT2
plasmid or depleted the protein by RNAi. Control cells were transfected with GFP
plasmid or a control Lamin A siRNA. The time of anaphase onset relative to nuclear
breakdown (NBD; defined as T=O) was determined morphologically. Anaphase times in
HeLa cells exhibit a characteristic skew-normal distribution with a modal peak time of
anaphase onset of 26 ± 1.5 min (Meraldi et al., 2004). All cells overexpressing GFP-
CMT2 underwent abnormal and premature anaphase, with chromosome separation at T =
12 min, while overexpression of GFP alone had no effect (Figure 3.2A). GFP-CMT2
overexpression closely phenocopied Mad2 depletion by RNAi, which accelerates the
overall timing of mitosis so that anaphase is highly premature with a peak onset of as
little as T=12 min (Figure 3.2A). Both GFP-CMT2 and Mad2 RNAi cells executed
anaphase with lagging and unattached chromosomes (Figure 3.2A). Conversely, CMT2-
depleted cells arrested in metaphase with congressed chromosomes (Figure 3.2B). This
arrest was robust, as 90% of the cells had not entered anaphase 45 minutes after NBD
compared to only 8% of control cells, and the arrest lasted up to 6 hours or longer. This
phenotype resembled that seen in overexpression of GFP-Mad2, in which over 60% of
cells arrest in mitosis (Figure 3.2B). Thus, CMT2 and Mad2 have
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Figure 3.1
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Figure 3.1: CMT2 RNAi arrests cells in mitosis
(A) Immunoblots of whole cell lysates from HeLa cells treated with siRNA against lamin
A (negative control) or CMT2. Blots were probed with antibodies as indicated. (B)
Light microscopy images of HeLa cells treated transfected with siRNAs against CMT2,
Mad2, or control. Mitotic index was assayed by rounding. Scale bar is 100pm.
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Figure 3.2: CMT2 regulates mitotic timing in unperturbed cells
(A) CMT2 over-expression and Mad2 depletion cause errors in DNA segregation. HeLa
Histone 2B-mRFP cells were transfected with GFP or GFP-CMT2 (top) and Histone 2B-
GFP cells were transfected with Mad2 siRNA or control siRNA (bottom) and followed
by time-lapse microscopy. The times represent minutes after NBD; scale bar, 10 ptm.
Graph shows fraction of cells undergoing premature anaphase, defined as chromosome
segregation at T<1 8min. Bars depict the mean of at least two experiments of at least 50
cells each (RNAi) or at least 5 cells each (overexpression). (B) CMT2 depletion and
Mad2 overexpression arrest cells in mitosis. As in (A), HeLa Histone 2B-GFP cells were
transfected with CMT2 or control siRNA and HeLa Histone 2b-mRFP cells were
transfected with GFP-Mad2. Graph depicts fraction of cells arrested in mitosis, defined
as still in metaphase at T>45min. (C) Immunoblots of whole cell lysates from HeLa cells
treated with siRNA against lamin A (negative control), CMT2, Mad2, and Madl. Blots
were probed with antibodies as indicated.
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opposing effects on progression of unperturbed mitosis: excess CMT2 abrogates the
checkpoint and accelerates mitosis while decreased CMT2 causes mitotic arrest.
3.3.2 Characterization of CMT2 RNAi arrest
We next sought to determine when in mitosis CMT2-depleted cells arrest.
Immunofluorescence microscopy indicated that CMT2-depleted cells arrested in
metaphase, with congressed chromosomes, high cyclin B levels and low cyclin A levels
(Figure 3.3A). Previous studies suggested that CMT2 negatively regulates checkpoint
signaling by binding to Mad2. However, it remains possible that CMT2 depletion
damages the spindle or interferes with chromosome-microtubule attachment, causing a
spindle checkpoint-dependent cell cycle arrest. To exclude this possibility, we examined
two markers of chromosome-microtubule attachment: kinetochore tension and checkpoint
protein localization. After chromosome congression, establishment of bipolar
kinetochore-microtubule attachment results in centromere stretching from pulling forces
(Shelby et al., 1996). Decreased or absent centromere stretching is indicative of defective
or immature attachment. We measured interkinetochore distances in live, unfixed HeLa-
CENP-B-GFP cells. Depletion of the human kinetochore protein hNuf2R to abolish
attachment resulted in inter-kinetochore distances of 0.6 tgm. + 0.2 (Figure 3.3B). In
contrast, inter-kinetochore distances in both control and CMT2-depleted cells averaged
1.7 m + 0.2. Chromosome congression was also normal in both control and CMT2
RNAi cells (Figure 3.2B and 3.3A).
We next monitored kinetochore-bound levels of Mad and Bub proteins by
immunofluorescence. High levels of checkpoint proteins are found on unattached
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Figure 3.3: CMT2 depletion arrests cells in a "checkpoint off" metaphase
(A) Cells depleted of CMT2 arrest in mitosis. HeLa cells were treated with control or
CMT2 siRNA and stained with DAPI (blue) and anti- cyclin B or anti-cyclin A (green).
(B) Kinetochores in CMT2-depleted cells are under tension. HeLa GFP-CENP-B cells
were transfected with siRNAs against CMT2 or hNuf2R or a control and interkinetochore
distances were measured in metaphase cells in vivo following 3D deconvolution
microscopy. Distances were measured for 10 kinetochore pairs in each of 5 cells for each
treatment. (C) Checkpoint proteins localize normally in CMT2 depleted cells. HeLa
cells depleted for CMT2 or Lamin A control were stained with DAPI (blue) and
antibodies against the indicated checkpoint proteins (red and green). Scale bars are
10pm .
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kinetochores during prometaphase and these levels fall as chromosomes bind
microtubules during metaphase (Hoffman et al., 2001; Waters et al., 1998). However,
high levels of Mad and Bub proteins remain associated with lagging and maloriented
chromosomes, making immunofluorescence signals of checkpoint proteins at
kinetochores a sensitive indicator of kinetochore-microtubule attachment status (Hoffman
et al., 2001). When Madl, Mad2, Bubl, and BubRI and levels were compared in CMT2-
depeleted and control cells, levels of kinetochore-bound checkpoint proteins were
indistinguishable (Figure 3.3C and Supplemental Figure 3.2). In both cases, Mad and
Bub proteins were present at high levels in prometaphase and at significantly lower levels
in metaphase. In CMT2-depleted metaphase cells, Mad2 had fully dissociated from
kinetochores, implying that all chromosomes had made correct attachments to
microtubules (Figure 3.3C). These experiments demonstrate that CMT2 is not required
for the recruitment of checkpoint proteins to kinetochores or their subsequent dissociation
in metaphase.
3.3.3 CMT2 localizes to kinetochores in a Mad2-dependent fashion
To understand how CMT2 promotes anaphase entry, we next examined its
subcellular localization. Previous studies conflict, stating that CMT2 may localize to
either the nucleoplasm or the mitotic spindle (Habu et al., 2002; Xia et al., 2004). Using
two different anti-CMT2 antibodies, we observed a dual localization pattern for CMT2 in
HeLa cells: it was present on unattached kinetochores in prometaphase as determined by
co-localization with CREST autoimmune serum and was also observed throughout the
cytosol (Figure 3.4A). This localization pattern was specific, as two different siRNAs
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Figure 3.4
CREST anti-CMT2
CREST
Figure 3.4: CMT2 undergoes Mad2-dependent kinetochore localization
(A) CMT2 localizes to kinetochores. HeLa cells were stained with DAPI, anti-CMT2,
and CREST sera. Scale bar is 5gm . (B) CMT2 binds to kinetochores in prometaphase
and requires Mad2. HeLa cells treated with the indicated siRNA were stained with
DAPI, CREST, and anti-CMT2. Scale bar is 2.5ptm. Indicative sister kinetochore pairs
are magnified at right; scale bar is 0.5ptm. (C) Quantitation of CMT2 loss from
kinetochores. CMT2/CREST signal ratios from individual cells are plotted as dots; bars
represent mean ratio values. (D) CMT2 forms ternary complexes with Madl-Mad2 and
Cdc20-Mad2 in vivo. Anti-CMT2 and pre-immune immunoprecipitates from
nocodazole-arrested HeLa cells were resolved by SDS-PAGE and immunoblotting. Input
lane represents 2% of protein used in IP.
138
against CMT2 strongly decreased both kinetochore and cytosolic staining (Figure 3.4B
and C and Supplemental Figure 3.3). This pattern is reminiscent of Mad2, which exists
both in a stably-bound pool at unattached kinetochores and a rapidly-cycling pool that
shuttles between kinetochores and the cytosol. Because CMT2 binds Mad2, we
investigated CMT2 localization in Mad2-depleted cells. Mad2 RNAi abrogated CMT2
levels on prometaphase kinetochores to an extent equal to CMT2 RNAi (Figure 3.4B and
3.4C). CMT2 is thus the first known protein whose kinetochore localization is Mad2
dependent (Vigneron et al., 2004). Like Mad2, CMT2 signal on kinetochores was high
after nocodazole treatment, and in the absence of nocodazole decreased to nearly
undetectable levels as kinetochores became attached and congressed on the metaphase
plate (Hoffman et al., 2001); Figure 3.4B and 3.4C). The localization pattern we observe
suggests that CMT2 may already interact with some population of Mad2 on kinetochores
during prometaphase, when the checkpoint is still active. CMT2 is known to form ternary
complexes with Mad2-Cdc20 in the cytosol, and we show in chapter 2 that CMT2 forms
ternary complexes in vitro with Mad2-Madl. To confirm that CMT2 participates in
kinetochore-bound complexes, we immunoprecipitated CMT2 from nocodazole-arrested
prometaphase cells and found that Mad2 and Cdc20 associated with CMT2 as expected
(Fig 3.4D). Notably, Madl was present in CMT2 immunoprecipitates as well. While
Mad2 and Cdc20 colocalize at kinetochores and in the cytosol, Madl is restricted to
kinetochores in mitosis (Kallio et al., 1998; Shah et al., 2004). Thus, CMT2 localizes to
kinetochores and forms stable ternary complexes with kinetochore checkpoint proteins.
As a final test of CMT2 localization, we transfected HEK 293 and HeLa cells
with GFP-CMT2 and imaged them with fluorescence microscopy. In live, unfixed
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interphase HEK 293 cells, GFP-CMT2 is confined to the nucleus (Figure 3.5A),
suggesting that its putative bipartite NLS is functional. In live, unfixed HeLa Histone
2B-mRFP cells, bright kinetochore foci of GFP-CMT2 were visible in prometaphase
(Figure 3.5B). Some GFP-CMT2 also remained in the mitotic cytoplasm. We observed a
similar localization for transiently expressed GFP-Mad2 (Figure 3.5C). It is notable that
in live prometaphase cells, GFP fusions of both CMT2 and Mad2 were visible on only a
subset of kinetochores, unlike GFP-ZW 10, which localize to every kinetochore (data not
shown). For Mad2, this is believed to reflect the existence of stably- and dynamically-
associated kinetochore populations of Mad2, (Shah et al., 2004)., though it may also
reflect failure of transiently-expressed protein to incorporate into pre-assembled
complexes.
3.3.5 CMT2 RNAi arrest is spindle checkpoint dependent
To determine if CMT2 RNAi arrest depends on the Mad2 checkpoint, we used
the live-cell assay described above to observe HeLa Histone 2B-GFP cells co-depleted of
CMT2 and other proteins by RNAi. Under these conditions, 71-18% of CMT2-depleted
cells remained in mitosis 45 minutes after NBD, compared to 118% of control cells
(Figure 3.2B and 3.6). As expected, depletion of Mad2 accelerated mitotic progression
such that no Mad2 RNAi cells were observed in mitosis at T = 45 minutes (0±0%). Co-
depletion of Mad2 with CMT2 alleviated the arrest caused by CMT2 RNAi, with 12+4%
of cells not yet in anaphase after 45 minutes, similar to control cells. Thus, Mad2 protein
is required for cell cycle arrest in the absence of CMT2.
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Figure 3.5
GFP-CMT2 DAPI Overlay
Figure 3.5: GFP-CMT2 localizes to kinetochores in live cells
(A) GFP-CMT2 is nuclear in interphase. HEK293 cells were transfected with GFP-
CMT2, fixed, and stained with DAPI. Scale bar represents 5ptm. (B) HeLa cells were
cotransfected with Histone 2B-mRFP and either GFP-CMT2 (top) or GFP-Mad2
(bottom) and imaged by deconvolution microscopy. Scale bar represents 3 gm.
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We next asked whether CMT2 depletion arrest requires upstream proteins that
generate the checkpoint signal or downstream checkpoint effectors. Mad and the
kinetochore protein Nuf2R are required for Mad2 to bind kinetochores and thus provide a
scaffold for checkpoint activation (Martin-Lluesma et al., 2002; Meraldi et al., 2004).
BubRl is a checkpoint effector that acts cooperatively with Mad2 to inhibit Cdc20 in
solution (Fang, 2002; Tang et al., 2001). BubRI RNAi phenocopied Mad2 RNAi, with
cells progressing rapidly into anaphase and only 1±1% remaining in metaphase at T = 45
minutes (Figure 3.6). After co-depletion of BubRI with CMT2, 9+8% of cells remained
in mitosis at T = 45, similar to Mad2-CMT2 co-depletion. However, cells co-depleted of
CMT2 with either Madl (87±18%) or Nuf2R (77+7%) remained arrest in mitosis
compared to cells depleted of only Madl (4+3%) or Nuf2R (10+4%). Thus, CMT2
depletion in a context where Mad2 cannot localize to kinetochores arrests cells in
metaphase, suggesting that CMT2 is necessary to inhibit cytosolic Mad2.
3.3.6 CMT2 functions on and off kinetochores
Does CMT2 also inhibit the generation of Mad2 signal on kinetochores? We
examined more closely the mitotic kinetics of RNAi treated HeLa Histone 2B-GFP cells
in order to probe on- and off-kinetochore Mad2 function. Cumulative frequency graphs
showed that populations of control RNAi cells progressed from NBD to anaphase with a
t1/2 = 21 minutes (Figure 3.7A), and all cells entered anaphase by 30 minutes. The
majority of CMT2 RNAi cells remained arrested for many hours or until photodamaged,
though 38% of cells entered mitosis after 3 hours, perhaps reflecting heterogeneity of
depletion. When cytoplasmic and kinetochore pools of Mad2 were both depleted by
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Figure 3.6: CMT2 RNAi arrest requires checkpoint effectors and targets cytosolic
Mad2
HeLa HeLa Histone 2B-GFP cells were treated with siRNA and mitotic arrest was
measured by live cell imaging as in Figure 1B. Graph depicts fraction of cells arrested in
mitosis, defined as remaining in metaphase at T>45 minutes after NBD. Bars indicate
mean and SEM of at least two independent experiments and at least 100 cells.
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Mad2 RNAi, anaphase entry occurred with a half-life of 9 minutes. As was observed
with mitotic arrest (Figure 3.6), BubRI RNAi phenocopied Mad2 depletion, with
extremely rapid kinetics of anaphase entry (t/2 = 12 minutes, Figure 3.7C). Madl RNAi,
which displaces kinetochore Mad2, caused cells to enter anaphase with normal kinetics
and a t1/2 = 20 minutes (Figure 3.7A).
When cells were co-depleted of CMT2 and Mad2 by double RNAi, we observed a
Mad2-like phenotype of accelerated mitosis (tl/2 = 11 min, Figure 3.6 and 3.7B). Co-
depletion of BubRI with CMT2 also abrogated CMT2 RNAi arrest, with cells entering
anaphase with wildtype-like kinetics (t1/2 = 21 minutes, Figure 3.7C). When CMT2 was
co-depleted with Madl, anaphase t/2 was 90 minutes and by 3 hours 80% of cells
overcame metaphase arrest and entered anaphase (Figure 3.7B). This "leak through"
phenotype may reflect the requirement for Madl to localize Mad2 to the kinetochore or it
may reflect a specific genetic interaction between Madl and CMT2. Because the
HEC1/Nuf2R complex is required for checkpoint proteins to localize to kinetochores, we
therefore examined the mitotic behavior of Nuf2R and Nuf2R-CMT2 depleted cells.
Nuf2R depletion did not alter anaphase entry significantly, with t/2 of approximately 28
minutes (Figure 3.7D). Cells co-depleted of Nuf2R and CMT2 entered anaphase with
slow, linear kinetics and a t1 12 = 70 minutes.
Thus, co-depletion of CMT2 with checkpoint signal generators or effectors gives
two separate sets of phenotypes. Checkpoint effectors such as BubRI or Mad2 are
absolutely required for metaphase arrest in the absence of CMT2. Co-depletion with
Mad2 or BubRI overcomes CMT2 RNAi arrest and cells enter anaphase before
chromosomes become attached. In comparison, checkpoint signal generators such as
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Figure 3.7: Kinetic analysis of CMT2 depletion
HeLa Histone 2B-GFP cells transfected with siRNA were followed in mitosis by live cell
imaging as described above. Graphs depict the cumulative frequency of anaphase entry
times, defined as time from nuclear breakdown to anaphase A.
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Madl and Nuf2R are not required for CMT2 RNAi arrest and co-depleted cells enter
anaphase, albeit with slow and heterogeneous kinetics..
3.4 Discussion
In this chapter we test the function of CMT2 in vivo and find that it is required for
progression of HeLa cells through mitosis. Cells depleted of CMT2 cannot pass the
metaphase-anaphase transition, and cells that overexpress CMT2 enter anaphase before
all their chromosomes have time to attach to the spindle. Strikingly, cells lacking CMT2
arrest in metaphase with aligned, attached chromosomes and checkpoint protein
localization consistent with a "checkpoint off' state. CMT2 and Mad2 have opposing
effects on cell cycle progression, and we demonstrate for the first time that CMT2 drives
cells into anaphase by targeting the Mad2/BubR1 checkpoint effector complex and not
upstream checkpoint signals. Previous studies have detected CMT2 function only in the
context of spindle damage provoked by anti-microtubule drugs (Habu et al., 2002; Xia et
al., 2004). We show, in contrast, that a cell cannot enter anaphase until CMT2 silences
the spindle checkpoint, consistent with findings that the spindle checkpoint is active in
every cell cycle (Dobles et al., 2000; Meraldi et al., 2004; Michel et al., 2001).
The mechanism by which CMT2 opposes Mad2 function and allows Cdc20
activity is not yet known. We demonstrate for the first time that CMT2 localizes to
prometaphase kinetochores and forms ternary complexes in vivo with the Mad 1-Mad2
kinetochore complex. The interaction of Mad2 and CMT2 at the kinetochore suggests
that CMT2 might inhibit the spindle checkpoint upon kinetochore-microtubule binding.
We suggest that CMT2 is required for inhibiting Mad2 both at kinetochores and in the
cytosol. Combined with biochemical data from chapter 2 and structural models of Mad2,
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we propose a model in which CMT2 drives cell cycle progression both by stemming the
flux of Mad2 through the kinetochore and by de-inhibiting Cdc20 in the cytosol. The
work presented here supports the notion that CMT2 is a potent "off switch" for the
spindle checkpoint and points to the urgency of identifying how that switch is flipped
when kinetochore-microtubule binding is achieved.
3.4.1 Checkpoint activation and inactivation
What is the molecular nature of the active spindle checkpoint signal? At least
three proteins are proposed as direct inhibitors of cell cycle progression: Bub 1, BubR1,
and Mad2. Recent work has shown that Bub 1 can phosphorylate Cdc20 in vitro and
inhibit APC/CCdc2 0 activation (Tang et al., 2004). Mutation of all phosphoacceptor
residues on Cdc20 abrogates the checkpoint and causes premature anaphase. In vitro,
BubRl binds Cdc20 and inhibits APC/C both on its own and synergistically with Mad2
(Fang, 2002). However, it is not clear whether in vivo BubRl acts independently or only
with Mad2 in a larger mitotic checkpoint complex known as MCC. Careful quantitation
of checkpoint complexes in yeast suggests that the BubRI homolog Mad3 only associates
with Cdc20 in conjunction with Mad2, while Mad2 associates with Cdc20 free of Mad3
(Poddar et al., 2005). Like Bubl, BubR1 is required for the kinetochore localization of
other checkpoint proteins, and the very strong phenotype seen in BubRl RNAi may
reflect multiple roles in checkpoint assembly and activation (Chen, 2002). Considerable
debate exists over the role of BubR1 kinase activity in checkpoint signaling. Kinase-
inactive BubR1 mutants sustain checkpoint signaling in Xenopus egg extracts and in vitro
APC/C activation assays, and budding yeast Mad3/BubR1, which clearly lacks a kinase
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domain, binds Cdc20 (Chen, 2002; Tang et al., 2001). However, in other assays,
impairment of BubR1 kinase activity prevents sustained arrest, implying that BubRlmay
inhibit Cdc20 both stoichiometrically and catalytically (Kops et al., 2004; Weaver et al.,
2003).
Mad2 cell cycle inhibitory activity appears to involve at least two components:
Cdc20 binding and Mad2 dimerization. Cdc20 binding by Mad2 is believed to inhibit
APC/C activation by sterically blocking access of Cdc20 either to APC/C or to Cdc20
substrates. Other "core" APC/C subunits such as Cdc27 and Cdc16 have been found in
complex with Mad2-Cdc20, suggesting that Mad2-bound Cdc20 may bind APC/C
without activating it (Kallio et al., 1998). However, these results differ between yeast
and mammals and are further confused by the obvious molecular heterogeneity of APC/C
complexes. Mad2 dimerization is proposed to promote checkpoint signaling by
promoting flux of open Mad2 conformers (O-Mad2) through the kinetochore by dynamic
association with closed (C-Mad2)-Madl complexes. However, neither Mad2
dimerization nor cycling through kinetochores has been observed in yeast. Furthermore,
mere positioning of O-Mad2 at kinetochore sites cannot be sufficient for Cdc20-binding
or checkpoint activation, as pools of O-Mad2 and Cdc20 co-exist in the cytosol without
binding. Clearly, some other aspect of checkpoint signaling is required to render O-
Mad2-Cdc20 interaction at kinetochores sensitive to the state of kinetochore-microtubule
attachment (Hagan and Sorger, 2005). As with BubRI, the relative inhibitory roles of
Mad2 alone and Mad2 bound to MCC have not been distinguished. Because CMT2 was
originally identified as a Mad2 binding protein, we tested its ability to oppose Mad2
function. CMT2 overexpression mirrors Mad2 depletion (Figure 3.2), and Mad2
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overexpression causes a similar, if perhaps weaker, metaphase arrest to CMT2 RNAi.
CMT2 and Mad2 colocalize at kinetochores and in the cytoplasm, and Mad2 is required
for the metaphase arrest caused by CMT2 RNAi.
If CMT2 specifically inhibits Mad2 function, why does loss of BubRI overcome
CMT2 RNAi arrest (Figure 3.6 and 3.7C)? One possibility is that BubRi is absolutely
required for APC/C inhibition in all contexts, and BubRI RNAi is epistatic to CMT2
depletion or interference with Mad2 activity. This is consistent with the finding in fission
yeast that Mad3p was required for the arrest caused by Mad2 overexpression (Millband
and Hardwick, 2002). However, as this arrest did not require Madlp, it may represent
simple Cdc20 inhibition by Mad2p mass action and not true kinetochore-sensitive
checkpoint signaling. A second possibility is that CMT2 interacts functionally, if not
directly, with BubRl. Careful quantitation in budding yeast found all prometaphase
Cdc20 in two complexes: a large pool of Mad2-Cdc20 and a small pool of MCC-Cdc20,
which contains Mad2, Mad3, and Bub3 (Poddar et al., 2005). An analogous MCC
complex containing BubRI exists throughout metazoan cell cycles (Sudakin et al., 2001)
but the existence of Mad2-free BubRl-Cdc20 has not been ruled out. This suggests a
scenario in which Mad3/BubRl is absolutely required for Cdc20 inhibition but functions
in vivo solely in Mad2-containing complexes. Binding of CMT2 to Mad2-Cdc20
complexes enabled them to activate APC/C in vitro (Xia et al., 2004), but these
experiments did not probe the involvement of BubR1 in APC/C activation. It therefore is
necessary to compare quantitatively APC/C activity for CMT2-BubRl-Cdc20 and CMT-
Mad2-BubR l-Cdc20. If Mad2 and BubR1 do, in fact, inhibit Cdc20 cooperatively, then
their negative regulation may occur in a cooperative or coupled fashion as well.
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Attempts at finding BubRI-binding proteins have not identified CMT2 but it remains to
be seen whether they interact indirectly. Clearly checkpoint inactivation cannot be well
characterized without a more complete catalog of checkpoint inhibitory complexes and
their mechanism of APC/C inhibition.
3.4.2 Mechanism of CMT2 function
How and where does CMT2 inhibit Mad2? We show that CMT2, like Mad2,
localizes to both the kinetochore and the cytosol, and that kinetochore localization
requires Mad2. CMT2 depletion arrests the cell cycle, and this arrest is mediated by
Mad2 (Figure 3.6 and 3.7A). Therefore, we use CMT2 RNAi arrest as a proxy for Mad2
activation to probe CMT2 function on and off kinetochores.
Kinetochore-dependent checkpoint signaling requires Nuf2R and Madl for
formation of Mad 1-Mad2 "core" complexes that promote cycling of cytosolic, open
Mad2 through the kinetochore (De Antoni et al., 2005; Howell et al., 2004). In the
absence of the Madl/Nuf2R scaffold, a pool of active, cytoplasmic Mad2 is formed early
in mitosis and inhibits Cdc20 (Meraldi et al., 2004). This Mad2 pool imposes a default
delay before anaphase entry but is not sensitive to kinetochore-microtubule attachment.
When we co-deplete CMT2 in this context of Mad 1 or Nuf2R RNAi, metaphase arrest
still occurs (Figure 3.6), providing strong evidence that CMT2 is required for silencing of
off-kinetochore, cytosolic Mad2.
To ask whether CMT2 inhibits Mad2 at kinetochores, we closely examined the
kinetics of anaphase entry to assess the size of the active Mad2 pool. In Madl or Nuf2R
RNAi, the cytoplasmic Mad2 pool is not replenished from the kinetochore and anaphase
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begins with a t/2 of approximately 20 min, identical to control cells (Figure 3.7A and
3.8). When this Mad2 pool is freed from inhibition by co-depletion of CMT2, cells
undergo prolonged a metaphase and most cells are effectively arrested, but this arrest is
not as long-lived as in CMT2 RNAi. More than 80% of cells depleted of Mad 1-CMT2 or
Nuf2R-CMT2 enter anaphase within 3 hours after NBD. We interpret this variation of
anaphase entry times, which range from 30 minutes to more than three hours, to reflect
differences in the size of active Mad2 pool generated in early mitosis independent of
Mad 1. Without silencing by CMT2, this pool becomes inactive with a half-life of
approximately 90 minutes. When CMT2 alone is depleted, the kinetochore-independent
pool of active Mad2 is augmented by active Mad2 generated at the kinetochore. The
resulting Mad2 activity is able to inhibit Cdc20 for many hours (Figures 3.2 and 3.7).
We infer that the different kinetics of anaphase entry observed in CMT2 and
Mad I/CMT2 RNAi reflects quantitatively different Cdc20-inhibition, strongly suggesting
that CMT2 also inhibits Madl-dependent Mad2 activity at the kinetochore. Further
parsing of on- and off-kinetochore function of CMT2 will require location-specific
probes and mutants of both CMT2 and Mad2.
How can CMT2 inhibit cytosolic Cdc20-Mad2 as well as kinetochore-bound
Cdc2O-Mad2 and Madl-Mad2? In chapter 2 we explored the ability of CMT2 to form
ternary complexes with both Mad2 binding partners and showed that CMT2-binding
regions in Mad2 are adjacent to residues required for Mad2 dimerization. We suggest
that by capping the dimer interface on closed Mad2, CMT2 inhibits the flux of Mad2
through the kinetochore and thus silences signal generation at the Mad 1-Mad2 complex
(Figure 3.8). If, as proposed, Cdc20-C-Mad2 complexes also undergo dynamic
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Figure 3.8: A model of CMT2 function
(A) CMT2 inhibits Mad2 by preventing dimerization and releasing inhibition of Mad2-
bound Cdc20. Mad2 (red) cycles between a cytosolic pool and the kinetochore. Binding
of Mad2 to Mad2-Madl at the kinetochore is required for generation of activity in the
cytosol. Upon checkpoint silencing, CMT2 binds Mad2-Madl and the kinetochore and
Mad2-Cdc20 in the cytosol. Kinetochore CMT2 inhibits Mad2 dimerization and prevents
replenishment of the cytosolic pool. CMT2 binding to Mad2-Cdc20 renders the complex
competent fr APC/C activation. (B) Comparison of anaphase entry half-lives reveals a
role for CMT2 at the kinetochore. When both CMT2 and Mad2 are depleted (top),
APC/C inhibition is minimal and anaphase begins shortly after NBD. When Madl and
CMT2 are depleted (middle), the cytosolic Mad2 pool that forms early in mitosis is not
replenished from the kinetochore by a Mad 1 complex. In the absence of inhibition by
CMT2, this Mad2 activity remains active for 60-90 minutes. When CMT2 alone is
depleted (bottom), a large pool of Mad2 activity is generated by kinetochore Mad2-Mad 1
and is not inhibited by CMT2. APC/C remains inhibited for many hours.
153
association with O-Mad2 from the cytosol, CMT2 would be predicted to cap and inhibit
this interaction as well (De Antoni et al., 2005; Hagan and Sorger, 2005). Very recent
experiments show that purified CMT2 competes with O-Mad2 for Madl-Mad2 binding
in vitro (M. Mapelli, personal communication).
Does CMT2 inhibit both of Mad2's checkpoint activating activities? Xia et al
show in vitro that CMT2 restores the ability of Mad2-bound Cdc20 to activate APC/C
without displacing Mad2 (Xia et al., 2004). This striking result contradicts the common
assumption that Mad2 inhibits Cdc20 by sequestration or steric hindrance and suggests
that in the Cdc20-Mad2-CMT2 complex CMT2 can effectively de-inhibit Mad2-bound
Cdc20. In the absence of structural insights into either APC/CCdc20 activation or Cdc20
inhibition by Mad2, it is difficult to envision how addition of CMT2 to the Cdc20-Mad2
complex relieves Cdc20 inhibition. CMT2 knockdown arrests cells with high cyclin B
and low cyclin A (Figure 3.3A). Because cyclin A is a Cdc20 substrate, this result shows
that CMT2 is not a general de-inhibitor of all mitotic Cdc20 (Dawson et al., 1995; Geley
et al., 2001; Sigrist et al., 1995). One possibility is that CMT2-Cdc20-Mad2 complexes
form in early mitosis but are incompetent for APC/C activation towards cyclin B and
securin because of modification of CMT2, Cdc20, or APC/C. Both Cdc20 and APC/C
are extensively modified in mitosis (Kotani et al., 1999; Rudner and Murray, 2000;
Yudkovsky et al., 2000) and APC/C purified from interphase cells is insensitive to
inhibition by MCC (Sudakin et al., 2001). A second possibility is that Cdc20 adopts
multiple conformations, and both checkpoint sensitivity and APC/C activation are
specific for Cdc20 conformers. We explore this possibility more fully in Chapter 4. The
evidence presented here suggests that CMT2 inhibits Mad2 both at the kinetochore and in
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the cytosol; understanding the mechanism of this impressive cell biological task will
require further biochemical and structural study.
3.4.3 CMT2 localization and the assembly of checkpoint complexes
Mitosis is a series of events in which complex mechanical tasks must be tightly
coordinated. A common theme of mitosis, as well as classical signal transduction, is the
regulated co-localization of interacting proteins. Two important aspects of checkpoint
protein localization have informed models of the spindle checkpoint. First, all known
metazoan spindle checkpoint proteins localize to kinetochores after nuclear envelope
breakdown (Lew and Burke, 2003). In budding yeast, Bub proteins localize to
kinetochores in every mitosis while Mad proteins appear to bind only to kinetochores that
become detached (Gillett et al., 2004). This difference between yeast and metazoans
likely reflects structural differences in spindle assembly between their closed and open
mitoses. The second major aspect of checkpoint protein localization is their dynamicity:
Mad2, Cdc2O, Bub3, BubRl, and Mps bind, dissociate, and rebind unattached
kinetochores with half-lives of 1-25 seconds, while Bubl, Madl, and a population of
Mad2 remain stably associated at kinetochores and do not cycle (Howell et al., 2004;
Shah et al., 2004). Upon kinetochore attachment, Bubl and BubRI levels decrease but
are still detectable, while all other checkpoint proteins leave the kinetochore and
relocalize to the cytosol, spindle, and spindle poles (Taylor et al., 1998). What is the
significance of checkpoint protein trafficking? Dynamic cycling of Mad2 and BubRl
between kinetochores and the cytosol is suspected to be critical for rapid sensing of
kinetochore-microtubule occupancy, as well as for transmission and amplification of the
155
"wait anaphase" signal to the rest of the cell. Depletion of checkpoint proteins from
kinetochores and relocalization to the spindle and poles in metaphase may contribute to
silencing of the checkpoint signal.
If CMT2 negatively regulates Mad2, why does CMT2 bind to unattached
kinetochores in prometaphase and nocodazole-treated cells (Figure 3.3 and 3.5) rather
than to attached, silenced kinetochores? This observation suggests that checkpoint
signaling is not a simple stepwise process, but that positive and negative regulators are
recruited simultaneously to the point of attachment sensing. Indeed, no evidence exists to
suggest that the kinetochore pool of a given checkpoint protein is homogenous; proteins
may be modified, activated, or inactivated at kinetochores such that multiple forms of one
protein are present on the same kinetochore. Thus CMT2 might bind to Mad2 on
checkpoint active kinetochores either (1) without activating Cdc20 due to APC/C
modification status (Kraft et al., 2003); (2) in insufficient amounts to silence the signal;
or (3) concomitant with CMT2 modification that leaves CMT2 Mad2-bound but inactive
for APC/C activation. We have begun gathering evidence of CMT2 modification by
other checkpoint proteins that is consistent with this possibility (R. Hagan and H. Hess,
unpublished).
To understand the significance of CMT2 kinetochore localization it will be
critical to ask by FRAP or other methods whether CMT2 binds statically to kinetochore
Mad2 or cycles dynamically between the kinetochore and the cytosol. We detect CMT2
in the cytosol as well as at kinetochores and provide evidence that CMT2 inhibits Mad2
at both sites, making it likely that CMT2 transits with Mad2. While it remains possible
that other factors than Mad2 are necessary for CMT2 to bind kinetochores, testing this
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experimentally is complicated by the fact that Mad2 sits atop the kinetochore localization
hierarchy, and RNAi of many kinetochore and checkpoint proteins displaces Mad2 and,
hence, CMT2.
How do Mad2, CMT2, and other checkpoint proteins leave the kinetochore in
metaphase? In PtK1 cells the minus-end directed motor dynein transports Mad2 onto the
spindle, and dynein inhibition leads to mitotic arrest (Howell et al., 2001). However,
dynein also forms complexes with Zw 10 and ROD, which are required for spindle
checkpoint function, and dynein may play multiple roles in establishment of tension and
chromosome segregation (Hunter and Wordeman, 2000; Starr et al., 1998; Wojcik et al.,
2001). For Mad2 to be completely removed from kinetochores, the stable Madl-Mad2
complex must either be removed or disassembled by Mad2 tail opening. An attractive
possibility is that microtubule attachment displaces checkpoint complexes from
kinetochores, either by competing for a common binding site or by leading to
colocalization of checkpoint-removing complexes such as dynein/dynactin. Finally, we
cannot exclude the possibility that capping of Mad2 complexes by CMT2 not only
silences them but tags them for removal.
3.4.4 CMT2 and chromosome segregation
Intense work has focused on finding ways in which spindle checkpoint
dysfunction might lead to genomic instability, aneuploidy, and cancer. Mutations in
human spindle checkpoint genes are rare in humans, though functional mutation of Bub 1,
BubR1, and the Zw10-ROD-Zwilch complex have been detected in human cancers
(Cahill et al., 1998; Hanks et al., 2004; Wang et al., 2004). Targeted deletion of Mad2,
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BubRl, CENPE, and Bub3 in mice has proven embryonic lethal in all cases with little
common evidence pointing to tumor promotion as a result of checkpoint failure. One
explanation for these results is that loss of an essential checkpoint gene yields massive
chromosome loss that is lethal in most mitoses. We observed that weak overexpression
of CMT2 causes an accelerated mitosis with obvious but not catastrophic chromosome
loss (Figure 3.2A). The majority of chromosomes congress and attach to the spindle in
GFP-CMT2 cells, and depletion of CMT2 does not alter attachment or spindle function.
Thus, we believe that these chromosomes missegregate not because of an attachment
defect but because CMT2 inhibition of Mad2 shortens prometaphase and metaphase and
overcomes the checkpoint. This phenotype requires only mild overexpression of GFP-
CMT2, as strong overexpression leads to the formation of GFP-CMT2 aggregates in
interphase, resulting in apoptosis (data not shown). Thus, we suggest that dysregulated
CMT2 expression might impair checkpoint activity sufficiently to induce mild
chromosome missegregation but not cell death. As discussed in Chapter 4, the CMT2
genomic locus is frequently amplified or translocated in human cancers, and careful
experimentation will be required to determine if this contributes to genomic instability
early in tumorigenesis.
3.4.5 Summary and conclusions
In summary, we show that CMT2 is a potent inhibitor of the human Mad2 spindle
checkpoint protein and is required for proper completion of mitosis. CMT2 colocalizes
with spindle checkpoint proteins in the cytosol and on unattached kinetochores and forms
complexes with Mad 1-Mad2 and Cdc20-Mad2 in vivo. Our data help to resolve the
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question of how multiple active pools of Mad2 can be efficiently regulated at different
cellular locations. More broadly, the work presented here highlights the essential nature
of checkpoint regulation in mitosis and questions the classic model of the spindle
checkpoint as a surveillance mechanism that is inactive in normal mitoses. Negative
regulation of the checkpoint is an unexplored avenue that promises to yield insight into
both the workings of the eukaryotic cell cycle and, perhaps, the early steps of tumor
progression.
3.5 Materials and methods
Generation of plasmids
Mad2 (EST Genbank ID R10991) was subcloned by PCR into pGEX-6P-2
(Amersham Biosciences) and pEGFPC I (Clontech). CMT2 (IMAGE clone 321778,
ATCC) was subcloned into pEGFPC1, pET28A, and pFBnHislOHA. CMT2-138 was
subcloned by PCR into pGEX-6P-2. The cDNA for mRFP, a kind gift of R. Tsien, was
fused to histone H2B in pCDNA3.1 (Invitrogen). All plasmids were confirmed by
sequencing.
Cell culture and antibodies
Polyclonal antibodies were raised in NZW rabbits against human CMT2 and
CMT21-'38 expressed in E. coli (Covance). A column of immobilized CMT21-'38 was
made with the SulfoLink kit (Pierce) for affinity purification of anti- CMT2 -138 immune
sera. Antibody dilutions for immunoblotting, immunofluorescence, and
immunporecipitation are in Supplementary Table 3.1.
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HeLa, Histone 2B-GFP HeLa, HeLa Histone 2B-mRFP, and HeLa CENPB-GFP
cells were generated and cultured as described (Meraldi et al, 2004). All siRNA oligos
were purchased from Dharmacon Research. The sequences for the CMT2 siRNA
duplexes are CMT2-1 (GGAGUUCUAUGAACUGGAC) and CMT2-3
(CUGUAAUCAUCGCUGAACA). Duplexes and RNAi for Lamin A (Elbashir et al.,
2001), Madl and Mad2 (Martin-Lluesma et al., 2002) and hNuf2R and BubRl(Meraldi et
al., 2004) have been described. HeLa cells were transfected with siRNA as described
(Elbashir et al., 2001) and analyzed 48 hours after transfection. GFP-CMT2 and GFP-
Mad2 were transiently expressed in HeLa Histone 2B-mRFP cells using Fugene 6 (Roche
Diagnostics) and cells analyzed 16 hours after transfection.
Immunoprecipitation and Immunoblotting
HeLa cells were arrested overnight in 200ng/mL nocodazole (Sigma), harvested
in lysis buffer (150mM NaCI, 0.5% NP-40, mM DTT, 10% glycerol, complete
phosphatase and protease inhibitors, 50mM Hepes pH 7.6, 1OO00M ATP, 2mM EDTA)
and clarified by centrifugation. Approximately 5-10 mg of cellular protein was pre-
cleared with protein A beads (Pharmacia) and incubated with antibody for 1 hour at 4°C
before addition of 20.iL protein A beads and incubation for 2-3 hours. Beads were
pelleted, washed in cold IP buffer, and boiled in 2x SDS sample buffer before SDS-
PAGE. Whole cell extracts were prepared by boiling cells in 2x SDS sample buffer with
15% p-ME before SDS-PAGE.
Microscopy
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Cells were fixed, permeabilized and blocked as described (Kapoor et al., 2000).
Cross-adsorbed secondary antibodies were used (Molecular Probes). Images were
acquired as described (Martinez-Exposito et al., 1999) and kinetochore fluorescence
intensities were calculated as described (Meraldi et al, 2004) .
Live cell imaging was performed in AT 0.15 mm-dishes (Bioptechs) in C0 2-
independent medium (GibcoBRL) at 37°C. 0.2s exposures were acquired every 3 min for
6 hr using a 20x NA0.75 objective on a Nikon Applied Precision Deltavision microscope
equipped with a Mercury 100W lamp, GFP-long pass filter set (for Histone 2B-GFP-Hela
cells) or a Sedat filter set (to follow GFP-proteins in Histone 2B-Red-Hela cells; Chroma)
and Coolsnap HQ camera. Point visitation was used to follow cells in multiple fields.
Interkinetochore distances were measured in unfixed HeLa GFP-CENP-B expressing
cells as described (Meraldi et al., 2004).
Estimation of anaphase entry half-lives
Anaphase entry half-lives were calculated by fitting cumulative frequency data
from live cell imaging by nonlinear least squares regression in the nlintool of Matlab 7.0
(The Mathworks). Observed half-lives were considered to be the sum of the observed lag
and the calculated t1/2.
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Table 3.1
Antibodies used
Antibody
anti-CMT2-N
anti-CMT2-FL
anti-Bub 1
anti-BubR1
anti-Mad2
anti-Mad2
anti-Madl
anti-actin
anti-p-tubulin
anti-cyclin A
anti-cyclin B 1
anti-Cdc20
CREST
in this study
Source
this study
this study
S. Taylor
S. Taylor
Covance
A. Burds
P. Meraldi
Sigma,
A2066
Sigma, Tub
2.1
Santa Cruz,
H-432
Santa Cruz,
GNS1
Santa Cruz,
E-7
Antibodies,
Inc
Supplemental Material
Supplemental Figure 3.1 depicts cumulative frequency data for anaphase entry times of
cells overexpressing GFP, GFP-Mad2, and GFP-CMT2. Supplemental Figure 3.2
summarizes checkpoint protein localization in control and CMT2 RNAi and presents
evidence that CENPE localization does not require CMT2. Supplemental Figure 3.3
demonstrates that CMT2 colocalizes with Bub 1 and that the siRNA duplex CMT2-3
abrogates CMT2 kinetochore localization.
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Antigen
hCMT2'1- 3 8
hCMT2
IP dilution
1:500
IF dilution
1-2gg/mL
1:500
0.3-1 pg/mL
1:1000
1:250
1:1500
WB
dilution
2gjg/mL
1:500
0.5-1 tg/mL
1:1000
1:500
1:1000
1:1000
1:1000
Organism
Rabbit
Rabbit
Sheep
Sheep
Rabbit
Rabbit
Rabbit
Rabbit
Mouse
Rabbit
Mouse
Mouse
Human
1:1000
1:500
1:500
1:1000
1:200
1:500
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Supplemental Figure 3.1: Anaphase entry kinetics of CMT2 and Mad2
overexpressing cells
HeLa Histone 2B-mRFP cells were transfected with GFP, GFP-CMT2, or GFP-Mad2
and the time from NBD to anaphase A was measured by fluorescence videomicroscopy
as in Figure 3.7.
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Supplemental Figure 3.2
Mad2 Mad1 Bubl CENP-E Cyclin B1
Mad2 Mad1 Bubl BubR1 Bub3 Mpsl CENP-E CENP-F
control prometaphase ++ ++ ++ ++ ++ ++ ++ ++
control metaphase - - + + + + ++ ++
CMT-2 RNAi prometaphase ++ ++ ++ ++ ++ ++ ++ ++
CMT-2 metaphase - - + + + + ++ ++
Supplemental Figure 3.2: Localization of checkpoint proteins in CMT2 RNAi
HeLa cells transfected with control or CMT2 siRNA were fixed and stained with
antibodies for checkpoint proteins as shown. Cell cycle phase was determined by DNA
and spindle morphology. Presence or absence of checkpoint proteins in Figure 3.3 and
Supplemental Figure 3.2 is summarized in the table. Images for CENP-F are not shown.
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Supplemental Figure 3.3
Prometaphase
Lamin A RNAi
Prometaphase
CMT2-1 RNAi
CMT2-3 RNAi
Supplemental Figure 3.3: Specificity of CMT2 kinetochore localization
To demonstrate that loss of CMT2 from kinetochores after CMT2 RNAi is not a specific
effect of the CMT2-1 siRNA, cells were transfected with control or CMT2-3 siRNA,
fixed, and stained for CMT2, Bubl, and DNA as in Figure 3. 4. CMT2 colocalizes with
Bubl in prometaphase.
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Chapter 4
Conclusions and Future Directions
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Analysis of spindle checkpoint combines many of the most interesting elements
of studying mitosis: elegant cell biology, challenging biochemistry, and the possibility of
linking basic processes with disease development. When I started my graduate work, the
connections between checkpoint proteins and their functions were just beginning to be
made. Few of the relevant proteins had been expressed or characterized and the lethality
of checkpoint gene deletion made it difficult, if not impossible, to probe a protein's
function by removing it from the cell. The basic question of how the checkpoint is
inactivated in higher eukaryotes remained largely unaddressed. Since then, many
interactions between checkpoint proteins have been discovered by indirect methods,
though few of them have been reconstituted in vitro or analyzed structurally. New genes
have been added to the spindle checkpoint, and the advent of RNAi has made it possible
for us to test the function of these genes in mammalian cells without gene targeting by
homologous recombination. At the same time, better imaging tools and software have
allowed us to probe protein function in single cells by watching the detailed movements
of mitotic chromosomes, giving us a far better understanding of mitosis than population-
based assays had yielded previously.
The work that I have presented in the preceding chapters answers basic questions
regarding the biochemistry and cell biology of the checkpoint protein Mad2 and its
regulator, CMT2. My findings serve to confirm certain notions of checkpoint signaling,
but also to call into question the idea of the spindle checkpoint as a passive surveillance
system. In this chapter I discuss these findings in the context of the field and propose
new models for checkpoint activation and inactivation. I also discuss the relevance of
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this work to genomic instability and tumorigenesis and propose future experiments for
understanding the spindle checkpoint.
4.1 Mad2 conformation and checkpoint signaling
The spindle checkpoint must sense either the structural state of kinetochore-
microtubule occupancy or a mechanical property of this interaction such as the tension
produced by microtubule pulling forces. Because of the short time span of mitosis and
the high cost of missegregation, the checkpoint must also be able to arrest the cell cycle
rapidly. As a result of these two facts, it was reasoned that conformational changes,
rather than post-translational modification, might provide a checkpoint signal that is both
rapid and coupled to changes in a kinetochore's mechanical properties. An early NMR
study of Mad2 implicated the C-terminal tail in ligand binding but was unable to resolve
the tail structure (Luo et al., 2000). Upon the discovery that Mad2 binds to Madl and
Cdc20, a critical question became how Mad2 binds upstream and downstream checkpoint
proteins. I mapped in detail the interactions of Mad2 with Madl and, identified a
minimal 9aa binding region, and explored the constraints on binding at each amino acid
position. My findings represent a refinement of earlier mapping efforts and allowed us to
construct an optimal Mad2-binding motif that is present not only in checkpoint proteins
but in experimentally validated non-checkpoint Mad2 interactors such as TACE, ER3,
and IR. In addition, I tested at the residue level predictions made by the Madl-Mad2 co-
crystal structure and extended them to Mad2-Cdc20 binding. These structural studies
posed two important questions: first, does Mad2 bind to its targets weakly, as suggested
by its dynamic localization and rapid activation, or tightly? Second, do Madl and Cdc20
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cooperate for Mad2 binding, as suggested by yeast genetics, or do they compete for a
common binding site? I next measured Madl-Mad2 and Cdc20-Mad2 interactions by
multiple biophysical assays and found them to be of higher affinity than previously
reported. I also demonstrated that these ligands compete for the same binding site on
Mad2 and their binding behavior is similarly affected by mutations in Mad2. In
agreement with later NMR studies, I found at low resolution that Mad and Cdc20
peptides induce similar conformations in Mad2.
Mad2 clearly switches conformations in the process of inhibiting Cdc20. The
finding that Mad and Cdc20 compete for Mad2 appears to contradict the requirement of
.Madl for Cdc20-Mad2 formation in yeast and frogs (Chung and Chen, 2002; Hwang et
al., 1998). This paradox may be partially resolved by the in vitro finding that O-Mad2
can dimerize with Mad 1-bound C-Mad2, potentially positioning O-Mad2 for association
with Cdc20 at kinetochores (De Antoni et al., 2005; Hagan and Sorger, 2005). As
discussed in Chapter 2, this model does not make clear how switching between open and
closed states is regulated or how the interaction of Mad2 and Cdc20 is made sensitive to
the status of the kinetochore. It will be critical to test dimerization-defective mutants in
both yeast and tissue culture cells, as well as to determine the structure of the O-Mad2-C-
Mad2-Madl complex.
Madl binds Mad2 with high affinity, and Madl is saturated with Mad2
throughout the cell cycle. How is the Mad2-Madl complex assembled in interphase?
Interconversion between the open and closed Mad2 conformers in isolation is extremely
slow (Luo et al., 2004), suggesting that Mad2 tail opening may require other factors such
as chaperones or a specific tail-regulating protein. Cdc20 is a conformationally unstable
175
protein that requires a specific chaperone, CCT, for stable expression and function
(Camasses et al., 2003). Madl is similarly difficult to express and purify and thus may
be a target for assisted folding and conformational regulation as well. It is notable that
the majority of studies, including those presented here, resort to the use of short Madl
and Cdc20 fragments. The Madl fragment in the Madl-Mad2 crystal structure
homodimerizes, and this dimerization imposes asymmetry on the two bound, closed
Mad2 molecules in the unit cell, but it is not known whether this is a crystal artifact, as
other domains of Mad 1 that are predicted to be near Mad2 could not be crystallized
(Sironi et al., 2002). A critical question for understanding Mad2 interactions in vivo is
whether other domains of Mad 1 or Cdc20 contribute to or affect Mad2 without being part
of the minimal binding motif.
While the conformational aspect of checkpoint signaling requires further
structural study, there is currently no way to assay Mad2 conformation in vivo. A major
advance in the field came with the first observation of dynamic Mad2 localization in cells
(Howell et al., 2000), and real-time measurements of Mad2 conformation would prove
equally illuminating. Fusion of fluorescent proteins at both termini has allowed
intramolecular FRET sensing of conformational changes in living cells and presents an
attractive method (Miyawaki and Tsien, 2000; Zhang et al., 2001). However, it remains
an open question whether fusion of a bulky fluorescent protein to the Mad2 C terminus
impairs tail closure. Real-time in vivo measurements of Mad2 conformation and the
dynamic interactions between spindle checkpoint proteins will be necessary to extend the
biochemical observations made here and by other groups.
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4.2 Checkpoint inactivation
Does checkpoint inactivation occur by an active process, by extinguishing
generation of checkpoint signal, or by sidestepping the requirement for Cdc20 activation?
Each of these theoretical models existed when I began this work, but there was no
experimental evidence for active silencing of the checkpoint or the idea that such
inactivation would be necessary in an unperturbed mitosis free of microtubule poisons.
The study of CMT2 presented here suggests not only that active inhibition is necessary
for checkpoint silencing but also that every mammalian mitosis depends on a proper
balance between simultaneous positive and negative regulation of the checkpoint.
Supporting this idea are recent findings that overexpression of checkpoint proteins such
as Mad2 in mammals and and Bub p or Mad3p in yeast can induce the very chromosome
instability against which these proteins are supposed to protect (Hernando et al., 2004;
Warren et al., 2002).
At a mechanistic level, previous models of checkpoint inactivation focused on
either sidestepping the spindle checkpoint by direct APC/C activation or removing Mad 1-
Mad2 complexes from the kinetochore by trafficking them onto the spindle or displacing
them with microtubules. Because closed Mad2 was presumed to be the activated state of
Mad2 in all cases, Mad2 inhibition might occur either by active tail opening or by
binding of a competitive ligand such as TACE that would sequester Mad2 and liberate
Cdc20. By focusing on simple inhibition of the closed Mad2 conformer, these
mechanisms fail to account for the dynamic localization of Mad2, the finding that both
kinetochore and cytosolic Mad2 function in the checkpoint (Chung and Chen, 2002), and
the heterodimerization of open and closed Mad2.
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Our work proposes that CMT2 is a versatile and potent Mad2 inhibitor that halts
generation of active Mad2 at kinetochores by inhibiting Mad2 dimerization on C-Mad2-
Madl complexes and inhibits cytosolic, Madl-free Mad2. This model rests initially on
our findings that CMT2 localizes to kinetochores and the cytosol and forms ternary
complexes with both Madl-Mad2 and Cdc20-Mad2 in vitro and in vivo. However, how
can we maintain that CMT2 is functional and not merely resident at both locations? Our
assertion that CMT2 inhibits Mad2 in the cytosol stems from the finding that CMT2
RNAi is sufficient to arrest cells in contexts where Mad2 does not localize to
kinetochores, i.e. Madl or Nuf2R RNAi. This result complements the discovery of a
Madl- and kinetochore-independent role for Mad2 in inhibiting Cdc20 early in
metaphase (Meraldi et al., 2004). It is not clear if this early Mad2 function involves
dimerization either at non-kinetochore sites such, as the nuclear pore, or on Cdc20-Mad2
complexes in the cytosol. De Antoni et al suggest that Mad2 dimerization may be
nucleated by Cdc20-Mad2 complexes, but this phenomenon has not been demonstrated in
vivo or in vitro (De Antoni et al., 2005). If C-Mad2 inhibits Cdc20 in the cytosol without
recruiting additional O-Mad2, how can CMT2 be proposed to inhibit this activity?
Central to this idea is a single experiment by Xia et al showing that a ternary CMT2-
Mad2-Cdc20 complex can activate APC/CCdc2 0 without disrupting Cdc20-Mad2 binding
(Xia et al., 2004). These in vitro APC/C activation assays have been simultaneously
illuminating and confusing for the field, given that they were the basis of the now-
disproven idea that higher order oligomers of Mad2 - which are now known to be
aggregates - represent the active state (Fang et al., 1998). While APC/C activation
assays have improved with time, our reliance on them highlights the need for in vivo and
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single-cell APC/C activity assays. Also, while a low resolution APC/C structure exists, it
has not revealed the basis of APC/C activation by Cdc20 and Cdhl and thus we cannot
envision a biochemical mechanism for how CMT2 reactivates inhibited Cdc20 (Gieffers
et al., 2001). Extensive work has shown that APC/C itself is the target of multiple
modifications, and its sensitivity to inhibition varies throughout the cell cycle (Kraft et
al., 2003; Sudakin et al., 2001). One possibility is that CMT2 recruits accessory proteins
that modify either Cdc20, Mad2, or core APC/C units, thus relieving inhibition without
displacing Mad2.
A basic feature of proteins required for checkpoint activation is their localization
to kinetochores and, in many cases, their dynamic shuttling between kinetochores and the
cytosol. In contrast with previous studies, we show for the first time that CMT2 resides
at kinetochores. We find that CMT2 is unique among examined proteins in that its
kinetochore localization requires Mad2. In chapter 3 we discuss the surprising result that
CMT2 is recruited to kinetochores in nocodazole-treated cells, which have an active
spindle checkpoint, and propose that pro- and anti-checkpoint signals are simultaneously
assembled at kinetochores to allow for rapid and tightly coupled checkpoint signaling. At
present, it is difficult to dissect apart kinetochore and cytosolic functions for many
proteins in mammalian cells. We examine cells depleted of CMT2 and other checkpoints
and infer the amount of Mad2 activity - and hence CMT2 activity - based on population
kinetics of anaphase entry. Confirming a function for CMT2 and other proteins at the
kinetochore will require more direct means of manipulating checkpoint protein
localization. It is currently possible to induce protein localization to a specific site such
as mitochondria or the cell membrane by attachment of minimal localization tags such as
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a CAAX motif (Bear et al., 2000), but no such kinetochore-localizing motifs are currently
known in either yeast or mammals. Forcing CMT2 onto kinetochores by fusion with
such a motif and then assaying for cell cycle progression in both unperturbed and
nocodazole-treated cells could provide a convincing test of whether kinetochore
localization contributes to Mad2 inhibition. Indeed, such an experiment would also
illuminate requirements for checkpoint activation. It remains an open question whether
the kinetochore localization of proteins such as BubRI, Bub 1, and Bub3 suffices for their
activation. Induced localization of wildtype and mutant checkpoint proteins would
constitute a useful tool for determining the requirements for checkpoint signaling.
Our data provide the first framework for understanding how Mad2 can be
inhibited at multiple sites by a single protein. It will be critical to determine if CMT2,
like Mad2, BubR1, and Cdc20, cycles through the kinetochore or if kinetochore and
cytosolic CMT2 are kept separate. Preliminary biochemical data exist to show that
CMT2 does, in fact, prevent the association of O-Mad2 with C-Mad2-Madl (M. Mapelli,
personal communication). There is now a pressing need to demonstrate this behavior in
vivo and to understand its structural basis. Are other components of the checkpoint such
as BubR1 or Bubl inhibited by proteins analogous to CMT2? BubR1 presents a special
problem in that it may require inactivation of both the Mad3-like N terminus and,
ostensibly, the kinase domain. Kinase inactivation may be modulated by CENP-E
conformation or displacement (Mao et al., 2003). Overexpression of BCSG1 protein
decreases BubRI levels in tissue culture cells, but it remains to be shown whether BubRI
degradation occurs and whether the kinetics of BubRi destruction are consistent with the
onset of anaphase (Gupta et al., 2003). Because low levels of BubR1 remain at
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kinetochores in metaphase and anaphase, BubRI inactivation likely involves multiple
steps.
4.3 Checkpoint activation and conformational inhibition of Cdc20
There are at least seven documented mechanisms by which cells inhibit Cdc20
directly to delay the metaphase-anaphase transition. Mad2, BubRI, the MCC complex,
and RASSF A each inhibit Cdc20 by binding to it (Fang, 2002; Hwang et al., 1998; Song
et al., 2004; Sudakin et al., 2001). Bubl, PKA, and Cdkl/cyclin B all phosphorylate
Cdc20 and impair its ability to activate APC/C (Searle et al., 2004; Tang et al., 2004;
Yudkovsky et al., 2000). Cdc20 thus integrates signals from at least two checkpoints
(spindle assembly and DNA damage) and the core cell cycle machinery. Because Cdc20
has proven difficult to purify and characterize in vitro, little is known at the residue or
atomic levels about the mechanisms by which it activates APC/C, specifies substrates for
ubiquitination, or is inhibited by checkpoint protein binding. Structural and biophysical
studies have not yet identified conformational changes in Cdc20, and NMR analysis has
been limited to the N terminal domain (Luo et al., 2000).
While it is known that the spindle checkpoint inhibits Cdc20, multiple active
checkpoint complexes have been identified and their relative contributions to checkpoint
activation in vivo remain unknown. Direct Cdc20-inhibitory activity has been
demonstrated in vitro for Mad2, BubRI, Bubl, and MCC and is suspected for Mpsl, but
depletion of single proteins inactivates the checkpoint, suggesting that each protein is
necessary but no one protein or complex is sufficient for Cdc20 inhibition in vivo. In
addition, it has long been suspected that successful checkpoint arrest by a single
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unattached kinetochore must involve amplification of the signal generated at that
kinetochore. Recent mathematical models suggest that on-kinetochore signal generation
without amplification cannot explain the kinetics of cell cycle arrest and progression
(Doncic et al., 2005). Despite fifteen years of spindle checkpoint research, two major
questions still loom: what is the active "wait anaphase" signal and how does it inactivate
Cdc20? Below, I propose a model of allosteric, conformational Cdc20 inhibition that
synthesizes work in this laboratory and others as well as ways of validating this model.
4.4 Cooperative inhibition of Cdc20
Despite the difficulty of working with Cdc20, important details of its structure
and biochemical behavior have emerged. (1) Cdc20 has two domains, a C-terminal WD
domain that is responsible for substrate specificity and an N-terminal domain (Cdc201-
165). (2) Cdc20 is conformationally labile and requires a chaperone for proper expression
and function (Camasses et al., 2003). (3) Mad2 binds Cdc20 in a portion of the N
terminus that is adjacent to the WD domain boundary, which we will term the "neck"
between domains. (4) BubR1/Mad3p binds Cdc20 but the binding region has not been
identified. (5) Bub 1 phosphorylates Cdc20 at up to six positions in the N terminal
domain, and these phosphorylations are inhibitory for APC/C activation (Tang et al.,
2004). (6) Cdc20 phosphorylation by several possible kinases is required for spindle
checkpoint activity (Chung and Chen, 2003). (7) As observed in this and other labs, full
length Cdc20 binds Mad2 in vitro with lower affinity than isolated Cdc20-1'6 5 (R. Hagan,
data not shown, Tang et al., 2001; Zhang and Lees, 2001).
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Cdc20 is an unstable and often insoluble protein. Observation (7) suggests that
the C-terminal WD domain partially inhibits binding of the N-terminal domain to ligands
such as Mad2. The WD domain may impair Mad2 binding either directly by steric
occlusion of the Mad2-binding motif or indirectly by inducing a binding-incompetent
conformation without actually masking the site. On the basis of these observations, I
propose a model in which Cdc20 inhibition involves four steps, each of which is
cooperative with the others: phosphorylation of the Cdc20 N terminus by Bubl or other
kinases; binding of Mad2 to the "neck" between Cdc20's two domains; binding of
BubR 1/Mad3p to either the WD or N-terminal domain of Cdc20; and dissociation of the
Cdc20 N terminal and WD domains (Figure 4.1). This model is reliant upon the
unproven idea that the Cdc20 N-terminal and C-terminal domains undergo intramolecular
association; each inhibitory event serves to prop open the closed Cdc20 structure, thus
promoting each of the other inhibitory events.
How might this model explain spindle checkpoint activation at kinetochores?
Mad2, Cdc2O, and BubR1 cycle through kinetochores with nearly equal kinetics, but it is
not known whether they cycle as monomers or a complex. The fast phases of Cdc20 and
BubR1 flux are close to the rate of diffusion, suggesting that the rapidly fluxing pool of
each either is not binding the other during its short transit time on the kinetochore or is
already bound in the cytosol (Howell et al., 2004). As a result, some additional
regulatory step or steps must promote association of Cdc20 and BubR1 as they pass
through unattached kinetochores. As for Mad2, it is clear that simple co-localization of
O-Mad2 and Cdc20 at kinetochores is not sufficient to render Cdc20-Mad2 binding
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Figure 4.1
Figure 4.1: A cooperative model for spindle checkpoint activation
The N-terminal and WD domains of Cdc20 may undergo intramolecular
association. Phosphorylation by Bub (top), binding of Mad2, or binding of
BubR /Mad3 disrupts the interdomain interaction. Dissociation of the domains by any
one event promotes the other two events by making their target surfaces more accessible.
Complete inhibition of Cdc20 is the sum of catalytic phosphorylation and stoichiometric
binding.
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sensitive to kinetochore-microtubule status, as these pools colocalize in the cytosol
regardless of the state of the checkpoint. While it remains possible that each checkpoint
protein occupies a distinct site on the kinetochore surface, there is evidence at least in
fission yeast that the two scaffolding complexes, Madl and
Bub 1, exist in a single complex that is required for checkpoint activation (Brady and
Hardwick, 2000). This suggests that the loci of Cdc20 phosphorylation by Bub 1 and
Cdc20 binding by Mad2 are closely apposed on the kinetochore and thus these events
may be spatially coupled.
This conformational model of Cdc20 inhibition predicts first that the Cdc20 N-
and C-terminal domains associate and, second, that phosphorylation of the N-terminus
inhibits this association. Cdc20 phosporylation sites are closely bunched and distributed
across the N-terminal domain, but they do not conform to a discernible consensus (Chung
and Chen, 2003; Tang et al., 2004). This suggests that these phosphorylations "paint" the
N-terminus with negative charge rather than causing a local alteration of the surface that
directs specific protein-protein interactions. The immediate predictions of this model
regarding intramolecular Cdc20 interactions can be tested in vitro using recombinant
Cdc2Ot '- 6 5 and Cdc20WD. An equally important task is determining the binding site on
Cdc20 for BubRI, though binding to either domain or a region near the Mad2-binding
motif fits within the model. As mentioned previously, understanding the dynamics of
Cdc20 conformation in vivo requires the development of better tools for probing protein
conformation in living cells. Like Mad2, Cdc20 is a prime candidate for intramolecular
FRET analysis (Miyawaki and Tsien, 2000). Of particular interest will be the role of the
chaperonin CCT, which is required for Cdc20 function in budding yeast. CCT, also
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known as TRiC or TCP 1, is conserved in humans but its role in mammalian mitosis has
not been examined. Cdc20 is positioned as the node for integrating multiple signals that
drive and dampen cell cycle progession, and I propose that it does this by a
conformational plasticity that mirrors that of its inhibitor Mad2.
4.5 CMT2 regulation
In chapters 2 and 3, 1 propose and test the idea that by opposing Mad2 activity,
CMT2 acts to switch off the spindle checkpoint. CMT2 is positioned at kinetochores in
prometaphase when the spindle checkpoint is active, as well as when cells are treated
with nocodazole. What flips this CMT2 switch upon kinetochore-MT binding? We are
only beginning to explore CMT2 regulation, but several possibilities are immediately
evident. Cell synchrony experiments suggested that CMT2 expression is cell cycle-
regulated, with levels rising as cells enter mitosis and then falling during telophase (Habu
et al., 2002). However, CMT2 protein remains detectable throughout the cell cycle, and
Northern blot analysis detected CMT2 mRNA in almost all tissues regardless of
proliferative status (Figure 1.4). A general observation of cell cycle research is that
inhibitors of cell cyle progression such as Cdk inhibitors (CDKIs) or checkpoint proteins
are often expressed throughout the cell cycle, while promoters of progression such as
cyclins, Cdc20, or Cdhl are only expressed during a narrow window of time. Regulation
of the spindle checkpoint by controlled expression of CMT2 would thus fit with our
understanding of cell cycle progression, and it will be necessary to determine the
transcriptional program of CMT2 expression. However, simply controlling the levels of
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CMT2 in the cell does not seem sufficient to create a rapid and sensitive "go anaphase"
signal.
The other common themes of mitotic regulation are post-translational
modification and regulated protein-protein binding. CMT2 interactors other than Mad2
have not been identified. Modification of CMT2 is not necessary for Mad2 binding or
reactivation of APC/CCdc2O, as shown by the activity of bacterially-expressed recombinant
CMT2. I have begun searching for modifications of CMT2. As presented in Appendix 1,
CMT2 undergoes a phosphatase-sensitive shift in electrophoretic mobility when HeLa
cells are treated with nocodazole. I have since found that CMT2 is an extremely efficient
substrate of Bub 1 but not Mps 1, and CMT2 phosphorylation by recombinant Bub 
exceeds that of the sole published substrate, Cdc20. With the help of Mustafa UnlQ, I
have mapped the Bub 1 phosphorylation site on human CMT2 by mass spectrometry to a
highly conserved threonine, T211. CMT2 pT211 phosphopeptides have been detected in
checkpoint-arrested cells (data not shown). On the basis of these preliminary results, I
propose that Bub 1 inactivates CMT2 under conditions of checkpoint activity by
phosphorylating it. This is the first evidence that checkpoint activation in higher
eukaryotes involves simultaneous inactivation of a negative signal. This idea fits well
with our finding that CMT2 associates with kinetochores in prophase, positioning it near
both its substrate (Mad2) and regulatory inputs (Bubl). This model also fits neatly with
the long-held observation that kinetochore phosphorylation corresponds with cell cycle
arrest while phosphatase activity is required for anaphase entry (Campbell and Gorbsky,
1995; Gorbsky and Ricketts, 1993; Nicklas et al., 1995).
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How might phosphorylation inhibit CMT2 function? At least two obvious models
must be tested. First, phosphorylation by Bub 1 may inhibit CMT2-Mad2 binding. While
this is possible, the strong Mad2-dependent localization of CMT2 to kinetochores in
nocodazole arrest suggests that it is not the case. The CMT2-Mad2-Cdc20 ternary
complex activates APC/C even though CMT2 alone does not (Xia et al., 2004), and a
second model is that phosphorylation of CMT2 blocks this activation. In addition to
searching for modification at sites other than T211, I have constructed mutants that
mimic the unphosphorylated and phosphorylated states of CMT2 and plan to test them
for Mad2 binding, kinetochore localization, and cell cycle progression effects. The
regulation of CMT2 is an extremely exciting area that will illustrate the complexity of
mitotic regulation in higher eukaryotes.
4.6 Spindle checkpoint dysfunction and cancer
Aneuploidy has been known as a common characteristic of solid tumors since the
observations of Theodor Boveri (Boveri, 1914). Tumor aneuploidy may reflect a causal
role for chromosome missegregation in genomic instability or it may result from
disregulation of the cell cycle after cellular transformation. A large body of work has
been dedicated to determining a causal role for spindle checkpoint dysfunction in
tumorigenesis but the link between aneuploidy and cancer is still mysterious. After initial
reports of spindle checkpoint gene mutation in human cancers (Cahill et al., 1998),
further studies have found that such mutations are in fact quite rare (Draviam et al., 2004;
Musacchio and Hardwick, 2002). Familial biallelic mutations in BubR1 give rise to
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mosaic variegated aneuploidy, a pleiotropic disease that is associated with strong cancer
predisposition much like inherited mutations in DNA checkpoint proteins (D'Andrea and
Grompe, 2003; Hanks et al., 2004). In all cases reported thus far, targeted deletion of
checkpoint genes causes embryonic lethality, as the massive chromosome loss observed
leads invariably to widescale mitotic catastrophe and apoptosis (Dobles et al., 2000;
Kalitsis et al., 2000; Wang et al., 2004a; Weaver et al., 2003). Mice heterozygous for
Mad2 deletion develop lung papillary adenocarcinoma late in life (Michel et al., 2001).
This tumor is extremely rare in humans and it is not clear how decreased Mad2
expression specifically primes tumorigenesis in the lungs. Bub3 heterozygotes exhibit
chromosome instability but do not develop tumors, though this may simply reflect the
suspected redundancy of Bub3 with the protein Rael (Babu et al., 2003; Kalitsis et al.,
2005). Very strikingly, mice carrying a hypomorphic BubR1 allele exhibit an accelerated
ageing phenotype but do not develop cancer (Baker et al., 2004). When combined with
cell biological data, these studies suggest that successful mitosis in mammals depends on
accurate checkpoint signaling, and frank loss of a checkpoint protein is rarely, if ever,
permissive for survival. How then might spindle checkpoint dysfunction contribute to
cancer development?
One way in which the spindle checkpoint might fail is by altered expression of
checkpoint genes. The transcriptional control of most checkpoint genes is not known, but
genes such as p53, BRCA1, FoxMl and E2F family members have been implicated in
controlling both basal checkpoint gene expression and upregulation of some checkpoint
genes following upstream stress or DNA damage (Hernando et al., 2004; Laoukili et al.,
2005; Oikawa et al., 2005; Ren et al., 2002; Seike et al., 2002; Wang et al., 2004b). The
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simplest hypothesis is that transcriptional dysregulation or epigenetic silencing would
lower expression of a critical checkpoint gene below the threshold required for
checkpoint function but perhaps above the threshold required for cell viability.
Intriguingly, evidence has begun to accumulate that some human cancers overexpress
spindle checkpoint proteins (Li and Zhang, 2004; Wu et al., 2004). This phenotype may
be secondary to unrestrained proliferation. However, experiments in yeast and some
mammalian systems suggest that the mitotic arrest caused by Mad2 or Mad3p
overexpression is impermanent and leads ultimately to genomic instability. In this case,
either under- or overexpression of checkpoint proteins may drive chromosome instability.
It is also possible that spindle checkpoint dysfunction occurs only transiently in
the life a cell undergoing transformation. This little-considered hypothesis is supported
by the finding that overexpression of the CDKI p21 represses the expression of BubR1,
Mad2, and CENP-F (Chang et al., 2000). Although several other critical checkpoint
genes were not examined, the authors found that p21 overexpression decreases transcript
levels for both checkpoint genes and genes controlling mitotic progression, such as Cdc2
and cyclin B 1. The cell cycle arrest imposed by p21 is dependent on the tumor
suppressor p16 for its maintenance (Stein et al., 1999). Mutations of p21 are extremely
rare in human cancers, but p 16 is frequently inactivated by mutation or deletion and such
cells slip through p21-induced arrest. After release from p21 arrest, expression of
mitosis-promoting genes such as cyclin B 1 and Cdc2 recovers before checkpoint gene
expression. These cells accumulate mitotic abnormalities and missegregate their
chromosomes with high frequency and a high incidence of aneuploidy, suggesting that
their spindle checkpoints are compromised. Confirmation of the idea that p21 arrest
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transiently impairs the checkpoint while still allowing mitotic progression requires further
experimentation and careful analysis.
A third way in which cells may lose their spindle checkpoint on the road to cancer
is viral inhibition. At least two transforming viruses have been shown to interact with the
spindle checkpoint. Human Mad l was initially cloned as a binding partner of the viral
oncoprotein Tax from human T cell leukemia virus type I (Jin et al., 1998). Expression
of Tax leads to multinucleation and polyploidy, but the contribution of Madl to adult T
cell leukemogenesis has not been examined. In addition, the large T antigen of simian
virus 40 binds Bubl, and large T expression overrides the spindle checkpoint (Cotsiki et
al., 2004). These findings are consistent with the well-established idea that tumor-
promoting viruses such as SV40 and HPV are known to target multiple cell cycle control
pathways simultaneously.
A fourth way in which the spindle checkpoint can fail without mutation of its
components is by overexpression or overactivity of a negative regulator. I demonstrate in
chapter 3 that even mild overexpression of CMT2 causes errors of chromosome
segregation. Human CMT2 is expressed from a locus on chromosome 6p2 1.1 (Chapter 1,
Figure 1.4). This locus is a frequent site of translocation and both high- and low-level
amplification in many human tumors across a wide spectrum of tumor types (Bergsagel
and Kuehl, 2001; Furge et al., 2005; Man et al., 2004; Rigaud et al., 2001). Previous
investigation of the role of 6p21 in tumorigenesis has focused on neighbors that flank
CMT2 on either side: cyclin D3, VEGF, and the slightly more distant MHC cluster.
Because CMT2 was only recently identified as a spindle checkpoint regulator, its
expression in 6p21-amplified or translocated tumors has not been examined. The
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possibility of CMT2's involvement in tumorigenesis is particularly intriguing when a
historical analogy is drawn between the spindle checkpoint and cyclin/Cdk signaling.
Upon the discovery that cyclins and Cdks controlled entry into mitosis, there was
widespread suspicion mutation in cyclin/Cdk genes might cause cancer. Intense search
efforts found that mutation or amplification of these genes is quite rare, with a few
notable exceptions such as cyclin D3. Subsequent research uncovered a second level of
cyclin regulation by the CDKI proteins such as p16 and p21. A major breakthrough came
with the realization that CDKI genes are frequently mutated in human cancers and these
mutations are critical steps in the pathway towards genomic instability and malignancy
(Kamb et al., 1994; Liggett and Sidransky, 1998; Lloyd et al., 1999). Discovery of a
second level of spindle checkpoint regulation has just begun with the identification of
BCSG1 and CMT2, negative regulators of BubR1 and Mad2, respectively. BCSG1 was
first identified as a gene that is overexpressed in breast tumors (Gupta et al., 2003).
These proteins and the mechanism by which they function in checkpoint regulation
provide a promising route to understanding the causes of chromosome instability.
4.7 Conclusions
The work I present here synthesizes biochemical and cell biological analysis to
reveal a central role for negative regulation of the spindle checkpoint in mammalian
mitosis. I argue that silencing of the checkpoint by proteins such as CMT2 is required for
mitotic progression and examine the mechanism by which CMT2 opposes Mad2. My
work raises questions concerning the molecular nature of the "wait anaphase" checkpoint
signal and provides a way forward in determining how such signals are transmitted and
192
modulated. However, the work here also points to problems that currently afflict the
field. Checkpoint components are often expressed in low abundance, and proteins such
as Bubl, BubR1, Cdc20, and even CMT2 have proven extremely difficult to characterize
biochemically. Checkpoint genes in higher eukaryotes do not yield easily to genetic
analysis, and there is a paucity of structural information in the field. Progress in
understanding the spindle checkpoint will require the identification of checkpoint kinase
substrates, dynamic analysis of the many complexes involved in checkpoint signaling, a
better understanding of the lesions detected by the checkpoint, and the development of
tools to follow checkpoint activity in individual living cells.
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Cell biology: The more MAD, the merrier
ROBERT S. HAGAN AND PETER K. SORGER
Cells must pass the correct number of chromosomes to their progeny through the
complex ballet of cell division. An unusual conformation-sensitive switch seems to
maintain accurate chromosome segregation.
The maintenance of normal chromosome number during cell division requires the
precise separation of duplicated sister chromosomes into two equal sets. Andrea
Mussachio and colleagues', writing in Current Biology, shed light on how a protein
called Mad2 ensures the fidelity of this process. The authors propose that two different
structural forms of Mad2 collaborate to change one of the partners from an inactive to an
active state. Such 'self-templated' changes in protein conformation are a characteristic of
prions, but represent a new mechanism for cell signalling.
To achieve the correct separation, each chromosome is attached through the
multi-protein 'kinetochore' complex to an intracellular scaffold called the spindle. In the
'anaphase' stage of cell division, this structure pulls the sister chromosomes apart to form
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two groups at opposite ends of the cell, each with one sister from each chromosome pair.
The two groups will be surrounded by membranes to become the nuclei of the daughter
cells. The onset of anaphase is blocked until all chromosomes are bound correctly to the
spindle. Defects in the proteins that make up this blockade (or 'spindle checkpoint') lead
to abnormal chromosome numbers in the daughter cells, with potentially disastrous
consequences - many tumour cells, for example, have abnormal chromosome
complements. The spindle checkpoint activates a cascade of signals that converge on
Cdc20, a protein that regulates the anaphase-promoting complex (APC)2. If even a single
kinetochore remains unattached to the spindle, a diffusible signal is generated that is
sufficient to restrain Cdc20 and block cell division at the start of anaphase for many
hours3. But the nature of the signal and the mechanism by which it is propagated remain
elusive.
Two highly conserved Cdc20-binding proteins, Mad2 and BubRI, are essential to
inhibit APC (and therefore anaphase). These attach to kinetochores early in cell division,
and dissociate as the kinetochore attaches to the spindle, but they persist on the
kinetochores of misoriented or unattached chromosomes (reviewed in ref.2). Cdc20,
Mad2 and BubRI cycle rapidly on and off kinetochores, suggesting that they might be
part of the diffusible checkpoint signal3 4.
Previous studies have focused on the ability of Mad2 to bind to Cdc20 and the
checkpoint protein Madl. The Madl-Mad2 interaction localizes Mad2 to kinetochores
and seems to occur early in the checkpoint pathway, whereas the binding of Mad2 to
Cdc20 blocks APC activation and happens later in the checkpoint cascade (for review see
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ref. 2). Upon associating with Madl or Cdc20, the carboxy-terminal tail of Mad2
rearranges from a disordered 'open' conformation (OMad2) to a closed conformation
(CMad2), thereby encircling Madl or Cdc20 peptides like a safety belt5' 6 . Madl and
Cdc20 compete for the same binding site on Mad2 but, paradoxically, Madl is required
for the formation of Cdc20-Mad2 complexes in vivo. The high stability of Madl-Mad2
complexes and the slow spontaneous interconversion of OMad2 and CMad2 seem at odds
with the rapid kinetics of checkpoint signalling.
De Antoni et al. use Mad2 mutants locked into open and closed conformations to
show that two Mad2 molecules participate in this complicated dance. Mad2 variants
lacking ten amino acids at the carboxy terminus cannot close the safety belt, are stuck in
the open state and do not bind to Madl or Cdc20. However, the authors show that
'always-open' Mad2 can bind stably to Madl-CMad2 complexes. Strikingly, OMad2 and
CMad2 can partner each other, but two molecules of the same conformation cannot
associate. In cells, the always-open OMad2 localizes to kinetochores when normal Mad2
is present, but it cannot engage the checkpoint, presumably because it cannot bind
directly to Cdc20. Importantly, Mad2 mutants that cannot form partnerships with other
Mad2 molecules do not bind to Mad 1-CMad2, localize to kinetochores or support
checkpoint fimnction.
From these data, the authors propose a model in which 'core' complexes of Madl-
CMad2 increase the concentration and stability of OMad2 at kinetochores (Fig. 1). When
the checkpoint is activated, the OMad2 in Madl-CMad2-OMad2 complexes can be
transferred to Cdc20, closing up to form Cdc20-CMad2. Such complexes prevent APC
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Figure 1
Mad2 encloses Madl to form a stable complex. Open-conformation Mad2 (OMad2)
molecules bind to and are released from the Madl-Mad2 complex in a cyclic fashion. At
kinetochores (brown) that lack microtubule attachment, the OMad2 molecule encloses
and binds activated Cdc20 (black), a step that may be promoted by the phosphorylation
(PP) of Cdc20. The resulting closed Mad2 (CMad2)-Cdc20 complex inhibits anaphase-
promoting complex (APC) and may bind BubRI and Bub3. This complex may also act as
a template for the formation of more CMad2-Cdc2O complexes from the cytosolic pool of
OMad2, amplifying the checkpoint signal. Multiple protein complexes may be
responsible for APC inhibition; their exact composition remains unknown.
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activation and thus arrest cell division. This is a striking shift from previous models in
which just a single CMad2 molecule bound to Madl before unfolding its safety belt and
transferring to Cdc20. This new model fits neatly with data showing that two distinct
pools of Mad2 associate with kinetochores: one that remains stably bound throughout cell
division, and one that continuously binds and dissociates with a half-life of about 20
seconds3, 7. As predicted by the model, Cdc20 also cycles on and off kinetochores with
similar kinetics, whereas Madl does not.
Despite the elegance of De Antoni and colleagues' model, many questions remain
unanswered. It is not clear how kinetochore-spindle attachment regulates Mad2-mediated
checkpoint signalling. Also unknown is the molecular nature of the diffusible signal; De
Antoni et al. suggest that Cdc20-CMad2 may constitute this signal and may act as an
amplifier by binding to and activating other OMad2 molecules. Finally, the notion that
Mad2 can inhibit Cdc20 only after being activated by Madl does not explain how
cytosolic Mad2 regulates Cdc20 early in the cell cycle in a Madl-independent manner 8.
One promising approach to tackling these issues is to focus on Cdc20. Cdc20 is found
in cells in association with Mad2, and two other proteins, BubRl and Bub3 (ref. 9), and is
phosphorylated at multiple sites. Intriguingly, Mad2 binds tightly in vitro to Cdc20 in the
absence of any other proteins (most notably Mad 1). In vivo, however, Mad2 requires
kinetochores that are not attached to the spindle to bind to Cdc20, implying that access to
the Mad2-binding site on Cdc20 is regulated. One possible regulator is BubRl, which is
required for both the kinetochore-dependent and kinetochore-independent functions of
Mad2. An attractive possibility is that all of these inputs regulate a transition in Cdc20
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between conformations that are susceptible to Mad2-dependent inhibition and those that
are resistant. Although much remains to be learned about Cdc20 and the spindle
checkpoint in general, the work of De Antoni et al. highlights the central role of Mad2 in
guiding a cell through cell division with all of its chromosomes in order.
1. De Antoni, A. et al. Curr. Biol. 15, 214-225 (2005).
2. Rieder, C. L., Cole, R. W., Khodjakov, A. & Sluder, G. J. Cell Biol. 130,
941-948 (1995).
3. Howell, B. J., Hoffman, D. B., Fang, G., Murray, A. W. & Salmon, E. D. J. Cell
Biol. 150, 1233-1250 (2000).
4. Musacchio, A. & Hardwick, K. G. Nature Rev. Mol. Cell Biol. 3, 731-741 (2002).
5. Luo, X., Tang, Z., Rizo, J. & Yu, H. Mol. Cell 9, 59-71 (2002).
6. Sironi, L. et al. EMBO J. 21, 2496-2506 (2002).
7. Shah, J. V. et al. Curr. Biol. 14, 942-952 (2004).
8. Meraldi, P., Draviam, V. M. & Sorger, P. K. Dev. Cell 7, 46-60 (2004).
9. Sudakin, V., Chan., G. K. & Yen, T. J. J. Cell Biol. 154, 925-936 (2001).
206
